UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


___________________________

FORM 10-K


___________________________

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended June 30, 2019
 OR
☐   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from             to             

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June 30, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number 000-27548



LIGHTPATH TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

___________________________

DELAWARE86-0708398

LIGHTPATH TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

___________________________

Delaware

86-0708398

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No)

http://www.lightpath.com

http://www.lightpath.com

2603 Challenger Tech Court, Suite 100

Orlando, Florida 32826

(407) 382-4003

(Address of principal executive offices, including zip code)

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common

Stock,CommonStock, par value $0.01

LPTH

LPTH

The Nasdaq Stock Market, LLC

Securities registered pursuant to Section 12(g) of the Act:

Series D Participating Preferred Stock Purchase Rights

(Title of Class)


___________________________

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES NO No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. YES NO No

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YESYes ☒    NO 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YESYes ☒ NO ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.    

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer”, “accelerated filer”, “non-accelerated filer,”  “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer

Accelerated filer

Non-accelerated filer ☒Filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 in the Exchange Act). YES NO ☒.

The aggregate market value of the registrant’s voting stock held by non-affiliates (based on the closing sale price of the registrant’s Class A Common Stock on The NASDAQ Capital Market) was approximately $30,121,560$64,792,006 as of December 31, 2018.

2021.

As of September 9, 2019,2022, the number of shares of the registrant’s Class A Common Stock outstanding was 25,827,265.

27,071,929.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Proxy Statement for the Fiscal 20202022 Annual Meeting of Stockholders are incorporated by reference in Part II and Part III.


LightPath Technologies, Inc.
Form 10-K
Table of Contents

 

LightPath Technologies, Inc.

Form 10-K

Table of Contents

PART I

4

Business

4

Item 1A.

Risk Factors

14

Item 2.

Properties

23

Item 3.

Legal Proceedings

23

PART II

24

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

24

Management’s Discussion and Analysis of Financial Condition and Results of Operations

24

Financial Statements and Supplementary Data

37

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

38

Controls and Procedures

38

Other Information

38

PART III

39

Directors, Executive Officers and Corporate Governance

39

Executive Compensation

39

Security Ownership of Certain Beneficial Owners and Management

39

Certain Relationships and Related Transactions, and Director Independence

39

Principal Accountant Fees and Services

39

PART IV

40

Exhibits, Financial Statement Schedules

40

Form 10-K Summary

43

F-1

Signatures

S-1

 
2

Table of Contents

CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS

Certain statements and information in this Annual Report on Form 10-K may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events, or performance, statements related to the expected effects on our business from the coronavirus (“COVID-19”) pandemic, and underlying assumptions and other statements, which are not statements of historical facts.  In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue,” or other comparable terminology.  These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us.  While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate.  Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements.  Forward-looking statements represent management’s beliefs and assumptions only as of the date of this Annual Report on Form 10-K.  You should read this Annual Report on Form 10-K completely and with the understanding that our actual future results may be materially different from what we expect.  Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

PART

3

Table of Contents

PART I

Item 1. Business.

Business.

General

Our Company

LightPath Technologies, Inc. (“LightPath”, the “Company”, “we”, “our”, or “us”) was incorporated under Delaware law in 1992 as the successor to LightPath Technologies Limited Partnership, a New Mexico limited partnership formed in 1989, and its predecessor, Integrated Solar Technologies Corporation, a New Mexico corporation formed in 1985.  Today, LightPath is a global company with major facilities in the United States, the People’s Republic of China and the Republic of Latvia.  Our capabilities include precision molded optics, thermal imaging optics and custom designed optics. These capabilities allow us to manufacture optical components and higher-level assemblies, including precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses and other optical materials used to produce products that manipulate light.  We design, develop, manufacture and distribute optical components and assemblies utilizing advanced optical manufacturing processes. We serve a wide and diverse number of industries including defense and security, optical systems and components, datacom/telecom, information technology, life sciences, machine vision and production technology. Our products are incorporated into a variety of applications by our broad and diverse customer base. These applications include defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunication optical networks, machine vision and sensors, among others. All the products we produce enable lasers and imaging devices to function more effectively.  For example:

Molded glass aspheres and assembliesare usedcorporate headquarters is located in various high-performance optical applications primarily based on laser technology;
Infrared molded lenses, diamond turned, conventional and CNC ground and polished lenses and assembliesusing short (“SWIR”), mid (“MWIR”) and long (“LWIR”) wave transmitting materials are used in applications for firefighting, predictive maintenance, homeland security, surveillance, automotive, cell phone infrared cameras, pharmaceutical research & development and defense; and
Collimator assembliesare used in applications involving light detection and ranging (“LIDAR”) technology for advanced driver assistance systems and autonomous vehicles, such as fork lifts and other automated warehouse equipment.
The Company has robust and innovative manufacturing technologies and is vertically integrated from optical design through testing. Manufacturing strengths include the ability to use multiple optical glasses (visible and infrared spectrums), multiple lens fabrication methods (precision molding, single point diamond turning, and both conventional and CNC grind and polish), anti-reflective coatings, wear resistant coatings (such as diamond-like carbon or “DLC”), assembly and test.
Orlando, Florida.

Subsidiaries

InNovember 2005,we formedLightPath Optical Instrumentation (Shanghai) Co., Ltd (“LPOI”), a wholly-owned subsidiary, located in Jiading, People’s Republic of China.  The LPOI facility (the “Shanghai Facility”) is primarily used for sales and support functions.


In December 2013, we formed LightPath Optical Instrumentation (Zhenjiang) Co., Ltd. (“LPOIZ”), a wholly-owned subsidiary located in the New City district, of the Jiangsu province, of the People’s Republic of China.  LPOIZ’s manufacturing facility (the “Zhenjiang Facility”) serves as our primary manufacturing facility in China and provides a lower cost structure for production of larger volumes of optical components and assemblies. Late in fiscal 2019, this facility was expanded from 39,000 to 55,000 square feet to add capacity for polishing to support our growing infrared business.

In December 2016, we acquired ISP Optics Corporation, a New York corporation (“ISP”), and its wholly-owned subsidiary, ISP Optics Latvia, SIA, a limited liability company founded in 1998 under the Laws of the Republic of Latvia (“ISP Latvia”).  ISP is a vertically integrated manufacturer offering a full range of infrared products from custom infrared optical elements to catalog and high-performance lens assemblies.  Historically, ISP’s Irvington, New York facility (the “Irvington Facility”) functioned as its global headquarters for operations, while also providing manufacturing capabilities, optical coatings, and optical and mechanical design, assembly, and testing. InSince June 2019, we completed the relocation of thisISP’s manufacturing facility tooperation has been located at our existing facilitiescorporate headquarters facility in Orlando, Florida and Riga, Latvia.(the “Orlando Facility”).  ISP Latvia is a manufacturer of high precision optics and offers a full range of infrared products, including catalog and custom infrared optics.  ISP Latvia’s manufacturing facility is located in Riga, Latvia (the “Riga Facility”).

Recent Organizational

Industry

We and Strategic Initiatives

To ensureour customers support a wide range of industries, including automotive, telecommunications, defense, medical, bio-technology, industrial, consumer goods and more.  A commonality among these industries is the use of photonics as an enabling technology in their products.

4

Table of Contents

Over the last ten years we fully leveragehave witnessed a pivotal shift in the expandedadoption of photonics in new applications.  In the early days of the photonics industry the technology was a specialty, which was both expensive and required highly specialized technical knowledge, leading to low adoption of the technology into industries other than defense and high-end medical applications.  Starting with the commercialization of fiber optic communication, and further driven by significant cost reduction in key technologies such as sensors and lasers, the adoption of the technology into more industries and applications began rapidly growing.

With the accelerated rate of adoption and highly diversified industries and applications utilizing an expanding array of photonics technologies, comes a change in both the needs of the customers and the supply chain, to support those needs.  In the past, we and other component suppliers mostly served customers that specialized in photonics.  The large equipment manufacturers (“ OEMs”) focused on component companies as their supply chain for optical parts and minor fabrication and assemblies.  OEMs typically produced their own designs and relied on the supply chain to fulfill their needs without any strategic product planning or collaboration. This supply chain was fragmented and consisted of a large number of small companies, many of which had particular specialties in the fabrication process. 

As the industry has evolved and sensory, visualization and imaging capabilities have become differentiators, if not a necessity for an expanding array of products in a myriad of industries, the specialized requirements of customers are no longer being adequately addressed. With the wider adaptation of the technology, and managewith customers that now possess different expertise in different technologies, the broaderneeds are different, as is often the case with a mature supply chain.  In our case, the change has created opportunities to now serve OEM customers for which photonics is only one of several technologies they embed into their product, portfolioand that we now have we begun introducing organizational changesor are transitioning from a distributed supply chain that would provide all components for the bill of materials (“BOM”) to a highly diversified and fragmented global customer base in July 2019. The positionwhich the optical parts of Chief Operating Officer was createdtheir system are only a part of multiple technologies integrated together. As a result, the expanding market of original equipment and filled. This position combines all operations, engineering, sales and marketing functions under one leaderend market manufacturers are increasingly requiring an ecosystem around them to ensure the closest possible ties between demandsupport their needs for domain knowledge, design, assembly and supply of their optical components. We refer to this ecosystem as “optical engineered solutions,” and believe we are positioned to serve as a single source, global optical solutions provider with leading engineering and manufacturing capabilities. This has led to our products.development of a new strategy and organizational alignment as discussed below, which we have begun to implement in recent months with significant initial success, including a return to double digit annual revenue growth, multiple new product designs and key multinational customer contract wins.

Growth Strategy

Historically, we operated with a focus on optical component manufacturing, and specifically on our leadership position as a precision molded lens manufacturer for visual light applications. While still positioned as a component provider, we expanded our addressable market with the acquisition of ISP, a manufacturer of infrared optical components, in December 2016.  Collectively, our operations lacked synergies, maintained a high cost structure, and lacked a defined path for capitalizing on the industry’s evolution and growth opportunities.

In March of 2020, our Board of Directors (our “Board”) recruited Mr. Sam Rubin, an industry veteran with a proven track record for delivering high growth through organic and inorganic means, to assume the role of Chief Executive Officer and to develop and implement a new strategy going forward.  In the fall of 2020, Mr. Rubin led our Board and the leadership team in collaborative discussions with the purpose of defining a new comprehensive strategy for our business.  The collaborative strategic planning process included leaders from across the organization, detailed dialogs with customers, vendors and partners, and an in-depth analysis of the environment we are in, changes and trends in and around the use of photonics, and an analysis of our capabilities, strengths and weaknesses.  Throughout the process, we focused on developing a strategy that creates a unique and long-lasting value to our customers, and utilizes our unique capabilities and differentiators, both existing capabilities and differentiators, as well as new capabilities we acquire and develop organically.

Understanding the shifts that are happening in the marketplace and the changes that come when a technology, like photonics, moves from being a specialty to being integrated into mainstream industries and applications, we redefined our strategic direction to provide our wide customer base with domain expertise in optics, and became their partner for the optical engine of their systems. In our view, as the use of photonics evolves, so do customer needs.  The industry is transforming from a fragmented industry with many component manufacturers into a solution-focused industry with the potential for partnerships for solution development and production.  We believe thissuch partnerships can start with us as the supplier.  We have in-house domain expertise in photonics, knowledge and experience in advanced optical technologies, and the necessary manufacturing techniques and capabilities.  We believe we can develop these partnerships by working closely with the customer throughout their design process, designing an optical solution that is tailored to their needs, often times using unique technologies that we own, and supplying the customer with a complete optical subsystem to be integrated into their product.  Such an approach builds on our unique, value-added technologies that we currently own, such as optical molding, fabrication, system design, and proprietary manufacturing technologies, along with other technologies that we may acquire or develop in the future, to create tailored solutions for our customers. 

5

Table of Contents

Our domain expertise and the extensive “know how” in optical design, fabrication, production and testing technologies will ensureallow our customers to focus on their own development efforts, freeing them from the need to develop subject matter expertise in optics.  By providing the bridge into the optical solution world, we are able to partner with our customers on a long-term basis, create value for our customers, and capture that value through the long-term supply relationships we seek to develop. 

Organizational Alignment

Along with the development of a new strategic direction, we are focused on the execution of such strategic plan.  First, we have taken steps to align the organization with the strategic plan.  Such alignment has been ongoing in all levels of the organization, starting at the leadership level through the creation of a new position, Vice President of Operations, and hiring Peter Grief, an expert at building and scaling manufacturing operations, in April 2022 to fill such position.  We also hired Albert Miranda, who has strong experience in financial management and mergers and acquisitions in the optical industry, as our Chief Financial Officer in May 2022 , to replace our former Chief Financial Officer who retired.  We believe that these actions will enhance our focus on building a strong foundation that is aligned with our strategic plan and create an operation that will be ready to take on significant growth, both organic and inorganic.  We also appointed S. Eric Creviston, who has extensive experience with wireless and mobile technology and the semiconductor industry, as a new director to our Board. 

To execute our new strategic plan, we also need, among other things, a strong manufacturing and technical organization that provides the domain expertise in photonics, from the design of an optical engineered solution tailored for the customer’s needs through the manufacturing, assembly and testing of such a sub-system.  Given the fast pace of advancements in photonics technologies, achieving a sustainable advantage will also depend on having unique capabilities and technologies that allow our team to design and deliver the best coordination between technicaltailored solutions.  To support those goals, we began a few different organization-wide efforts, including standardizing and operational requirements.optimizing our processes and systems, taking steps to realigning our organizational structure, such as breaking down our single combined engineering group into the separate engineering functions that are a part of and better support operations, and creating a new product development group that focuses on developing capabilities and technologies that allow us to design and deliver better solutions. By having a small, focused new product development group, we are able to develop unique technologies that allow us to design solutions that we believe are better than what is otherwise available.  Such unique technologies include developing tailored and optimized optical coatings, and advanced fabrication techniques such as freeform optical components, custom materials not available elsewhere, and cutting edge optical design capabilities.

In the longer term, we have identified capabilities and technologies that could be important differentiators, including, for example, optical detectors and active optical components such as lasers, motion systems, and more. The positioncollection of many such unique technologies is responsible for managing annual plan objectives, i.e., revenues, gross margin, controllable operating incomewhat will allow us to differentiate our optical solution, and return on asset objectives. We have also implemented a product management function,provide the customer with a product managerthat is tailored exactly to their needs.

In addition to all of the organizational alignment initiatives we are implementing, we have also had a leadership transition and operational enhancements at our Chinese subsidiaries.  As discussed in more detail in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, we terminated certain of our management employees at our Chinese subsidiaries, LPOIZ and LPOI, in late fiscal year 2021, and transitioned to new management personnel.  These events adversely impacted domestic sales in China beginning in late fiscal year 2021 through fiscal year 2022. 

Technologies

We believe that to be the preferred partner to fulfill the photonics needs of our customers, domain expertise in photonics is the key element.  Optics and photonics require multidisciplinary skills, including physics, mechanical engineering, material sciences, electrical engineering, and chemistry, among others.  This is part of what makes using photonics so complicated, and at the same time part of what we see as the opportunity. Knowing what can and cannot be produced, designing the architecture and detailed design of the optical system, including electrical and mechanical interfaces, choosing and executing advanced manufacturing technologies, and delivering both the engineering prototypes that are needed, as well as producing a high volume of goods for the long-term, are all part of the domain expertise required. Additionally, to design the best solution for a customer, we not only need to know what can be produced and how to design it, we also must have unique capabilities that differentiate our solutions and allow us to design and produce a better solution that is more profitable than what may otherwise be available.

Along those lines, we continue to focus on developing new, innovative capabilities and technologies in all of our engineering and manufacturing groups, including systems design and testing, optical fabrication of components, material production, optical coatings, and electro mechanical design and production.

6

Table of Contents

Among the manufacturing technologies we own are:

·

High precision molded lenses. Historically, precision molding of lenses is the key technology we have built upon. Precision molding of optics is a unique technology that is well suited for both high volume production of optical components, as well as production of optics with unique shapes, which otherwise would require a very lengthy and complex process to individually polish each lens to shape. Precision molded optics (“PMOs”) is a technology in which we continuously invest to pursue advancements in what materials can be molded and the shapes and sizes of the optics we can mold. Although there are several other competitors that can mold optical elements, we have an established leadership position in this area as the original developer of the technology, and we believe we are the preferred vendor for the most complex, high-end projects of many of our customers. Some recent advancements we have made in precision molded optics include molding of non-symmetric shapes such as freeform optical components, and qualifying new materials for availability as moldable materials.

·

Traditional polishing, and diamond turned optics. Our capabilities include a wide range of traditional fabrication processes. These include CNC (computer numerical control) grinding and polishing of optical elements, traditional grinding and polishing of lenses, and diamond turning of infrared materials.

·

Materials. Materials play an important role in providing design flexibility and allow tradeoffs between optical performance, weight, and performance in varying conditions. Traditionally, infrared applications have only a small number of materials, all of which are crystal based. However, the introduction of synthetic chalcogenide glass in recent years, which allows for synthesizing of different materials, has created a larger library of materials to design with. We produce four materials: BD6, our flagship chalcogenide glass; (ii) BD2, which we have been producing for over 15 years; (iii) NaCl and (iv) KBr crystals. We believe that having a larger selection of optical materials will provide us more tools to design better solutions than exists with current materials, and we plan to continue to invest in our materials development. In addition, through a grant from Space Florida’s Space Foundation and Israel’s Ministry of Science received in August 2021, we are in the process of qualifying our chalcogenide glass for space applications and in particular thermal imaging from space, which is a fast-growing application. As part of our continued focus on adding unique, value added technologies that will enable us to design and produce better optical systems, we had licensed from US Navy Research Laboratories, on an exclusive basis, their portfolio of Infrared Materials that they have developed in recent years. We believe this expansion of our portfolio of materials places us in a unique position for the rapidly growing market of infrared imaging. The exclusive license enables us to develop, use and sell materials that have been specifically developed to improve overall performance, cost, size and weight of infrared systems, and in particular to enable to new application of multi spectral infrared imaging.

·

Optical coatings. Thin film coatings are designed to reduce losses and protect the optical material, which are a key part of any optical system. Through our recent investments, we have the ability to coat lenses in all of our facilities, providing efficient, high quality antireflective coatings, as well as reflective and protective coatings. Our coating facilities employ both physical vapor deposition techniques as well as chemical vapor deposition techniques. In addition to our library of dozens of standard coatings, our coating engineers often design coatings specific for an application, optimizing the performance of the system for a specific customer use. One of our most known advanced coatings is Diamond Like Carbon (“DLC”), which provides materials such as chalcogenide glass significant environmental protection. This coating is currently available only at a small number of vendors, and is an example of a capability that we believe gives us a competitive advantage by allowing us to design better optical solutions.

·

Assembly and testing. In recent years, we have invested significantly in capabilities for sub-system level assemblies and testing in two of our facilities. Even more recently, we have added capabilities of active alignment, and extended testing including environmental testing, to support our growing business of optical assemblies and engineered solutions. We expect to continue to invest in this area as activity grows, particularly in volume manufacturing and testing of assemblies.

New Product Development

Consistent with our new strategic direction, our development efforts during fiscal years 2021 and 2022 also shifted to focus on developing products, technologies and capabilities that allow us to provide better solutions, using the most fit technology for each customer and with alignment to customer product lifecycle. This includes developing unique materials, processing techniques, optical coating offerings and more, which allow us to design a better optical system for customers than we believe is available elsewhere or through in-house/captive capabilities. Examples of such development efforts include our development of the Freeform optics technology, which won us the esteemed industry prism award, the development of new infrared materials, and continuing to stretch and improve our capabilities in all existing technologies, such as optical coating, fabrication and assembly.  We generally rely on trade secret protection for technology we develop, but do pursue patents for certain of such technology.  In many cases the benefits of patent protection is offset by the requirement to disclose in detail the processes, and so we intend to apply for a patent only in the case when we believe the patent is enforceable and does not compromise our trade secrets and intellectual properties developed over three decades.

7

Table of Contents

We incurred expenditures for new product development during fiscal years 2022 and 2021 of approximately $2.1 million and $2.2 million, respectively. 

In some cases our product and technology development is supported through billing of engineering services, such as non-recurring engineering (“NRE”) fees. In other cases we receive external funding, such as our previously announced funding from Space Florida’s Space Foundation and Israel’s Ministry of Science.  Our efforts are self-funded in all other cases.

As part of our product development and research and development efforts, we have over 50 employees with engineering and related advanced degrees located in our facilities in the United States, China and Latvia.  Our facilities in Orlando, Florida and Zhenjiang, China are located in or near industrial technology campuses with substantial access to optical industry constituencies, including a major product capabilities: molded optics, thermal imaging opticsuniversity.  This enables us and custom designed optics. Product management is principally a portfolio management process that analyzes products withinour staff to remain on the product capability areas as defined above. This function will facilitate choosing investment prioritiescutting edge of industry design trends and ensuring successful product life cycle management. We have also defined, but not filled, the position of Senior Vice President, Strategic Business Assessment. This person will be responsible to strategically align LighPath’s competencies with strategic industry revenue opportunities, and will manage the product management function.

enter into collaborative engagements.

Product Groups and Markets

Overview

In fiscal 2019, we reorganized our

Our business is organized into three product groups: precision molded optics (“PMO”),PMOs, infrared products and specialty products.  These product groups are supported by our major product capabilities:  molded optics, thermal imaging optics, and custom designed optics.

Our PMO product group consists of visible precision molded optics with varying applications.  Our infrared product group is comprised of infrared optics, both molded and diamond-turned, and thermal imaging assemblies.  This product group also includes both conventional and CNC ground and polished lenses.  Between these two product groups, we have the capability to manufacture lenses from very small (with diameters of sub-millimeter) to over 300 millimeters, and with focal lengths from approximately 0.4mm0.4 millimeters to over 2000mm.2000 millimeters.  In addition, both product groups offer both catalog and custom designed optics.

Our specialty product group is comprised of value-added products, such as optical subsystems, assemblies, and collimators, and non-recurring engineering (“NRE”)NRE products, consisting of those products we develop pursuant to product development agreements that we enter into with customers.  Typically, customers approach us and request that we develop new products or applications forutilizing our existing products to fit their particular needs or specifications.  The timing and extent of any such product development isrequests are outside of our control.

We have also aligned

Product Groups

There is a product manager for each of our marketing efforts by our capabilities (i.e.,major product capabilities: molded optics, thermal imaging optics and custom optics), and then by industry. We currently servedesigned optics.  Product management is principally a portfolio management process that analyzes products within the following major markets: defense and security, optical systems and components, datacom/telecom, information technology,product capability areas as defined above.  This function facilitates choosing investment priorities to help strategically align our competencies with strategic industry revenue opportunities.  Over the long term, this function will also help ensure successful product life sciences, machine vision and production technology. Customers in each of these markets may select the best optical technologies that suit their needs from our entire suite of products, availing us to cross-selling opportunities, particularly where we can leverage our knowledge base against our expanding design library. Within our product groups, we have various applications that serve our major markets. For example, our infrared products can be used for gas sensing devices, spectrometers, night vision systems, advanced driver-assistance systems (“ADAS”), thermal weapon gun sights, and infrared counter measure systems, among others.


The photonics market drives our growth and is comprised of eight application areas: information and communication technology, display, lighting, photovoltaic, production technology, life sciences, and measurement and automated vision. In 2018, the market size for these applications at the system level was $556.4 billion. LightPath has product applications in six of the eight application areas, all except for displays and photovoltaic. According to the latest Markets and Markets survey, these six application areas had an estimated market value of $401 billion and are growing at a 7% compound annual growth rate. Within the larger overall markets, we believe there is a market of approximately $2.0 billion for our current products and capabilities. We continue to believe our products will provide significant growth opportunities over the next several years and, therefore, we will continue to target specific applications in each of these major markets. In addition to these major markets, a large percentage of our revenues are derived from sales to unaffiliated companies that purchase our products to fulfill their customers’ orders, as well as unaffiliated companies that offer our products for sale in their catalogs. Our strategy is to leverage our technology, know-how, established low-cost manufacturing capability and partnerships to grow our business. Our product managers will focus on pursuing customer growth opportunities where our differential advantages coincide with key customer needs.
Product Groups
cycle management.  The following sections further discussesdiscuss the various products we offer and certain growth opportunities we anticipate for each such product.

PMO Product Group.Aspheric lenses are known for their optimal performance.  Aspheric lenses simplify and shrink optical systems by replacing several conventional lenses.  However, aspheric lenses can be difficult and costly to machine.  Our glass molding technology enables the production of both low and high volumes of aspheric optics, while still maintaining the highest quality at an affordable price.  Molding is the most consistent and economical way to produce aspheres and we have perfected this method to offer the most precise molded aspheric lenses available.

Infrared Product Group.Group. Our infrared product group is comprised of both molded and turned infrared lenses and assemblies using a variety of infrared glass materials.  Advances in chalcogenide materials have enabled compression molding for MWIRmid-wave (“MWIR”), and LWIRlong-wave (“LWIR”), optics in a process similar to precision molded lenses. Our molded infrared optics technology enables high performance, cost-effective infrared aspheric lenses that do not rely on traditional diamond turning or lengthy polishing methods. Utilizing precision molded aspheric optics significantly reduces the number of lenses required for typical thermal imaging systems and the cost to manufacture these lenses. Molding is an excellent alternative to traditional lens processing methods particularly where volume and repeatability is required.

Through ISP, our wholly-owned subsidiary, we also offer germanium, silicon or zinc selenide aspheres and spherical lenses, which are manufactured by diamond turning.  This manufacturing technique allows us to offer larger lens sizes and the ability to use other optical materials that cannot be effectively molded.  TheISP’s capabilities we have from ISP give us theincrease our ability to meet complex optical challenges that demand more exotic optical substrate materials that are non-moldable, as well as larger size optics.

Near

We also have the end of fiscal 2018,ability to manufacture chalcogenide glass from which we announced comprehensive production capabilities and global availability for a new line ofproduce infrared lenses made from chalcogenide glass.lenses.  We developed this glass and melt it internally to produce our Black Diamond glass, which has been trademarked, and is marketed as BD6.  Currently,Historically, the majority of our thermal imaging products arehave been germanium-based, which is subject to market pricing and availability.  BD6 offers a lower-cost alternative to germanium, which we expect will benefit the cost structure of some of our current infrared products and allow us to expand our product offerings in response to the markets’ increasing requirement for low-cost infrared optics applications.

8

Table of Contents

Overall, we anticipate continued growth for our infrared optics, particularly as BD6 continues to be adopted into new applications and increased requirements for systems requiring aspheric optics.new designs.  Infrared systems, which include thermal imaging cameras, temperature sensing, gas sensing devices, spectrometers, night vision systems, automotive driver awareness systems, such as blind spot detection, thermal weapon sights, and infrared counter measure systems, represent a marketis an area that is growing rapidly and are applications into which we are selling.selling products that are utilized in a number of these applications.  As infrared imaging systems become widely available, market demand will increase as the cost of optical components needs to decrease before the market demand will increase.decreases. Our aspheric molding process is an enabling technology for the cost reduction and commercialization of infrared imaging systems utilizing smaller lenses because the aspheric shape of our lenses enables system designers to reduce the lens element in a system and provide similar performance at a lower cost.  In addition, there is a trend toward utilizing smaller size sensors in these devices which require smaller size lenses and that fits well with our molding technology.

Specialty Product Group.Group.We haveoffer a growing group of custom specialty optics products and assemblies that take advantage of our unique technologies and capabilities. These products include custom optical designs, mounted lenses, optical assemblies, and collimator assemblies.  Collimator assemblies are utilized in applications involving light detection and ranging (“LIDAR”) technology for advanced driver assistance systems and autonomous vehicles, such as forklifts and other automated warehouse equipment.  This continues to be an emerging market with long-term growth potential for us.  We also expect growth from defense communicationsmedical programs and commercial optical sub-assemblies.

We design, build, and sell optical assemblies intoin markets for test and measurement, medical devices, military, industrial, and communications based on our proprietary technologies. Many of our optical assemblies consist of several products that we manufacture.


Growth Strategy
Our strategy is to leverage

In connection with our technology, know-how, established low cost manufacturing capabilitynew strategic direction and partnerships to grow our business. We plan to accomplish this growth through the implementationexpanding portfolio of products and services, we are evaluating the following objectives:

● 
Leverage our Leadership to Drive Organic Growth. We plan to continue to capitalize on our global operations network, distribution infrastructure, and technology to pursue global growth. We will focus our efforts on those geographic areas and end products thatways in which we believe offermay optimize the most attractive growth and long-term profit prospects.
● 
Focus on Cash Flow Generation. Our goal is to focus on cash flow generation and return on invested capital through the continuing optimizationfinancial reporting of our cost structure, improvement in working capital and supply chain efficiencies, a disciplined approach to capital expenditures, and profitable revenue growth. We have a proven track record of mitigating fixed cost inflation with cost saving actions and productivity improvements. We intend to continue to identify incremental cost saving opportunities based in large part on benchmarks of industry-leading performance and productivity improvements by utilizing our engineering and manufacturing technology expertise and partnerships with low cost producers. Our goal is to maintain a cost structure that positions us favorably to compete and grow. In particular, we view our BD6 material manufacturing capability as a key differential advantage to drive growth in our infrared product group. We intend to continue to upgrade our customer and product mix by adding products that move up the supply chain by offering assemblies that use our lenses, thereby increasing our sales of value-added, differentiated products, and achieving premium pricing to improve margins and enhance cash flow.
● 
Increase Customer Base and Continue to Develop New Products.A key component of our strategy is to produce innovative, high-performance products that offer enhanced value propositions to our customers at competitive prices. Our goal is to continually work closely with our customers to provide solutions and productions that optimize their products. This market-driven product development enables us to offer a high-quality product portfolio to our customers and provide our business with the ability to respond quickly and efficiently to changes in market demands.
● 
Deepen Our Presence in Emerging Markets. Emerging markets are a strategic priority for our business. We are well positioned not only to leverage our strong market positions in mature but highly sophisticated markets in North America and Europe, but also to participate in the expected growth of emerging markets in Asia and Eastern Europe. We believe that improving living standards and growth in GDP across emerging markets are combining to create increased demand for our products. We expect to capitalize on this growth opportunity by expanding our customer base and local capabilities in order to increase our market share across emerging markets, especially in China. To accelerate our penetration of these markets and maintain our competitive cost position, we may develop relationships with leading local partners, especially in businesses where participation in the fast-growing Chinese market is particularly important for long-term sustainable growth. For example, we are well positioned to leverage our strong production technology in the Chinese market as a result of an increasing percentage of aerospace, automotive, semiconductor, electronics, and telecommunications manufacturing transitioning to China.
● 
Continue to Drive Operational Excellence and Asset Efficiency. Operational excellence, which includes a commitment to safety, environmental stewardship, and improved reliability, is key to our future success. We continually evaluate our business to identify opportunities to increase operational efficiency throughout our production facilities, with a focus on maintaining operational excellence, reducing costs, and maximizing asset efficiency. We intend to continue focusing on increasing manufacturing efficiencies through selected capital projects, process improvements, and best practices in order to lower unit costs. We will also carefully manage our portfolio and take appropriate actions to address product lines that face challenging market conditions and do not generate returns on invested capital that we believe are sufficient to create long-term shareholder value.
● 
Drive Organizational Alignment. We believe that maintaining alignment of the efforts of our employees with our overall business strategy and operational excellence goals is critical to our success. We have outstanding people and assets and, with the commitment to values of safety, customer appreciation, simplicity, collective entrepreneurship, and integrity, we believe that we can maintain our competitiveness and help achieve our operational excellence and asset efficiency strategic objectives.

groups.

Sales and Marketing

Marketing.  Extensive product diversity and varying levels of product maturity characterize the optics industry.  Product marketsverticals range from consumer (e.g., AR/VR, cameras, cell phones, gaming, and copiers) to industrial (e.g., lasers, data storage, and infrared imaging), from products where the lenses are the central feature (e.g., telescopes, microscopes, and lens systems) to products incorporating lens components (e.g., 3D printing, machine vision, LIDAR, robotics and semiconductor production equipment) and communications (e.g., various optics are required for bandwidth expansionfiber and improved data transfer for the optical network)laser based). As a result, we market our products across a wide variety of customer groups, including laser systems manufacturers, laser OEMs,OEM’s, infrared-imaging systems vendors, automotive OEMs, industrial laser tool manufacturers, telecommunications equipment manufacturers, medical instrumentation manufacturers and industrial measurement equipment manufacturers, government defense agencies, and research institutions worldwide.

Technical   Our marketing efforts include a global unification of our messaging with the use of digital advertising, branding activities that utilize social media, our website and direct marketing activities. As our focus shifts from the sale of components and standard products to being a value-add supply partner for customized solutions, our marketing activities also shift from a focus on technical aspects of standard components to a focus on best practice use cases, the overall outcome from our solutions and end user benefit.  Our market messaging will look to inspire interest and promote engagement.

Sales Model.Model & Structure.To align the organization to better serve our new solution strategy and for specific goalsaccountability of our key corporate objectives, we have made organizational changes designed to ensure customer satisfaction and accountability, we created the position of Chief Operating Officer with the responsibility for all operations, engineering, and sales and marketing. Thisoperational efficiency.  Our organizational structure includes a product management function that enables the close coordination of supply with demand.demand to help us leverage our core offerings and coordinate our engineering development efforts that will leverage and expand our portfolio of capabilities.  We have also createdtransitioned from a business unit focus to a unified global direct sales team that promotes the overall company portfolio and is standardized on a problem solving, needs analysis process.  The team recently went through Sandler Training to help with this shift and to empower action with improved communication techniques.  We have added technical program managers and product life cycle management function(“PLCM”) to managebetter support the portfolio of productsnew customized customer programs and define the best growth opportunities for LightPath. Our Sales and Marketing organization will be led by the Vice President of Global Sales and Marketing.

transition from prototype engineering to full scale manufacturing.

Sales Team & Channel. We have aligned our sales engineering efforts to be account based and application focused. We have taken a more proactive approach to our direct selling efforts to increase our customer engagement, especially within Europe, where we recently transitioned away from working exclusively through a distributor.  We have expanded our inside sales and application engineering organization to better support our regional sales forces that market and sell our products directly to customers in North America, Europe and China. We also have a master distributor in Europe. We have formalized relationships with 15 industrial, laser, and optoelectronics distributors and channel partners located in the United States (“U.S.”) and various foreign countries to assist in the distribution of our products in highly specific target markets. We also have reseller arrangementsstandard product offerings with the top three producttwo catalog companies in the world for optics and opto-electronics market.photonics which increases our exposure to new revenue opportunities.  In addition, we also maintaincontinue to enhance our own product catalog and internet websites (www.lightpath.comandwww.ispoptics.com) as vehicleswebsite (www.lightpath.com), which is our main communication vehicle for broader promotion of our products.company, our value-add capabilities, our growing chalcogenide material portfolio, and similarly have optimized our social media assets.  We make use of digital and print media advertisements in various trade magazines andplus participate in appropriate domesticmany key industry associations and foreignglobal trade shows.

All of our partners work diligently to expand opportunities in emerging geographic markets and through alternate channels of distribution. We believe that we provide a high level of support in developing and maintaining our long-term relationships with our customers. Customer service and support are provided through our offices and those of our partners that are located throughout the world.

9

Table of Contents

Trade Shows.We display our product line additionsstandard products, promote new innovative offerings and enhancementsmeet with industry influencers at one or morea number of trade shows each year. For example,year throughout North America, Europe and Asia.  As a result of COVID-19, some of these annual trade shows have been rescheduled or modified into virtual online exchanges.  So far in 2022, we participated in a few virtual shows plus several U.S.-basedin person shows including Society of Photographic Instrumentation Engineers (“SPIE”)which included the SHOT Show in Las Vegas, the largest professional event for the sport shooting, hunting and outdoor industry in North America; SPIE Photonics Westin February 2019San Francisco, where LightPath won a PRISM Award which honors the best new optics and photonics products on the market; SPIE Defense, SecurityDCS, AUVSI which promotes emerging technologies supporting autonomous vehicles, drones and Sensing in April 2019. In addition, we exhibit at therobotics; and Laser World of Photonics in Munich, Germany to maintain our European presence, and intend to exhibit at the China International Optoelectronic Expo (“CIOE”) in September 2019.  This strategy underscores our strategic directive of broadening our base of innovative optical components and assemblies.Munich. These trade shows also provide us an opportunity to meet with andfurther expand our brand, network to enhance existing business relationships meet and develop potential customers, andgain valuable insight into technology trends in our target markets.

Competition

Engineered Solutions

The market for non-captive optical engineered solutions is emerging. As companies such as LightPath begin transitioning their offering from components to distribute information and samples regardingengineered solutions, we compete on several fronts:

·

Engineered solutions companies. While there are not many, companies such as Excelitas Technologies Corp. and Jenoptik AG offer optical engineered solutions to the market, with a specific focus on solutions in visible and ultraviolet light bands, and with a vertical industry focus, such as life sciences and semiconductor systems.

·

Engineering firms. Though less popular, in some cases customers prefer to work with engineering firms that provide design services, which then the customer produces or sub-contracts to third-party component manufacturers. An example of such companies providing engineering services are Lighthouse Imaging, LLC, Optikos Corporation, and Photon Engineering, LLC.

·

In-house or captive design. The most common approach today is for customers to design the optical system internally by the OEM. This requires customers to have expertise in optical system and component design capabilities, along with knowledge of the most advanced available technologies, however limited the scope of their capabilities or the profitability of their solutions may be.

Our key differentiator is our products.

Competition
Theunique technologies that allow us to design better solutions.

Optical Components

In our optical components business, the market for optical components generally is highly competitive and highly fragmented.  We compete with manufacturers of conventional spherical lenses and optical components, providers of aspheric lenses and optical components, and producers of optical quality glass.  To a lesser extent,While the global market for component supply is fragmented and highly competitive, we compete with developers of specialty optical components and assemblies, particularly as related to our custom products within the infrared product group. Many of these competitors have greater financial, manufacturing, marketing, and other resources than we do.

We believemaintain advantages through our unique capabilitiestechnologies that often build on our leadership in optical design engineering,precision molded optics, as well as our low-cost structure and our substantial presencevertical integration in Europe and Asia, provides us with a competitive edge and assists us in securing business. Additionally, we believe that we offer value to some customers as a primary or backup supply source in the U.S. should they be unwilling to commit to purchase their supply of a critical componentinfrared optics, from a foreign production source. We also have a broad product offering to satisfy a variety of applications and markets.
raw materials through assemblies.

PMO Product GroupGroup.Our PMO products compete with conventional lenses and optical components manufactured byfrom companies such as Asia Optical Co., Inc., Anteryon BV, Rochester Precision Optics, and Sunny Optical Technology (Group) Company Limited.  Aspheric lens system manufacturers include Panasonic Corporation, Alps Electric Co., Ltd., Hoya Corporation, as well as newerother competitors from China and Taiwan, such as E-Pin Optical Industry Co., Ltd., and Kinik Company.

Our aspheric lenses compete with lens systems comprised of multiple conventional lenses. Machined aspheric lenses compete with our molded glass aspheric lenses.  The use of aspheric surfaces provides the optical designer with a powerful tool in correcting spherical aberrations and enhancing performance in state-of-the-art optical products. However, we believe that our optical design expertise and our flexibility in providing custom high-performance optical components at a low price are key competitive advantages for us over these competitors.


  An additional competitive advantage is our ability to switch production between different facilities on different continents. We do not depend on one facility and are able to move production in and out of China, which we believe creates a significant advantage by giving us supply chain continuity and an ability to adjust to customers’ geographical preferences.

Plastic molded aspheres and hybrid plastic/glass aspheric optics on the other hand, allow for high volume production, but primarily are limited to low costlow-cost consumer products that do not place a high demand on performance (such as plastic lenses in disposable or mobile phone cameras). Molded plastic aspheres appear in products that stress cost or weight as their measure of success over performance and durability. Our low-cost structure allows us to compete with these lenses based on higher performance and durability from our glass lenses at only a small premium in price.

  We do not compete in the market for plastic lenses unless a glass substitution presents a viable alternative.

10

Table of Contents

Infrared Product Group.Group.Our infrared aspheric opticsoptical components compete with optical products produced by Janos Technology LLC, Ophir Optronics Solutions Ernst Leitz Canada (ELCAN) Optical Technologies,Ltd. (a subsidiary of MKS Instruments, Inc.), Clear Align, II-VI, Inc. and a variety of Eastern European and Asian manufacturers.  TheseInfrared optical components can be produced using several techniques.  Historically, infrared optical components were produced only using traditional fabrication technologies, which later changed when diamond turning was introduced (a form of advanced CNC for optical materials), and most recently, with the adoption of synthetic chalcogenide glass, we began to precision mold infrared optical components, by leveraging our years of leadership and expertise in precision molding.  Being synthetically produced, chalcogenide glass, such as our proprietary BD6 material, has an inherently lower cost than crystalline materials such as germanium.  Additionally, glass such as our BD6 material provides further advantages, including a-thermal behavior, lower weight, and an ability to produce high-volumes through precision molding, something traditional infrared materials cannot achieve due to their crystal structure.  In addition to molding lenses can eitherdirectly into finished form, we also developed and patented a process to mold large optical elements into near net shape, which offers a significant cost savings for components that cannot be polished spherical or are diamond turned aspherical. Our molded lenses compete with spherical lenses because like all aspheres they can replace doublets or triplets based on the higher performanceproduced directly from molding.  All of an aspheric lens. Our diamond turned aspheres from germanium arethis is related in part to our choice to vertically integrate, and produce our own chalcogenide glass, positioning us to create more expensivetechnical advantages for our customers, by leveraging and optimizing our glass manufacturing to produce in high volumesunique materials and time consuming to manufacture. We now also offer diamond-turned BD6 (chalcogenide) at lower cost giving us a competitive advantage. better overall system performance.

We believe our low cost, high volume lens businessthat the market shift towards the use of synthetic materials in infrared products represents a significant opportunity for us, and we continue to invest in further pushing the limits of both molding of infrared components, as well as the glass manufacturing technology combined with our recently added traditional polishing and diamond turning capabilities enables us to compete withproducts.  We believe this process will create significant differentiators and value in this industry segment, and will further change the other manufacturersdynamics of traditional infrared lens by offering the best technology fit at a competitive price.

this industry segment.

Our molded infrared optics competes with products manufactured by Umicore N.V. (“Umicore”), Rochester Precision Optics, and Yunnan KIRP-CH Photonics Co., Ltd.a number of Asian and European manufacturers. We believe that leadership in glass molding technologies, our optical design expertise,vertical integration by producing our BD6-based product offerings,own glass, and our continued investment in technology development in this area, coupled with our diverse manufacturing flexibility, and our manufacturing facilities located in Asia, Europe and North America are key advantages over the products manufactured by these competitors.

Manufacturing

Facilities. Our manufacturing is largely performed in our combined 38,00062,000 square feet of production facilities in Orlando, Florida, (the “Orlando Facility”), in LPOIZ’s combined 55,000 square feet of production facilities in Zhenjiang, China, and in ISP Latvia’s 23,00029,000 square feet of production facilities in Riga, Latvia.  LPOI sales and support functions occupy a 1,900 square foot facility in Shanghai. ISP previously had an approximately 13,000 square foot facility in Irvington, New York that functioned as its operations headquarters, providing manufacturing capabilities, optical coatings, optical and mechanical design, assembly and testing, as well as some engineering, administrative and sales functions. During fiscal 2019, we added manufacturing space near our existing Orlando Facility, and relocated the manufacturing operations of ISP’s Irvington Facility to our existing Orlando Facility and Riga Facility, which is expected to result in substantial cost savings. Some of the manufacturing operations previously performed in the Irvington Facility were transitioned to our Zhenjiang Facility.

Shanghai, China. 

Our Orlando Facility and LPOIZ’s Zhenjiang Facility feature areas for each step of the manufacturing process, including coating work areas, preformdiamond turning, manufacturing and a clean room for precision glass molding and integrated assembly. The Orlando and Zhenjiang Facilities include new product development laboratories and space that includes development and metrology equipment.  The Orlando and Zhenjiang Facilities have anti-reflective and infrared coating equipment to coat our lenses in-house.  ISP Latvia’s Riga Facility includes fully vertically integrated manufacturing processes to produce high precision infrared lenses and infrared lens assemblies, including crystal growth, CNC grinding, conventional polishing, diamond turning, multilayer coatings, assemblies and state of the art metrology.

  During fiscal year 2021, we began adding infrared coating capabilities in the Riga Facility as well.

We are routinely adding additional production equipment at our Orlando, Zhenjiang and Riga Facilities. DuringIn fiscal 2018,year 2021, we added additional space in both our ZhenjiangRiga Facility, and Riga Facilities. In fiscal 2019, we completedalso executed a lease agreement for additional space at our expansion in Orlando and closed the Irvington Facility, moving the manufacturing operations to the Orlando Facility, and the Riga Facility. We also completed an expansionwhich we expect to our Zhenjiang operation increasing our preform capacity.occupy in mid-fiscal year 2023. In addition to adding additional equipment or space at our manufacturing facilities, we add additional work shifts, as needed, to increase capacity and meet forecasted demand.  We intend to monitor the capacity at our facilities, and will increase such space as needed.  We believe our facilities and planned expansions are adequate to accommodate our needs over the next year.

Production and Equipment.Equipment.Our Orlando Facility contains glass melting capability for BD6 chalcogenide glass, a manufacturing area for our molded glass aspheres, multiple anti-reflective and wear resistant coating chambers, diamond turning machines and accompanying metrology equipment offering full scale diamond turning lens capability, a tooling and machine shop to support new product development, commercial production requirements for our machined parts, the fabrication of proprietary precision glass molding machines and mold equipment, and a clean room for our molding and assembly workstations and related metrology equipment. 

LPOIZ’s Zhenjiang Facility features a precision glass molding manufacturing area, clean room, machine shop, dicing area, and thin film coating chambers for anti-reflective coatings on both visible and infrared optics and related metrology equipment.

ISP Latvia’s Riga Facility consists of crystal growth, grinding, polishing, diamond turning, quality control departments and a mechanical shop to provide the departments with the necessary tooling.  The crystal growth department is equipped with multiple furnaces to grow water soluble crystals.  The grind and polish department has modern CNC equipment, lens centering and conventional equipment to perform spindle, double sided and continuous polishing operations.  The diamond turning department has numerous diamond turningdiamond-turning machines accompanied with the latest metrology tools.  In connection withDuring fiscal year 2021, we began adding infrared coating capabilities at the relocationRiga Facility, which was completed the second half of the Irvington Facility, we have increased the diamond turning capacity in this facility.fiscal year 2022.  The quality control department contains numerous inspection stations with various equipment to perform optical testing of finished optics.


11

Table of Contents

The Orlando, Zhenjiang, and Riga Facilities are ISO 9001:2015 certified. The Zhenjiang Facility is also ISO/TS 1649:2009 automotive certified for manufacturing of optical lenses and accessories.  The Orlando Facility is International Traffic in Arms Regulations (“ITAR”) compliant and registered with the U.S. Department of State.  The Riga Facility has a DSP-5 ITAR license and Technical Assistance Agreement in place that allows this facility to manufacture items with ITAR requirements.

For more information regarding our facilities, please seeItem 2. Propertiesin this Annual Report on Form 10-K.

Subcontractors and Strategic Alliances.  Alliances.We believe that low-cost manufacturing is crucial to our long-term success.  In that regard, we generally use subcontractors in our production process to accomplish certain processing steps requiring specialized capabilities.  For example, we presently use a number of qualified subcontractors for fabricating, polishing, and coating certain lenses, as necessary.  We have taken steps to protect our proprietary methods of repeatable high-quality manufacturing by patent disclosures and internal trade secret controls.

Suppliers.   

Suppliers.We utilize a number of glass compositions in manufacturing our molded glass aspheres and lens array products.  These glasses or equivalents are available from a large number of suppliers, including CDGM Glass Company Ltd., Ohara Corporation, and Sumita Optical Glass, Inc.  Base optical materials, used in both infrared glass and collimator products, are manufactured and supplied by a number of optical and glass manufacturers. ISP utilizes major infrared material suppliers located around the globe for a broad spectrum of infrared crystal and glass.  The development of our manufacturing capability for BD6 glass provides a low-cost internal source for infrared glass.  We believe that a satisfactory supply of such production materials will continue to be available, at reasonable or, in some cases, increased prices, although there can be no assurance in this regard.

We also rely on local and regional vendors for component materials and services such as housings, fixtures, chemicals and inert gases, specialty ceramics, UV and AR coatings, and other specialty coatings. In addition, certain products require external processing, such as anodizing and metallization. To date, we are not dependent on any of these manufacturers and have found a suitable number of qualified vendors and suppliers for these materials and services.

We currently purchase a few key materials from single or limited sources.  We believe that a satisfactory supply of production materials will continue to be available at competitive prices, although we are experiencing inflationary pricing pressure in the short term, however there can be no assuranceassurances in this regard.

Intellectual Property

Our policy is to protect our technology by, among other things, patents, trade secret protection, trademarks, and copyrights.  We primarily rely upon trade secrets and unpatented proprietary know-how to protect certain process inventions, lens designs, and innovations.  We have taken reasonable security measures to protect our trade secrets and proprietary know-how,know-how.

We are aggressively pursuing patents for new products that provide new features, capabilities or other advantages to our customers.  Over the extent that is reasonable.

In addition to trade secrets and proprietary know-how,past three years, we have been granted two new patents.  We also have three remainingother patents that relate to the fusing of certain of our lenses that are part of our specialty products group.  These patents expire at various times throughthroughout 2023.  We also are inFor 2022, we have three new groups of patents being submitted.  The first is for the fabrication of mold tooling and the molding process for acylindrical arrays.  The second is for the molding of applyinglarge freeform optics, with respect to the proprietary molding equipment. The third is for multiple new patents.
the molding of doublets.

Our means of protecting our proprietary rights may not be adequate and our competitors may independently develop technology or products that are similar to ours or that compete with ours.  Patent, trademark, and trade secret laws afford only limited protection for our technology and products.  The laws of many countries do not protect our proprietary rights to as great an extent as do the laws of the United States (“U.S.”).  Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to obtain and use information that we regard as proprietary.  Third parties may also design around our proprietary rights, which may render our protected technology and products less valuable, if the design around is favorably received in the marketplace.  In addition, if any of our products or technology is covered by third-party patents or other intellectual property rights, we could be subject to various legal actions.  We cannot assure you that our technology platform and products do not infringe patents held by others or that they will not in the future.  Litigation may be necessary to enforce our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others, or to defend against claims of infringement, invalidity, misappropriation, or other claims.

12

Table of Contents

We own several registered and unregistered service marks and trademarks (collectively, “marks”) that are used in the marketing and sale of our products.  The following table sets forth our registered and unregistered service marks, and trademarks, ifdenotes whether each mark is registered, the country in which the mark is filed, and the renewal date for such mark.


Mark

Type

Registered

Type

Country

Registered

Country

Renewal

Date

LightPath®

Service mark

Yes

Yes

United States

October 22, 2022

GRADIUM™

Trademark

Yes

Trademark

Yes

United States

April 29, 2027

Circulight

Trademark

No

Trademark

-

No

-

-

BLACK DIAMOND

Trademark

No

Trademark

-

No

-

-

GelTech

Trademark

No

Trademark

-

No

-

-

Oasis

Trademark

No

Trademark

-

No

-

-

LightPath®

Service mark

Yes

Yes

People’s Republic of China

September 13, 2025

ISP Optics®

Optics®

Trademark

Yes

Trademark

Yes

United States

August 12, 20202023

Environmental and Governmental Regulation

Currently, emissions and waste from our manufacturing processes are at such low levels that no special environmental permits or licenses are required.  In the future, we may need to obtain special permits for disposal of increased waste by-products.  The glass materials we utilize contain some toxic elements in a stabilized molecular form.  However, the high temperature diffusion process results in low-level emissions of such elements in gaseous form.  If production reaches a certain level, we believe that we will be able to efficiently recycle certain of our raw material waste, thereby reducing disposal levels.  We believe that we are presently in compliance with all material federal, state, and local laws and regulations governing our operations and have obtained all material licenses and permits necessary for the operation of our business.

We also utilize certain chemicals, solvents, and adhesives in our manufacturing process.  We believe we maintain all necessary permits and are in full compliance with all applicable regulations.

To our knowledge, there are currently no U.S. federal, state, or local regulations that restrict the manufacturing and distribution of our products.  Certain end-user applications require government approval of the complete optical system, such as U.S. Food and Drug Administration approval for use in endoscopy.  In these cases, we will generally be involved on a secondary level and our OEM customer will be responsible for the license and approval process.

The Dodd-Frank Wall Street Reform and Consumer Protection Act imposes disclosure requirements regarding the use of “conflict minerals” mined from the Democratic Republic of Congo and adjoining countries in products, whether or not these products are manufactured by third parties.  The conflict minerals include tin, tantalum, tungsten, and gold, and their derivatives.  Pursuant to these requirements, we are required to report on Form SD the procedures we employ to determine the sourcing of such minerals and metals produced from those minerals.  There are costs associated with complying with these disclosure requirements, including for diligence in regards to the sources of any conflict minerals used in our products, in addition to the cost of remediation and other changes to products, processes, or sources of supply as a consequence of such verification activities.  In addition, the implementation of these rules could adversely affect the sourcing, supply, and pricing of materials used in our products.  We strive to only use suppliers that source from conflict-free smelters and refiners; however, in the future, we may face difficulties in gathering information regarding our suppliers and the source of any such conflict minerals.

New Product Development
In recent years, our new product development efforts have been focused on the development of our capabilities in molded aspheric lenses and infrared lenses. We incurred expenditures for new product development during fiscal 2019 and 2018 of approximately $2.0 million and $1.6 million, respectively. In fiscal 2019 and 2018, our efforts were concentrated on expanding our product capabilities for molded optics and thermal imaging optics, to continue increasing our product offerings, and lower costs within our PMO and infrared product groups.
In fiscal 2020, we anticipate focusing our new product development efforts on infrared optics products for imaging and sensing, fiber lasers, spectrophotometry, defense, medical devices, industrial, optical data storage, machine vision, sensors, and environmental monitoring. We currently plan to expend approximately between 5% and 6% of revenue for new product development during fiscal 2020, which could vary depending upon revenue levels, customer requirements, and perceived market opportunities.
For more difficult or customized products, we typically bill our customers for engineering services as a non-recurring engineering fee.

Concentration of Customer Risk

In fiscal 2019,year 2022, we had sales to three customers that comprised an aggregate of approximately 32%35% of our annual revenue with one customer at 17%19% of our sales, another customer at 8%9% of our sales, and the third customer at 7% of our sales.  In fiscal 2018,year 2021, we had sales to three customers that comprised an aggregate of approximately 28%38% of our annual revenue with one customer at 16%18% of our sales, another customer at 7%10% of our sales, and the third customer at 5%10% of our sales.  The loss of any of these customers, or a significant reduction in sales to any such customer, would adversely affect our revenues and profits. We continue to diversify our business in order to minimize our sales concentration risk.

In fiscal 2019, 62%year 2022, 61% of our net revenue was derived from sales outside of the U.S., with 94%95% of our foreign sales derived from customers in Europe and Asia.  In fiscal 2018, 58%year 2021, 68% of our net revenue was derived from sales outside of the U.S., with 84%95% of our foreign sales derived from customers in Europe and Asia.

13

Table of Contents

Employees

As of June 30, 2019,2022, we had 350334 employees, of which 339329 were full-time equivalent employees, with 97108 in the U.S., including 93101 located in Orlando, Florida and 47 working remotely from various locations, 98 located in Riga, Latvia, and 144128 located in Jiading and Zhenjiang, China.  Of our 339329 full-time equivalent employees, we have 4033 employees engaged in management, administrative, and clerical functions, 2932 employees in new product development, 1711 employees in sales and marketing, and 253 employees in production and quality control functions.  Any employee additions or terminations over the next twelve months will be dependent upon the actual sales levels realized during fiscal 2020.year 2022.  We have used and will continue utilizing part-time help, including interns, temporary employment agencies, and outside consultants, where appropriate, to qualify prospective employees and to ramp up production as required from time to time. None of our employees are represented by a labor union.

Item 1A.  RiskRisk Factors.

The following is a discussion of the primary factors that may affect the operations and/or financial performance of our business.  Refer to the section entitled Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report on Form 10-K for an additional discussion of these and other related factors that affect our operations and/or financial performance.

Risks Related to Our Business and Financial Results

Our business, results of operations, financial condition, cash flows, and the stock price of our Class A common stock can be adversely affected by pandemics, epidemics, or other public health emergencies, such as the recent outbreak of COVID-19.  Our business, results of operations financial condition, cash flows, and the stock price of our Class A common stock can be adversely affected by pandemics, epidemics, or other public health emergencies, such as the recent global outbreak of COVID-19.  In March 2020, the World Health Organization (the “WHO”) declared COVID-19 as a pandemic.  The COVID-19 pandemic resulted in governments around the world implementing measures to help control the spread of the virus, including “stay at home” orders, travel restrictions, business curtailments, school closures, and other measures.  These restrictions significantly impacted economic conditions in the U.S. in 2020 and continued into 2021.  Beginning in the spring of 2021, we have seen some restrictions lift as vaccines have become more available.

We are considered an “essential business,” as a critical supplier to both the medical and defense industries.  To date, we have continued to operate our manufacturing facilities consistent with government guidelines and state and local orders; however, the outbreak of COVID-19 and any preventive or protective actions taken by governmental authorities may have a material adverse effect on our operations, supply chain, customers, and transportation networks, including business shutdown or disruptions.  The extent to which COVID-19 may adversely impact our business depends on future developments, which are highly uncertain and unpredictable, depends upon the severity and duration of the outbreak and the effectiveness of actions taken globally to contain or mitigate its effect.  Any resulting financial impact cannot be estimated reasonably at this time, but may materially adversely affect our business, results of operations, financial condition, and cash flows.  Even after the COVID-19 pandemic has subsided, we may experience materially adverse impacts to our business due to any resulting economic recession or depression.  Additionally, concerns over the economic impact of COVID-19 have caused extreme volatility in financial and other capital markets, which has and may continue to adversely impact our stock price and our ability to access capital markets.  To the extent the COVID-19 pandemic may adversely affect our business and financial results, it may also have the effect of heightening many of the other risks described in this Annual Report on Form 10-K.

We have a history of losses.We reported net losses of $3.5 million and $3.2 million for fiscal years 2022 and 2021, respectively, and although we reported net income of $0.9 million for fiscal year 2020, we incurred a net loss of $2.7 million for fiscal 2019 and although we reported net income of $1.1 million and $7.7 million for fiscal 2018 and 2017, respectively, we have a history of losses prior to fiscal 2016.year 2019.  As of June 30, 2019,2022, we had an accumulated deficit of approximately $197.9$203.8 million.  We may incur losses in the future if we do not achieve sufficient revenue to return tomaintain profitability, or if we continue to incur unusual costs.  We expect revenue to grow by generating additional sales through promotion of our infrared products, with a focus on engineered solutions, and continued cost reduction efforts for our precision molded products, and we expect to achieve significant cost savings as a result of closing the Irvington Facility,across all product groups, but we cannot guarantee such improvement or growth.

Factors which could adversely affect our future profitability, include, but are not limited to, a decline in revenue either due to lower sales unit volumes or decreasing selling prices, or both, our ability to order supplies from vendors, which, in turn, affects our ability to manufacture our products, and slow payments from our customers on accounts receivable.

Any failure to maintain profitability would have a materially adverse effect on our ability to implement our business plan, our results and operations, and our financial condition, and could cause the value of our Class A common stock to decline.

We are dependent on a few key customers, and the loss of any key customer could cause a significant decline in our revenues. In fiscal 2019, year 2022, we had sales to three customers that comprised an aggregate of approximately 32%35% of our annual revenue, with one customer at 17%19% of our sales, another customer at 8%9% of our sales, and the third customer at 7% of our sales.  In fiscal 2018, year 2021, we had sales to three customers that comprised an aggregate of approximately 28%38% of our annual revenue, with one customer at 16%18% of our sales, another customer at 7%10% of our sales, and the third customer at 5%10% of our sales.  In bothThe third customer lost a significant bid in 2021 which adversely affected our sales in fiscal 2019 and 2018, these top three customers include a distributor, which actually represents sales to numerous customers.year 2022.  Our current strategy isof providing the domain expertise and the extensive “know how” in optical design, fabrication, production and testing technologies will allow our customers to leveragefocus on their own development efforts, without needing to develop subject matter expertise in optics.  By providing the bridge into the optical solution world, we partner with our broader portfolio of productscustomers on a long term basis, create value to expand our customer base usingcustomers, and capture that value through the capabilities gained as a result oflong-term supply relationships we develop. However the ISP acquisition. However, we continue to diversify our business in order to minimize our sales concentration risk. The loss of any of these customers, or a significant reduction in sales to any such customer, would adversely affect our revenues.


14

Table of Contents

We may be affected by political and other risks as a result of our sales to international customers and/or our sourcing of materials from international suppliers.In fiscal 2019, 62%year 2022, 61% of our net revenue was derived from sales outside of the U.S., with 94%95% of our foreign sales derived from customers in Europe and Asia.  In fiscal 2018, 58%year 2021, 68% of our net revenue was derived from sales outside of the U.S., with 84%95% of our foreign sales derived from customers in Europe and Asia.  Our international sales will be limited, and may even decline, if we cannot establish relationships with new international distributors, maintain relationships with our existing international distributions, maintain and expand our foreign operations, expand international sales, and develop relationships with international service providers.  Additionally, our international sales may be adversely affected if international economies weaken.  We are subject to the following risks, among others:

●             
greater difficulty in accounts receivable collection and longer collection periods;
●             
potentially different pricing environments and longer sales cycles;
●             
the impact of recessions in economies outside the U.S.;
●             
unexpected changes in foreign regulatory requirements;
●             
the burdens of complying with a wide variety of foreign laws and different legal standards;
●             
certification requirements;
●             
reduced protection for intellectual property rights in some countries;
●             
difficulties in managing the staffing of international operations, including labor unrest and current and changing regulatory environments;
●             
potentially adverse tax consequences, including the complexities of foreign value-added tax systems, restrictions on the repatriation of earnings, and changes in tax rates;
●             
price controls and exchange controls;
●             
government embargoes or foreign trade restrictions;
●             
imposition of duties and tariffs and other trade barriers;
●             
import and export controls;
●             
transportation delays and interruptions;
●             
terrorist attacks and security concerns in general; and
●             
political, social, economic instability and disruptions. 

·

greater difficulty in accounts receivable collection and longer collection periods;

·

potentially different pricing environments and longer sales cycles;

·

the impact of recessions in economies outside the U.S.;

·

the impact of high, sustained inflation;

·

unexpected changes in foreign regulatory requirements;

·

the burdens of complying with a wide variety of foreign laws and different legal standards;

·

certification requirements;

·

reduced protection for intellectual property rights in some countries;

·

difficulties in managing the staffing of international operations, including labor unrest and current and changing regulatory environments;

·

potentially adverse tax consequences, including the complexities of foreign value-added tax systems, restrictions on the repatriation of earnings, and changes in tax rates;

·

price controls and exchange controls;

·

government embargoes or foreign trade restrictions;

·

imposition of duties and tariffs and other trade barriers;

·

import and export controls;

·

transportation delays and interruptions;

·

terrorist attacks and security concerns in general; and

·

political, social, economic instability and disruptions.

As a U.S. corporation with international operations, we are subject to the U.S. Foreign Corrupt Practices Act and other similar foreign anti-corruption laws, as well as other laws governing our operations.  If we fail to comply with these laws, we could be subject to civil or criminal penalties, other remedial measures, and legal expenses, which could adversely affect our business, financial condition, and results of operations.Our operations are subject to anti-corruption laws, including the U.S. Foreign Corrupt Practices Act (“FCPA”), and other foreign anti-corruption laws that apply in countries where we do business.  The FCPA and these other laws generally prohibit us and our employees and intermediaries from offering, promising, authorizing or making payments to government officials or other persons to obtain or retain business or gain some other business advantage.  In addition, we cannot predict the nature, scope, or effect of future regulatory requirements to which our international operations might be subject or the manner in which existing laws might be administered or interpreted.  Operations outside of the U.S. may be affected by changes in trade production laws, policies, and measures, and other regulatory requirements affecting trade and investment.

We are also subject to other laws and regulations governing our international operations, including regulations administered by the U.S. Department of Commerce’s Bureau of Industry and Security, the U.S. Department of Treasury’s Office of Foreign Asset Control, and various non-U.S. government entities, including applicable export control regulations, economic sanctions on countries and persons, customs, requirements, currency exchange regulations, and transfer pricing regulations (collectively, the “Trade Control Laws”).

Despite our compliance programs, there can be no assurance that we will be completely effective in ensuring our compliance with all applicable anti-corruption laws, including the FCPA or other legal requirements, or Trade Control Laws.  If we are not in compliance with the FCPA and other foreign anti-corruption laws or Trade Control Laws, we may be subject to criminal and civil penalties, disgorgement, and other sanctions and remedial measures, and legal expenses, which could have an adverse impact on our business, financial condition, results of operations and liquidity. Likewise, any investigation of any potential violations of the FCPA, other anti-corruption laws, or Trade Control Laws by the U.S. or foreign authorities could also have an adverse impact on our reputation, business, financial condition, and results of operations.

15

Table of Contents

If the custodians or authorized users of our controlling non-tangible assets, including corporate chops and seals of our Chinese subsidiaries, fail to fulfill their responsibilities or misappropriate or misuse those assets, our business and operations could be materially and adversely affected.  In China, a company chop or seal serves as the legal representation of the company towards third parties even when unaccompanied by a signature. Under law of the People’s Republic of China, legal documents for corporate transactions, including contracts and leases that our business relies upon, are executed using “corporate chops,” which are instruments that contain either the official seal of the signing entity or the signature of a legal representative whose designation is registered and filed with the State Administration for Industry and Commerce, or SAIC.

Our Chinese subsidiaries, LPOI and LPOIZ, generally execute legal documents with corporate chops. One or more of our corporate chops may be used to, among other things, execute commercial sales or purchase contracts, procurement contracts and office leases, open bank accounts, issue checks and to issue invoices. We have controls in place over access to and use of the chops.  However, we cannot assure you that unauthorized access to or use of those chops can be prevented. Our designated employees who hold the corporate chops could abuse their authority by, for example, binding us to contracts against our interests or intentions, which could result in economic harm, disruption or our operations or other damages to them as a result of any contractual obligations, or resulting disputes, that might arise. If the party contracting with us asserted that we did not act in good faith under such circumstances, then we could incur costs to nullify such contracts. Such corporate or legal action could involve significant time and resources, while distracting management from our operations. In addition, we may not be able to recover corporate assets that are sold or transferred out of our control in the event of such a misappropriation if a transferee relies on the apparent authority of the representative and acts in good faith.

If a designated employee uses a chop in an effort to obtain control over one or more of our Chinese subsidiaries, we would need to take legal action to seek the return of the applicable chop(s), apply for a new chop(s) with the relevant authorities, or otherwise seek legal redress for the violation of their duties. During any period where we lose effective control of the corporate activities of one or more of our Chinese subsidiaries as a result of such misuse or misappropriation, the business activities of the affected entity could be disrupted and we could lose the economic benefits of that aspect of our business. To the extent those chops are stolen or are used by unauthorized persons or for unauthorized purposes, the corporate governance of these entities could be severely and adversely compromised and the operations of those entities could be significantly and adversely impacted.

International tariffs, including tariffs applied to goods traded between the U.S. and China, could materially and adversely affect our business and results of operationsTheIn recent years, the U.S. government has made statements and takentook certain actions that have led to, and may lead to, further changes to U.S. and international trade policies, including recently imposedthe imposition of tariffs affecting certain products exported by a number of U.S. trading partners, including China.  The institution of trade tariffs both globally and between the U.S. and China specifically carries the risk of negatively impacting China’s overall economic condition, which could have negative repercussions for us.  Furthermore, imposition of tariffs could cause a decrease in the sales of our products to customers located in China or other customers selling to Chinese end users, which would directly impact our business.


The current U.S. President, members of his Administration, and other public officials, including members of the current United States Congress, continue to signal that

It remains unclear how tax or trade policies, tariffs, or trade relations may change or evolve with changes in the U.S. may further alter its trade policy, including taking certain actions that may further impact U.S. trade policy, including newPresidential Administration.  Perceived or increased tariffs on certain goods imported into the U.S. Further,actual changes in U.S. trade policy could trigger retaliatory actions by affected countries, which could impose restrictions on our ability to do business in or with affected countries or prohibit, reduce, or discourage purchases of our products by foreign customers, leading to increased costs of products that contain our components, increased costs of manufacturing our products, and higher prices of our products in foreign markets.  Changes in, and responses to, U.S. trade policy could reduce the competitiveness of our products and cause our sales and revenues to drop, which could materially and adversely impact our business and results of operations.

Tariffs have already begun to havehad a negative impact on our cost of sales beginning late in fiscal year 2019.  We are evaluating and implementingAs a result, we implemented a number of strategies to mitigate the current and, hopefully, future impact of tariffs.  These strategies mitigated the impact of tariffs beginning in the second quarter of fiscal year 2020 and continued through fiscal years 2021 and 2022.  However, given the uncertainty regarding the scope and duration of the effective and proposed tariffs, as well as the potential for additional trade actions by the U.S. or other countries in the continuedfuture, any future impact on our operations and financial results is uncertain and these impacts could be more significant than those we experienced in fiscal 2019. Weyear 2020.  Further, we can provide no assurance that anythe strategies we implementimplemented to mitigate the impact of such tariffs or other trade actions will continue to be successful.  To the extent that our supply chain, costs, sales, or profitability are negatively affected by the tariffs or other trade actions, our business, financial condition, and results of operations may be materially adversely affected.

Our future growth is partially dependent on our market penetration efforts.Our future growth is partially dependent on our market penetration efforts, which include diversifying our sales and offering to high-volume, low-costprovide complete optical applicationssolutions such as assemblies to existing and other new market and product opportunities in multiple industries.markets.  While we believe our existing productswe are commercially viable,able to provide such engineered solutions, we anticipate the need to educategain the customer’s trust in providing more than the optical components markets in order to generate market demand and market feedback may require us to further refine these products.component, a process that can sometimes take months, if not years.  Expansion of our product lines and sales into new markets will require significant investment in equipment, facilities, and materials.  There can be no assurance that any proposed products will be successfully developed, demonstrate desirable optical performance, be capable of being produced in commercial quantities at reasonable costs, or be successfully marketed.

16

Table of Contents

We rely, in large part, on key business and sales relationships for the successful commercialization of our products, which, if not developed or maintained, will have an adverse impact on achieving market awareness and acceptance and will result in a loss of business opportunities.To achieve wide market awareness and acceptance of our products and technologies, as part of our business strategy, we will attempt to enter into a variety of business relationships with other companies that will incorporate our technologies into their products and/or market products based on our technologies.  The successful commercialization of our products and technologies will depend in part on our ability to meet obligations under contracts with respect to the products and related development requirements.  The failure of these business relationships will limit the commercialization of our products and technologies, which will have an adverse impact on our business development and our ability to generate revenues.

If we do not expand our sales and marketing organization, our revenues may not increase.  The sale of our products requires prolonged sales and marketing efforts targeted at several key departments within our prospective customers’ organizations and often involves our executives, personnel, and specialized systems and applications engineers working together.  Currently, our direct sales and marketing organization is somewhat limited.  We believe we will need to continue to strengthen our sales and marketing organization in order to increase market awareness and sales of our products.  There is significant competition for qualified personnel, and we might not be able to hire the kind and number of sales and marketing personnel and applications engineers we need.  If we are unable to continue to expand our sales operations particularly in China,globally, we may not be able to continue to increase market awareness or sales of our products, which would adversely affect our revenues, results of operations, and financial condition.

If we are unable to develop and successfully introduce new and enhanced products that meet the needs of our customers, our business may not be successful.  Our future success depends, in part, on our ability to anticipate our customers’ needs and develop products that address those needs.  Introduction of new products and product enhancements will require that we effectively transfer production processes from research and development to manufacturing, and coordinate our efforts with the efforts of our suppliers to rapidly achieve efficient volume production.  If we fail to effectively transfer production processes, develop product enhancements, or introduce new products that meet the needs of our customers as scheduled, our net revenues may decline, which would adversely affect our results of operations and financial condition.

If we are unable to effectively compete, our business and operating results could be negatively affected.  We face substantial competition in the optical markets in which we operate.  Many of our competitors are large public and private companies that have longer operating histories and significantly greater financial, technical, marketing, and other resources than we have.  As a result, these competitors are able to devote greater resources than we can to the development, promotion, sale, and support of their products.  In addition, the market capitalization and cash reserves of several of our competitors are much larger than ours, and, as a result, these competitors are better positioned than we are to exploit markets, develop new technologies, and acquire other companies in order to gain new technologies or products.  We also compete with manufacturers of conventional spherical lens products and aspherical lens products, producers of optical quality glass, and other developers of gradient lens technology, as well as telecommunications product manufacturers. In both the optical lens and communications markets, we are competing against, among others, established international companies, especially in Asia.  Many of these companies also are primary customers for optical and communication components, and, therefore, have significant control over certain markets for our products.  There can be no assurance that existing or new competitors will not develop technologies that are superior to or more commercially acceptable than our existing and planned technologies and products or that competition in our industry will not lead to reduced prices for our products.  If we are unable to successfully compete with existing companies and new entrants to the markets we compete in, our business, results of operations, and financial condition could be adversely affected.


We anticipate further reductions in the average selling prices of some of our products over time, and, therefore, must increase our sales volumes, reduce our costs, and/or introduce higher margin products to reach and maintain consistent profitable results.  We have experienced decreases in the average selling prices of some of our products over the last ten years, including most of our passive component products.  We anticipate that as certain products in the optical component and module market become more commodity-like, the average selling prices of our products will decrease in response to competitive pricing pressures, new product introductions by us or our competitors, or other factors.  We attempt to offset anticipated decreases in our average selling prices by increasing our sales volumes and/or changing our product mix.  If we are unable to offset anticipated future decreases in our average selling prices by increasing our sales volumes or changing our product mix, our net revenues and gross margins will decline, increasing the projected cash needed to fund operations.  To address these pricing pressures, we must develop and introduce new products and product enhancements that will generate higher margins, continue to reduce costs, and/or change our product mix in order to generate higher margins.  If we cannot maintain or improve our gross margins, our financial position, and results of operations may be harmed. 

Because of our limited product offerings, our ability to generate additional revenues may be limited without additional growth.  We organized our business based on three product groups: PMOs, infrared products, and specialty products.  In fiscal 2019,year 2022, sales of PMO products represented approximately 42% of our net revenues, sales of infrared products represented approximately 51%53% of our net revenues, and sales of specialty products represented 5% of our revenues.  In the future, we expect a larger percentage ofgrowth in both our revenues to be generated from sales of ourPMO and infrared products.product groups.  Continued and expanding market acceptance of these products, particularly our BD6-based infrared products, is critical to our future success.  There can be no assurance that our current or new products will achieve market acceptance at the rate at which we expect, or at all, which could adversely affect our results of operations and financial condition.

17

Table of Contents

We may need additional capital to sustain our operations in the future, and may need to seek further financing, which we may not be able to obtain on acceptable terms or at all, which could affect our ability to implement our business strategies.  We have limited capital resources.  Our operations have historically been largely funded from the proceeds of equity financings with some level of debt financing as well as cash flow from operations.  In recent years we have generated sufficient capital to fund our operations and necessary investments.  Accordingly, in future years, we anticipate only requiring additional capital to support acquisitions that would further expand our business and product lines.  We may not be able to obtain additional financing when we need it on terms acceptable to us, or at all.

Our future capital needs will depend on numerous factors including: (i) profitability; (ii) the release of competitive products by our competition; (iii) the level of our investment in research and development; and (iv) the amount of our capital expenditures, including equipment and acquisitions.  We cannot assure you that we will be able to obtain capital in the future to meet our needs.  If we are unable to raise capital when needed, our business, financial condition, and results of operations would be materially adversely affected, and we could be forced to reduce or discontinue our operations.

Litigation may adversely affect our business, financial condition, and results of operations.  From time to time in the normal course of business operations, we may become subject to litigation that may result in liability material to our financial statements as a whole or may negatively affect our operating results if changes to our business operations are required.  The cost to defend such litigation may be significant and is subject to inherent uncertainties.  Insurance may not be available at all or in sufficient amounts to cover any liabilities with respect to these or other matters.  There also may be adverse publicity with litigation that could negatively affect customer perception of our business, regardless of whether the allegations are valid or whether we are ultimately found liable.  An adverse result in any such matter could adversely impact our operating results or financial condition.  Additionally, any litigation to which we are subject could also require significant involvement of our senior management and may divert management’s attention from our business and operations.

We are exposed to fluctuations in currency exchange rates that could negatively impact our financial results and cash flows.  We execute all foreign sales from our U.S.-based facilities and inter-company transactions in U.S. dollars in order to partially mitigate the impact of foreign currency fluctuations.  However, a portion of our international revenues and expenses are denominated in foreign currencies.  Accordingly, we experience the risks of fluctuating currencies and corresponding exchange rates.  In fiscal years 20192022 and 2018, 2021, we recognized a net losslosses of approximately $436,000$3,000 and a net gain of $141,000$1,000 on foreign currency transactions, respectively.  Any such fluctuations that result in a less favorable exchange rate could adversely affect a portion of our revenues and expenses, which could negatively impact our results of operations and financial condition.

We also source certain raw materials from outside the U.S.  Some of those materials, priced in non-dollar currencies, fluctuate in price due to the value of the U.S. dollar against non-dollar-pegged currencies, especially the Euro and Renminbi.  As the dollar strengthens, this increases our margins and helps with our ability to reach positive cash flow and profitability.  If the strength of the U.S. dollar decreases, the cost of foreign sourced materials could increase, which would adversely affect our financial condition and results of operations.


  If the Euro or Renminbi currencies were to trend unfavorably against the U.S. dollar on a long-term basis, then we would seek to rebalance our strategic materials sourcing.

A significant portion of our cash is generated and held outside of the U.S.  The risks of maintaining significant cash abroad could adversely affect our cash flows and financial results.During fiscal 2019,year 2022, greater than 50% of our cash was held abroad.  WeHistorically, we generally considerconsidered unremitted earnings of our subsidiaries operating outside of the U.S. to be indefinitely reinvested and it is notreinvested.  During fiscal year 2020, we began declaring intercompany dividends to remit a portion of the earnings of our current intentforeign subsidiaries to change this position. Cashus.  Remaining cash held outside of the U.S. is primarily used for the ongoing operations of the business in the locations in which the cash is held.  Certain countries, such as China, have monetary laws that limit our ability to utilize cash resources in China for operations in other countries.  Before any funds can be repatriated, the retained earnings in Chinaof the legal entity must equal at least 150%50% of theits registered capital.  As of June 30, 2019, we2022, LPOIZ had approximately $3.9 million in retained earnings in Chinaavailable for repatriation, and LPOI did not have any earnings available for repatriation, based on earnings accumulated through December 31, 2021, the end of $3.3 million and we need to have retained earningsthe most recent statutory tax year, that remained undistributed as of $11.3 million before repatriation will be allowed.June 30, 2022.  This limitation may affect our ability to fully utilize our cash resources for needs in the U.S. or other countries and may adversely affect our liquidity.  Further, since repatriation of such cash is subject to limitations and may be subject to significant taxation, we cannot be certain that we will be able to repatriate such cash on favorable terms or in a timely manner.  If we incur operating losses and/or require cash that is held in international accounts for use in our operations based in the U.S., a failure to repatriate such cash in a timely and cost-effective manner could adversely affect our business and financial results.

18

Table of Contents

Our business may be materially affected by changes to fiscal and tax policies.  Potentially negative or unexpected tax consequences of these policies, or the uncertainty surrounding their potential effects, could adversely affect our results of operations and the price of our Class A common stock.The U.S. Tax Cuts and Jobs Act of 2017 (the “TCJA”) was approved by the U.S. Congress on December 20, 2017 and signed into law on December 22, 2017.  This legislation makesmade significant changes to the U.S. Internal Revenue Code of 1986, as amended (the “IRC”).  Such changes include a reduction in the corporate tax rate from 35% to 21%,limitation on the deductibility of interest expense and performance basedperformance-based incentive compensation, and implementation of a modified territorial tax system, including a provision that requirescompanies to include theirglobal intangible low-taxed income (GILTI) and its effect on our U.S. taxable income (effectively, non-U.S. income in excess of a deemed return on tangible assets of non-U.S. corporations), among other changes.

In addition, the TCJA requires complex computations to be performed that were not previously required in U.S. tax law, significant judgments to be made in interpretation of the provisions of the TCJA and significant estimates in calculations, and the preparation and analysis of information not previously relevant or regularly produced.  Implementation of the TCJA required us to calculate a one-time transition tax on certain foreign earnings and profits (“foreign E&P”) that had not been previously repatriated.  During fiscal year 2018, we provisionally determined our foreign E&P inclusion, and anticipated that we would not owe any one-time transition tax due to the utilization of U.S. net operating loss (“NOL”) carryforward benefits against these earnings.  During fiscal year 2019, we completed our analysis of the TCJA, and although we did not owe any one-time transition tax, the deferred tax asset related to our NOL carryforwards was impacteddecreased by approximately $202,000.  This amount iswas offset by our valuation allowance for a net impact of zero to our income tax provision.

The TCJA may also impact our repatriation strategies in the future.  Foreign governments may enact tax laws in response to the TCJA that could result in further changes to global taxation and materially affect our financial position and results of operations.  The uncertainty surrounding the effect of the reforms on our financial results and business could also weaken confidence among investors in our financial condition.  This could, in turn, have a materially adverse effect on the price of our Class A common stock.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was signed into law, which, among other things, is intended to provide emergency assistance to qualifying businesses and individuals.  The CARES Act also suspends the limitation on the deduction of NOLs arising in taxable years beginning before January 1, 2021, permits a five-year carryback of NOLs arising in taxable years beginning after December 31, 2017 and before January 1, 2021, and generally modifies the limitation on the deduction for net interest expense to 50% of adjusted taxable income for taxable years beginning in 2019 and 2020.  During fiscal year 2020, as a result of the CARES Act, the Company was able to accelerate the recovery of an income tax receivable related to previously paid alternative minimum tax. The receivable amount of approximately $107,000 as of June 30, 2020 was collected in July 2020.  In addition, the Company elected to utilize the payroll tax deferral under the CARES Act, resulting in cash savings in fiscal 2021 of approximately $325,000, accrued as of June 30, 2021.  Half of this amount was remitted on December 31, 2021, with the remainder deferred until December 31, 2022. While we may receive further financial, tax, or other relief and other benefits under and as a result of the CARES Act, it is not possible to estimate at this time the availability, extent, or impact of any such relief.

Further, our worldwide operations subject us to the jurisdiction of a number of taxing authorities.  The income earned in these various jurisdictions is taxed on differing basis, including net income actually earned, net income deemed earned, and revenue-based tax withholding.  The final determination of our income tax liabilities involves the interpretation of local tax laws, tax treaties, and related authorities in each jurisdiction, as well as the use of estimates and assumptions regarding the scope of future operations and results achieved and the timing and nature of income earned and expenditures incurred.  Changes in or interpretations of tax law and currency/repatriation control could impact the determination of our income tax liabilities for a tax year, which, in turn, could have a materially adverse effect on our financial condition and results of operations.

  For example, President Biden has proposed various changes to existing U.S. tax laws, including increasing the corporate income tax rate and increasing the income tax rate on certain earnings of foreign subsidiaries, which if enacted could have a material impact on our business, results of operations, financial condition, and cash flows.

Our future success depends on our key executive officers and our ability to attract, retain, and motivate qualified personnel.  Our future success largely depends upon the continued services of our key executive officers, management team, and other engineering, sales, marketing, manufacturing, and support personnel.  If one or more of our key employees are unable or unwilling to continue in their present positions, we may not be able to replace them readily, if at all.  Additionally, we may incur additional expenses to recruit and retain new key employees.  If any of our key employees joins a competitor or forms a competing company, we may lose some or a significant portion of our customers.  Because of these factors, the loss of the services of any of these key employees could adversely affect our business, financial condition, and results of operations.

Our continuing ability to attract and retain highly qualified personnel will also be critical to our success because we will need to hire and retain additional personnel to support our business strategy.  We expect to continue to hire selectively in the manufacturing, engineering, sales and marketing, and administrative functions to the extent consistent with our business levels and to further our business strategy.  We face significant competition for skilled personnel in our industry.  This competition may make it more difficult and expensive to attract, hire, and retain qualified managers and employees.  Because of these factors, we may not be able to effectively manage or grow our business, which could adversely affect our financial condition or business.


19

Table of Contents

We depend on single or limited source suppliers for some of the key materials or process steps in our products, making us susceptible to supply shortages, poor performance, or price fluctuations.  We currently purchase several key materials, or have outside vendors perform process steps, such as lens coatings, used in or during the manufacture of our products from single or limited source suppliers.  We may fail to obtain required materials or services in a timely manner in the future, or could experience delays as a result of evaluating and testing the products or services of potential alternative suppliers.  The decline in demand in the telecommunications equipment industry may have adversely impacted the financial condition of certain of our suppliers, some of whom have limited financial resources.  We have in the past, and may in the future, be required to provide advance payments in order to secure key materials from financially limited suppliers.  Financial or other difficulties faced by these suppliers could limit the availability of key components or materials.  For example, increasing labor costs in China has increased the risk of bankruptcy for suppliers with operations in China, and has led to higher manufacturing costs for us and the need to identify alternate suppliers.  Additionally, financial difficulties could impair our ability to recover advances made to these suppliers.  Any interruption or delay in the supply of any of these materials or services, or the inability to obtain these materials or services from alternate sources at acceptable prices and within a reasonable amount of time, would impair our ability to meet scheduled product deliveries to our customers and could cause customers to cancel orders, thereby negatively affecting our business, financial condition, and results of operation.

We face product liability risks, which could adversely affect our business.  The sale of our optical products involves the inherent risk of product liability claims by others.  We do not currently maintain product liability insurance coverage.  Product liability insurance is expensive, subject to various coverage exclusions, and may not be obtainable on terms acceptable to us if we decide to procure such insurance in the future.  Moreover, the amount and scope of any coverage may be inadequate to protect us in the event that a product liability claim is successfully asserted.  If a claim is asserted and successfully litigated by an adverse party, our financial position and results of operations could be adversely affected.

Business interruptions could adversely affect our business.  We manufacture our products at manufacturing facilities located in Orlando, Florida,Florida; Riga, Latvia,Latvia; and Zhenjiang, China.  Our revenues are dependent upon the continued operation of these facilities.  The Orlando Facility is subject to two leases, one that expires in AprilNovember 2022 and the other in November 2022.2032. The Riga Facility is subject to a lease that expirestwo leases which expire in December 2022,2030, and the Zhenjiang Facility is subject to three leasesone lease that expireexpires in December 2021, March 2022, and June 2022.2024.  Our operations are vulnerable to interruption by fire, hurricane winds and rain, earthquakes, electric power loss, telecommunications failure, and other events beyond our control.  We do not have detailed disaster recovery plans for our facilities and we do not have a backup facility, other than our other facilities, or contractual arrangements with any other manufacturers in the event of a casualty to or destruction of any facility or if any facility ceases to be available to us for any other reason.  If we are required to rebuild or relocate either of our manufacturing facilities, a substantial investment in improvements and equipment would be necessary.  We carry only a limited amount of business interruption insurance, which may not sufficiently compensate us for losses that may occur.

Our facilities may be subject to electrical blackouts as a consequence of a shortage of available electrical power.  We currently do not have backup generators or alternate sources of power in the event of a blackout.  If blackouts interrupt our power supply, we would be temporarily unable to continue operations at such facility.

Any losses or damages incurred by us as a result of blackouts, rebuilding, relocation, or other business interruptions, could result in a significant delay or reduction in manufacturing and production capabilities, impair our reputation, harm our ability to retain existing customers and to obtain new customers, and could result in reduced sales, lost revenue, increased costs and/or loss of market share, any of which could substantially harm our business and our results of operations.

Our failure to accurately forecast material requirements could cause us to incur additional costs, have excess inventories, or have insufficient materials to manufacture our products.  Our material requirements forecasts are based on actual or anticipated product orders.  It is very important that we accurately predict both the demand for our products and the lead times required to obtain the necessary materials.  Lead times for materials that we order vary significantly and depend on factors, such as specific supplier requirements, the size of the order, contract terms, and the market demand for the materials at any given time.  If we overestimate our material requirements, we may have excess inventory, which would increase our costs.  If we underestimate our material requirements, we may have inadequate inventory, which could interrupt our manufacturing and delay delivery of our products to our customers.  Any of these occurrences would negatively impact our results of operations.  Additionally, in order to avoid excess material inventories, we may incur cancellation charges associated with modifying existing purchase orders with our vendors, which, depending on the magnitude of such cancellation charges, may adversely affect our results of operations.

20

Table of Contents

If we do not achieve acceptable manufacturing yields our operating results could suffer.  The manufacture of our products involves complex and precise processes.  Our manufacturing costs for several products are relatively fixed, and, thus, manufacturing yields are critical to the success of our business and our results of operations.  Changes in our manufacturing processes or those of our suppliers could significantly reduce our manufacturing yields.  In addition, we may experience manufacturing delays and reduced manufacturing yields upon introducing new products to our manufacturing lines. The occurrence of unacceptable manufacturing yields or product yields could adversely affect our financial condition and results of operations.


If our customers do not qualify our manufacturing lines for volume shipments, our operating results could suffer.  Our manufacturing lines have passed our qualification standards, as well as our technical standards.  However, our customers may also require that our manufacturing lines pass their specific qualification standards, and that we be registered under international quality standards, beyond our ISO 9001:2015 certification.  This customer qualification process determines whether our manufacturing lines meet the customers’ quality, performance, and reliability standards.  Generally, customers do not purchase our products, other than limited numbers of evaluation units, prior to qualification of the manufacturing line for volume production.  We may be unable to obtain customer qualification of our manufacturing lines or we may experience delays in obtaining customer qualification of our manufacturing lines.  If there are delays in the qualification of our products or manufacturing lines, our customers may drop the product from a long-term supply program, which would result in significant lost revenue opportunity over the term of each such customer’s supply program, or our customers may purchase from other manufacturers.  The inability to obtain customer qualification of our manufacturing lines, or the delay in obtaining such qualification, could adversely affect our financial condition and results of operations.

Our business could suffer as a result of the United Kingdom’s decision to end its membership in the European UnionThe decision ofIn January 2020, the United Kingdom and the European Union entered into a withdrawal agreement pursuant to exitwhich the United Kingdom formally withdrew from the European Union on January 31, 2020 (generally referred to as “BREXIT”) could cause disruptions to and create uncertainty surrounding our business, including affecting our relationships with existing and potential customers, suppliers, and employees. The effects of BREXIT will depend on any agreements.  Following such withdrawal, the United Kingdom makesentered into a transition period scheduled to retain access toend on December 31, 2020.  Effective May 1, 2021, the United Kingdom and the European Union struck a bilateral trade and cooperation deal governing the future relationship between the United Kingdom and the European Union. However, there remains uncertainties and risks to our business related to Brexit and the new relationship between the United Kingdom and European Union, which will continue to be developed and defined, as well as any resulting political and economic instability created by Brexit. The political and economic impact of Brexit has caused and may continue to cause significant volatility in global markets either duringas well as greater restrictions on imports and exports between the United Kingdom and European Union countries, a transitional periodfluctuation in currency exchange rates, and increased regulatory complexities. The impact of the withdrawal of the United Kingdom may adversely affect business activity, political stability, and economic conditions in the United Kingdom, the European Union, and elsewhere. Such developments and their ultimate impact, or more permanently. The measuresthe perception that any of these developments are likely to occur, could potentially disrupthave a material adverse effect on economic growth or business activity in the United Kingdom, the Eurozone ,or the European Union, and could result in the relocation of businesses, cause business interruptions, lead to economic recession or depression, inhibit the growth of the European economy, cause greater volatility in all of the global currencies that we currently use to transact business and impact the stability of the financial markets, availability of credit, political systems or financial institutions, and the financial and monetary system. Such developments could have a material adverse effect on our business, financial position, liquidity and results of operations.

Russia’s ongoing conflict with Ukraine has disrupted the global economy. Our business, financial condition, and results of operations could be adversely affected by continued disruption and global consequences stemming from the conflict. Although we have no direct operations in Russia or Ukraine, the broader consequences of this conflict have negatively affected, and are expected to continue to negatively affect, the global economy, including the imposition of sanctions, cyber incidents or information technology failures, supply disruptions, increases in inflation rates, increase in energy costs, changes to foreign currency exchange rates, constraints, volatility, or disruption in financial markets, the availability of raw materials, supplies, freight, and labor, and uncertainty about economic and global stability. Historically, we have sourced germanium from suppliers located in Russia and China. We have, and intend to continue, sourcing germanium from suppliers located in China through the continuation of the Russian-Ukraine conflict and the Russian trade embargo.  Though we do not anticipate any challenges from sourcing germanium solely from suppliers in China, we cannot provide any assurances that we will be able to obtain adequate supplies in the future or, if adequate supplies are available, that the timing or costs of obtaining such raw materials will be acceptable to us. Further, some of our target marketsmajor customers in Europe may be directly impacted by the Russian-Ukraine conflict, which could impact the amount and jurisdictions in which we operate,frequency of orders they place with us, as well as impact the timing and adversely change tax benefits or liabilities in these or other jurisdictions. In addition, BREXIT could leadability to legal uncertainty and potentially divergent national laws and regulations as the United Kingdom determines which European Union lawspay for products ordered from us. Any material impacts to replace or replicate. BREXIT also may create global economic uncertainty, which may cause our customers and potential customers to monitor their costs and reduce their budgets for either our products or other products that incorporate our products. Any of these effects of BREXIT, among others, could materially adversely affecthave a material adverse effect on our business business opportunities, results of operations, financial condition, and cash flows.

If we fail to meet all applicable Nasdaq Capital Market (“NCM”) requirements and the Nasdaq Stock Market, LLC (“Nasdaq”) determines to delist our Class A common stock, the delisting could adversely affect the market liquidity of our Class A common stock, and, impair the value of your investment.Our Class A common stock is listed on the NCM. In order to maintain that listing, we must satisfy minimum financial and other requirements. On July 15, 2019, we received a notice from the Listing Qualifications Department of Nasdaq stating that, for the last 30 consecutive business days, the closing bid price for our Class A common stock had been below the minimum $1.00 per share requirement for continued listing on the NCM as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have been provided 180 calendar days, or until January 13, 2020, to regain compliance with the minimum bid price requirement. The July 15, 2019 notification letter has no effect at this time on the listing of our common stock on the NCM or trading of our Class A common stock. We may achieve compliance during thisadditional 180-day period if the closing bid price of our Class A common stock is at least $1.00 per share for a minimum of 10 consecutive business days by January 13, 2020. If we fail to regain compliance on or prior to January 13, 2020, our Class A common stock will be subject to delisting by Nasdaq if Nasdaq does not approve an additional 180-day compliance period, during which time we may have to effect a reverse stock split.
If we fail to meet all applicable NCM requirements in the future and Nasdaq determines to delist our Class A common stock, the delisting could adversely affect the market liquidity of our Class A common stock and adversely affect our ability to obtain financing for the continuation of our operations. This delisting could also impair the value of your investment.
operating results.

Risks Related To Our Intellectual Property

If we are unable to protect and enforce our intellectual property rights, we may be unable to compete effectively. We believe that our intellectual property rights are important to our success and our competitive position, and we rely on a combination of patent, copyright, trademark, and trade secret laws and restrictions on disclosure to protect our intellectual property rights.  Although we have devoted substantial resources to the establishment and protection of our intellectual property rights, the actions taken by us may be inadequate to prevent imitation or improper use of our products by others or to prevent others from claiming violations of their intellectual property rights by us.

21

Table of Contents

In addition, we cannot assure that, in the future, our patent applications will be approved, that any patents that may be issued will protect our intellectual property, or that third parties will not challenge any issued patents.  Other parties may independently develop similar or competing technology or design around any patents that may be issued to us.  We also rely on confidentiality procedures and contractual provisions with our employees, consultants, and corporate partners to protect our proprietary rights, but we cannot assure the compliance by such parties with their confidentiality obligations, which could be very time consuming, expensive, and difficult to enforce.

It may be necessary to litigate to enforce our patents, copyrights, and other intellectual property rights, to protect our trade secrets, to determine the validity of and scope of the proprietary rights of others, or to defend against claims of infringement or invalidity.  Such litigation can be time consuming, distracting to management, expensive, and difficult to predict.  Our failure to protect or enforce our intellectual property could have an adverse effect on our business, financial condition, prospects, and results of operation.


We do not have patent protection for our formulas and processes, and a loss of ownership of any of our formulas and processes would negatively impact our business. We believe that we own our formulas and processes.  However, we have not sought, and do not intend to seek, patent protection for all of our formulas and processes.  Instead, we rely on the complexity of our formulas and processes, trade secrecy laws, and employee confidentiality agreements.  However, we cannot assure you that other companies will not acquire our confidential information or trade secrets or will not independently develop equivalent or superior products or technology and obtain patent or similar rights.  Although we believe that our formulas and processes have been independently developed and do not infringe the patents or rights of others, a variety of components of our processes could infringe existing or future patents, in which event we may be required to modify our processes or obtain a license.  We cannot assure you that we will be able to do so in a timely manner or upon acceptable terms and conditions and the failure to do either of the foregoing would negatively affect our business, results of operations, financial condition, and cash flows.

We may not be able to protect our intellectual property rights throughout the world.  Filing, prosecuting, and defending patents or establishing other intellectual property rights in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. or non-existent.  Further, many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions.  The legal systems of some countries do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents or misappropriation of our intellectual property rights generally. Proceedings to enforce our patent and other intellectual property rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents or intellectual property rights at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. We believe that we have adequate protections in place with respect to our intellectual property; however, we cannot provide any assurances that such protections will be sufficient in the future.  Any infringement or misappropriations of our patents and intellectual property rights would adversely affect our business, results of operations, financial condition, and cash flows.

We may become involved in intellectual property disputes and litigation, which could adversely affect our business.  We anticipate, based on the size and sophistication of our competitors and the history of rapid technological advances in our industry that several competitors may have patent applications in progress in the U.S. or in foreign countries that, if issued, could relate to products similar to ours.  If such patents were to be issued, the patent holders or licensees may assert infringement claims against us or claim that we have violated other intellectual property rights.  These claims and any resulting lawsuits, if successful, could subject us to significant liability for damages and invalidate our proprietary rights.  The lawsuits, regardless of their merits, could be time-consuming and expensive to resolve and would divert management time and attention.  Any potential intellectual property litigation could also force us to do one or more of the following, any of which could harm our business and adversely affect our financial condition and results of operations:

●             
stop selling, incorporating or using our products that use the disputed intellectual property;
● 
obtain from third parties a license to sell or use the disputed technology, which license may not be available on reasonable terms, or at all; or
●             
redesign our products that use the disputed intellectual property.

·

stop selling, incorporating or using our products that use the disputed intellectual property;

·

obtain from third parties a license to sell or use the disputed technology, which license may not be available on reasonable terms, or at all; or

·

redesign our products that use the disputed intellectual property.

22

Table of Contents

Item 2. Properties.

Properties.

Our properties consist primarily of leased office and manufacturing facilities. Our corporate headquarters are located in Orlando, Florida and our manufacturing facilities are primarily located in Zhenjiang, China and Riga, Latvia. We also have a sales, marketing, and administrative office in Shanghai, China.  The following schedule presents the approximate square footage of our offices and facilities as of June 30, 2019:

2022:

Location

Square Feet

Commitment and Use

Orlando, Florida

38,000

62,000

Leased; 3 suites used for corporate headquarters offices, manufacturing, and research and development

Irvington, New York

Riga, Latvia

13,000

29,000

Leased; ceased use as of June 30, 20193 suites used for administrative offices, manufacturing and crystal growing

Zhenjiang, China

55,000

55,000

Leased; 1 building used for manufacturing, and 1 floor of 1 building used for manufacturing

Shanghai, China

1,900

1,900

Leased; 1 office suite used for sales, marketing and administrative offices

Riga, Latvia23,000Leased; 2 suites used for administrative offices, manufacturing and crystal growing

Our territorial sales personnel maintain an office from their homes to serve their geographical territories. 

For additional information regarding our facilities, please seeItem 1. Businessin this Annual Report on Form 10-K.  For additional information regarding leases, see Note 13, Lease Commitments,12, Leases, to the Notes to the Consolidated Financial Statements to this Annual Report on Form 10-K.

Item 3. Legal Proceedings.

Proceedings.

From time to time, we are involved in various legal actions arising in the normal course of business.  We currently have no material legal proceeding to which we are a party to or to which our property is subject to and, to the best of our knowledge, no material adverse legal activity is anticipated or threatened.


Item 4. Mine Safety Disclosures.

Not Applicable.

23

Table of Contents

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity SecuritiesSecurities.

Market Information

Our Class A common stock is traded on the NCMNasdaq Capital Market under the symbol “LPTH”.

Holders

As of August 1, 2019,September 8, 2022, we estimate there were approximately 202199 holders of record and approximately 9,45910,930 street name holders of our Class A common stock.

Dividends

We have never declared or paid any cash dividends on our Class A common stock and do not intend to pay any cash dividends in the foreseeable future. We currently intend to retain all future earnings in order to finance the operation and expansion of our business. In addition, thethe payment of dividends, if any, in the future, will depend on our earnings, capital requirements, financial conditions, and other relevant factors.

Item 6. Reserved.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Operations.

You should read the following discussion and analysis by our management of our financial condition and results of operations in conjunction with our consolidated financial statements and the accompanying notes.

The following discussion contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions.  Our actual results could differ materially from those discussed in the forward-looking statements.  Please also see the cautionary language at the beginning of this Annual Report on Form 10-K regarding forward-looking statements.

24

Table of Contents

The following discussions also include use of the non-GAAP term “gross margin,” as well as other non-GAAP measures discussed in more detail under the heading “Non-GAAP Financial Measures.”   Gross margin is determined by deducting the cost of sales from operating revenue.  Cost of sales includes manufacturing direct and indirect labor, materials, services, fixed costs for rent, utilities and depreciation, and variable overhead.  Gross margin should not be considered an alternative to operating income or net income, both of which are determined in accordance with GAAP.  We believe that gross margin, although a non-GAAP financial measure, is useful and meaningful to investors as a basis for making investment decisions.  It provides investors with information that demonstrates our cost structure and providesindicates the amount of funds foravailable to cover our total costs and expenses.  We use gross margin in measuring the performance of our business and have historically analyzed and reported gross margin information publicly.  Other companies may calculate gross margin in a different manner.

Potential Impact of COVID-19

In March 2020, the WHO declared the outbreak of COVID-19 as a pandemic based on the rapid increase in global exposure.  COVID-19 has spread throughout world, including the U.S., and continues to spread as additional variants emerge.  As a result of the COVID-19 pandemic, our employees at our facilities in China, Latvia, and the U.S. were subject to stay-at-home orders during a portion of fiscal year 2021, which restrictions have since been lifted as of the date of this Annual Report on Form 10-K.  In addition to stay-at-home orders, many jurisdictions also implemented social distancing and other restrictions and measures to slow the spread of COVID-19.  These restrictions significantly impacted economic conditions in the U.S. in 2020 and continued into 2021 and 2022.  Beginning in the spring of 2021, restrictions began to lift as vaccines became more available.  Despite these stay-at-home orders and other measures and restrictions implemented in the areas in which we operate, as a critical supplier to both the medical and defense industries, we were deemed to be an essential business; thus, regardless of the stay-at-home orders, our workforce was permitted to work from our facilities and our business operations have generally continued to operate as normal.  Nonetheless, despite the lifting of these stay-at-home orders, out of concern for our workforce, our U.S.- and Latvia-based non-manufacturing employees have continued to work remotely to some extent.  To date, we have not seen any significant direct financial impact of COVID-19 to our business.  However, the COVID-19 pandemic continues to impact economic conditions, which could impact the short-term and long-term demand from our customers and, therefore, has the potential to negatively impact our results of operations, cash flows, and financial position in the future.  Management is actively monitoring this situation and any impact on our financial condition, liquidity, and results of operations.  However, given the daily evolution of the COVID-19 pandemic and the global responses to curb its spread, we are not presently able to estimate the effects of the COVID-19 pandemic on our future results of operations, financials, or liquidity in fiscal year 2023 or beyond.

Effect of Certain Events Occurring at Our Chinese Subsidiaries

In April 2021, we terminated several employees of our China subsidiaries, LPOIZ and LPOI, including the General Manager, the Sales Manager, and the Engineering Manager, after determining that they had engaged in malfeasance and conduct adverse to our interests, including efforts to misappropriate certain of our proprietary technology, diverting sales to entities owned or controlled by these former employees and other suspected acts of fraud, theft and embezzlement.  In connection with such terminations, our China subsidiaries have engaged in certain legal proceedings with the terminated employees.

We have incurred various expenses associated with our investigation into these matters prior and subsequent to the termination of the employees and the associated legal proceedings.  These expenses, which included legal, consulting and other transitional management fees, totaled $718,000 during the year ended June 30, 2021.  During the year ended June 30, 2022, approximately $400,000 of related expenses were incurred.  Such expenses were recorded as “Selling, general and administrative” expenses in the accompanying Consolidated Statements of Comprehensive Income (Loss). 

We also identified a further liability in the amount of $210,000, which could have been incurred in the future due to the actions of these employees. This amount was accrued as of June 30, 2021, pending further investigation, and was included in “Other Expense, net” in the Consolidated Statement of Comprehensive Income (Loss) for the year ended June 30, 2021. During the third quarter of fiscal year 2022, it was determined that our Chinese subsidiary would not be responsible for this amount. As such, this accrual was reversed and is included in the accompanying Consolidated Statements of Comprehensive Income (Loss) in the line item entitled “Other income (expense), net” for the year ended June 30, 2022.

Knowing that employee transitions in international subsidiaries can lead to lengthy legal proceedings that can interrupt the subsidiary’s ability to operate, compounded by the fact that our officers could not travel to China to oversee the transitions because of the travel restrictions imposed by COVID-19, we chose to enter into severance agreements with certain of the employees at the time of termination.  Pursuant to the severance agreements, LPOIZ and LPOI agreed to pay such employees severance of approximately $485,000 in the aggregate, to be paid over a six-month period.  After the execution of the severance agreements, we discovered additional wrongdoing by the terminated employees.  As a result, LPOIZ and LPOI have not yet paid the severance payments and have disputed the employees’ rights to such payments. Currently, there are ongoing civil actions in China in connection with LPOIZ’s and LPOI’s refusal to pay these severance amounts due to the employees’ non-compliance.  However, based on the likelihood that the courts in China will determine that our subsidiaries will ultimately be obligated to pay these amounts, we have accrued for these payments as of June 30, 2021, and such expenses were recorded as “Selling, general and administrative” expenses in the accompanying Consolidated Statement of Comprehensive Income (Loss) in fiscal year 2021.  As of June 30, 2022, approximately $430,000 remains accrued.  The Chinese Labor Court has ruled in favor of the former employees, as expected.  We are continuing litigation and negotiation as an option.

25

Table of Contents

We have transitioned the management of LPOI and LPOIZ to a new management team without any significant detrimental effects on their ability to operate.  We do not expect any material adverse impact to the business operations of LPOI or LPOIZ as a result of the transition.

We expect to incur additional legal fees and consulting expenses in future periods as we continue to pursue our legal options and remedies; however, such future fees are expected to be at lower levels than have been incurred to date.

Although we have taken steps to minimize the business impacts from the termination of the local management employees and transition to new management personnel, we experienced some short-term adverse impacts on LPOIZ’s and LPOI’s domestic sales in China and results of operations in the three-month period ended June 30, 2021, which continued through fiscal year 2022.  We have not experienced, nor do we anticipate, any material adverse impact on LPOIZ’s or LPOI’s production and supply of products to LightPath for LightPath’s customers.

Results of Operations

Operating Results for Fiscal Year Ended June 30, 20192022 compared to the Fiscal Year Ended June 30, 2018:

Revenues:
2021:

Revenue.

Revenue for fiscal 2019 totaledyear 2022 was approximately $33.7$35.6 million, an increasea decrease of $1.2 million, or 4%8%, as compared to $38.5 million in fiscal year 2021.  Revenue generated by infrared products was approximately $32.5$18.7 million in fiscal year 2022, a decrease of 11%, as compared to the prior fiscal year.  The decrease in revenue is primarily driven by sales to customers in the industrial market, particularly for our BD6-based molded infrared products.  Industrial applications, firefighting cameras, and other public safety applications continue to be the primary drivers of demand for infrared products, including thermal imaging assemblies.  During fiscal 2018. years 2020 and 2021, we saw an increase in demand for medical and temperature sensing applications, such as fever detection. Demand for temperature sensing applications were accelerated by COVID-19, and although the demand has leveled off since the initial spike, it remains elevated.

Revenue generated by PMO products was approximately $14.1$15.0 million an increasefor fiscal year 2022, a decrease of approximately $576,000, or 4%5%, as compared to $13.5 millionthe prior fiscal year.  The decrease in fiscal 2018. The increaserevenue is primarily dueattributed to increased sales to customersa reduction in orders from a key customer in the telecommunications market, due to a decrease in that customer’s market share. This decrease was partially offset by a decreasean increase in sales through our catalog and distribution channels, as well as increases in sales to customers in the commercial market. industrial and medical industries.

Revenue generated by infraredspecialty products was approximately $17.3$1.8 million forin fiscal 2019,year 2022, an increase of approximately $1.312% as compared to fiscal year 2021.  This increase is primarily due to higher NRE project revenue in fiscal year 2022.  NRE revenue is project based and the timing of any such projects is wholly dependent on our customers and their project activity.

Cost of Sales and Gross Margin.

Gross margin for fiscal year 2022 was approximately $11.8 million, or 8%a decrease of 12%, as compared to approximately $16.0$13.4 million in fiscal 2018. This increase was primarily driven by our new line of BD6 molded infrared products, including thermal imaging assemblies. The increased demand for our infrared products continues to be led by industrial applications, firefighting cameras and other public safety applications. We have entered into several new supply agreements with new customers for these types of products, and we expect this business to continue to grow. Revenue generated by our specialty products was $2.4 million for fiscal 2019, a decrease of $644,000, or 21%, as compared to $3.0 million for fiscal 2018. This decrease is due to timing of orders from customers in the defense industry, as well as some customer development projects related to LIDAR applications that did not continue in fiscal 2019.


Cost of Sales and Gross Margin:
Gross margin was approximately $12.5 million for both fiscal 2019 and 2018.year 2021.  Total cost of sales was approximately $21.2$23.7 million for fiscal 2019,year 2022, compared to $20.0$25.0 million for the prior fiscal year.year 2021, a decrease of 5%.  Gross margin as a percentage of revenue was 33% for fiscal 2019 was 37%,year 2022, compared to 39% in35% for the prior fiscal 2018. The increase in cost of sales,year. Although the product mix is similar for PMO and associated decrease ininfrared products for fiscal year 2022, as compared to the prior fiscal year, the gross margin as a percentage of revenue is primarilyunfavorably impacted by the result of certain cost increases, such as the elevated, non-recurring8% decrease in revenue, which resulted in under-utilized capacity in some areas.  Infrared product margins also reflect increased costs associated with the relocationcompletion of the Irvingtoncoating department in our Riga Facility, and higher duties and freight charges resulting from newly effective tariffs, which primarily impact our PMO product group. In addition, gross margin for fiscal 2019 was lower as a result of the decrease in specialty products revenue, duebegan to the absence of higher margin orders and projects, which benefited gross marginimprove in the prior year. With respectfourth quarter of fiscal year 2022 and is expected to infraredcontinue to improve over time, as that facility works through the qualification stages for more products we beganand begins to see some benefit from our margin improvement efforts inproduce at higher volumes.  In the second half of fiscal 2019 with respect to both existing products and our new BD6-based products. With respect to material costs, the standard material for the majority of our infrared products continues to be germanium, which has inherent pricing volatility. As we convert many of these products to our BD6 material, we expect our infraredyear 2022, margins to improve over time. Sales of infrared products made with this material more than doubled in fiscal 2019, as compared to the prior fiscal year. However, these products still represent less than 20% of our infrared revenue and, therefore, have not yet had a significant impact on our gross margin. We expect them to represent the majority of our infrared saleswere also negatively impacted by inflationary pressure in the future. With respect to the relocationcost of the Irvington Facility, we expected to have higherraw materials, and significantly increased energy costs, associated with the relocation of the Irvington Facility forparticularly in Latvia.

Selling, General and Administrative.

For fiscal 2019, and we expect costs to improve beginning in fiscal 2020, as the facility relocation was complete as of June 30, 2019.

year 2022, Selling, General and Administrative Expenses:
Selling, general and administrative (“SG&A”) costs for fiscal 2019 were approximately $10.5$11.2 million, an increasea decrease of approximately $1.3 million, as compared to approximately $9.2 million in the prior fiscal year. SG&A for fiscal 2019 included approximately $1.2 million of non-recurring expenses related to the relocation of the Irvington Facility to our existing Orlando Facility and Riga Facility. SG&A costs for fiscal 2019 were partially offset by a business interruption insurance settlement of approximately $306,000, associated with an incident that occurred in the Irvington Facility, unrelated to the facility relocation. This settlement is included in other receivables as of June 30, 2019, and was collected in August 2019. In addition to these non-recurring items, the following impacted SG&A costs for fiscal 2019, as compared to fiscal 2018: (i) advertising expenses increased by approximately $52,000, (ii) commission expenses increased approximately $40,000, driven by increased sales, and (iii) personnel costs increased by approximately $490,000, primarily due to newly created$768,000, or restructured executive positions in fiscal 2019. We expected SG&A costs to be elevated in fiscal 2019, due to the Irvington Facility relocation and positions added, however, on a long-term basis, we expect the consolidation of our manufacturing facilities to reduce our operating and overhead costs, which should improve our SG&A expenses.
New Product Development:
New product development costs were approximately $2.0 million in fiscal 2019, an increase of approximately $397,000, or 25%6%, as compared to the prior fiscal year.  This increase wasThe decrease in SG&A for fiscal year 2022 is primarily due to increased wagesan approximate $800,000 decrease in expenses associated with the previously described events that occurred at our Chinese subsidiaries, including severance, legal and consulting fees.  This decrease was partially offset by an increase in expenses for travel and tradeshows, with fewer COVID-19 restrictions in place, as well as expenses for certain “value-added taxes” (“VAT”) and related taxes owed by one of our Chinese subsidiaries from prior years, which was identified and settled in fiscal year 2022.  These increases were offset by the absence of the following non-recurring expenses that were incurred in fiscal year 2021: (i) approximately $400,000 of additional engineering employeescompensation to supportour former Chief Executive Officer, as previously disclosed in the demand forCurrent Report on Form 8-K filed with the SEC on November 18, 2020, and (ii) approximately $150,000 of additional stock compensation recorded as certain RSUs vested upon the retirement of two directors.

26

Table of Contents

New Product Development.

New product development particularlycosts were approximately $2.1 million in fiscal year 2022, a decrease of approximately 4%, as related to our new line of BD6-based infrared products.

Interest Expense:
In fiscal 2019, interest expense was approximately $697,000, compared to approximately $187,000$2.2 million in the prior fiscal year. InThis decrease was primarily due to lower spending on internally-funded development projects, while customer- and government-funded NRE projects increased in fiscal 2019,year 2022.

Other Expense.

Interest expense was approximately $229,000 for fiscal year 2022, compared to approximately $215,000 in the prior fiscal year.  The increase in interest expense is due to rising interest rates, partially offset by a 14% reduction in our total debt, including finance lease obligations, and excluding operating lease liabilities, as of June 30, 2022, as compared to the end of the prior fiscal year.

Other income, net, was impacted by the write-off of debt costsapproximately $177,000 in for fiscal year 2022, compared to other expense, net, of approximately $94,000 associated with the termination$194,000 for fiscal year 2021. Other income, net, for fiscal year 2022 includes a benefit of that certain Amended and Restated Loan and Security Agreement, as subsequently amended, entered into initially on December 21, 2016, by and between Avidbank Corporate Finance, a division of Avidbank (“Avidbank”), in the original principal amount of $7.3 million (the “Term II Loan”). The termination occurred on February 26, 2019 and, on the same date, we refinanced the Term II Loan by entering into a Loan Agreement (the “Loan Agreement”) with BankUnited, N.A. (“BankUnited”) for (i) a revolving line of credit up to a maximum amount of $2 million (the “Bank United Revolving Line”), (ii) a term loan in the amount of approximately $5.8 million (“BankUnited Term Loan”), and (iii) a non-revolving guidance line of credit up to a maximum amount of $10 million (the “Guidance Line” and, together with the BankUnited Revolving Line and BankUnited Term Loan, the “BankUnited Loans”). In fiscal 2018, net interest expense was reduced by a gain of approximately $467,000 associated with the satisfaction of the note payable to the sellers of ISP (the “Sellers Note”), in full, and$210,000, which represents the reversal of thea potential liability related fair value adjustment liability. Excluding these discrete items, interest expense decreased by approximately $50,000 for fiscal 2019, as compared to fiscal 2018, due to the more favorable terms associated withactions of the BankUnited Term Loan entered into duringterminated employees of our subsidiaries in China, as previously discussed. This potential liability was accrued as of June 30, 2021, pending further investigation, and it was determined in the third quarter of fiscal 2019. For additional information regarding the Term II Loan, the BankUnited Term Loan, and the Sellers Note, see “Liquidity and Capital Resources” below.

Other Income (Expense):
In fiscal 2018, we recognized non-cash expense of approximately $194,000 related to the change in the fair value of the warrants issued in connection withyear 2022 that our June 2012 private placement (the “June 2012 Warrants”). The June 2012 Warrants expired on December 11, 2017; therefore, there was no remaining warrant liability as of that date. Accordingly, we didChinese subsidiary would not recognize any income or expense in fiscal 2019 related to these warrants.

be responsible for this amount.  Other expense, net, was approximately $388,000 in fiscal 2019, compared to other income, net, of approximately $241,000 in the priorfor fiscal year primarily resulting from2021 included an expense of $210,000 associated with this accrual. Other income (expense), net also includes net foreign exchangecurrency transaction gains and losses.losses, which were minimal for fiscal years 2022 and 2021.  We execute all foreign sales from our Orlando and New YorkU.S. facilities and inter-company transactions in U.S. dollars, partially mitigating the impact of foreign currency fluctuations. Assets and liabilities denominated in non-U.S.non-United States currencies, primarily the Chinese Yuan and Euro, are translated at rates of exchange prevailing on the balance sheet date, and revenues and expenses are translated at average rates of exchange for the year.  During fiscal 2019,year 2022, we incurred a loss onnet foreign currency translationtransaction losses of approximately $436,000,$3,000, compared to a gain of $141,000$1,000 for the prior fiscal year.
year 2021. 

Income taxes:

IncomeTaxes.

During fiscal year 2022, we recorded income tax expense of approximately $863,000, compared to approximately $934,000 in fiscal year 2021, primarily related to income taxes from our operations in China.  Income taxes for fiscal 2019 was $455,000, comparedyears 2022 and 2021 also included Chinese withholding tax expenses of $230,000 and $524,000, respectively, the majority of which are associated with intercompany dividends declared by LPOIZ, payable to anus as the parent company.  While this repatriation transaction resulted in some additional Chinese withholding taxes, LPOIZ currently qualifies for a reduced Chinese income tax benefit of approximately $827,000 for fiscal 2018.rate; therefore, the total tax on those earnings was still below the normal income tax rate.  The income tax benefitprovision for fiscal 2018 is attributable to changes in taxation related to certain subsidiaries in Chinayear 2022 also includes a true-up of deferred tax liabilities for LPOIZ, and Latvia, as well as a decreasethe income tax provision for fiscal year 2021 reflects an increase in the valuation allowance on our U.S. deferred tax assets.  For fiscal 2019, income tax expense is largely attributablePlease refer to income taxesNote 8, Income Taxes, in the Notes to the Consolidated Financial Statements in this Annual Report on Form 10-K for additional information related to each of our Chinese subsidiary LPOIZ.

Our Chinese subsidiaries, LPOI and LPOIZ, are governed by the Income Tax Law of the People’s Republic of China, which is applicable to privately run and foreign invested enterprises, and which generally subjects such enterprises to a statutory rate of 25% on income reported in the statutory financial statements after appropriate tax adjustments.  During fiscal 2018, the statutory rate applicable to LPOIZ decreased from 25% to 15%, in accordance with an incentive program for technology companies in China. This rate change was retroactive to January 1, 2017. Accordingly, we recognized a benefit during fiscal 2018 related to this rate change. ISP Latvia is governed by the Law of Corporate Income Tax of Latvia, which is applicable to privately run and foreign invested enterprises, and which, through December 31, 2017, generally subjected such enterprises to a statutory rate of 15% on income reported in the statutory financial statements after appropriate tax adjustments. Effective January 1, 2018, the Republic of Latvia enacted tax reform, which resulted in the recognition of a tax benefit, due to the reduction of the previously recorded net deferred tax liability to zero during fiscal 2018.
jurisdictions.

Net Income (Loss):

For.

Net loss for fiscal 2019, we incurred a net loss of $2.7year 2022 was approximately $3.5 million, or $0.10$0.13 basic and diluted loss per share, compared to net income of approximately $1.1$3.2 million, or $0.04$0.12 basic and diluted earningsloss per share, for fiscal 2018.year 2021.  The approximately $3.7 million decreaseincrease in net loss for fiscal year 2022, as compared to fiscal year 2021, is primarily dueattributable to a $785,000 increase in operating loss resulting from lower gross margin, which was partially offset by lower operating expenses.  Non-operating items include a $420,000 favorable difference for the following: (1) fiscal 2019 includes approximately $1.2 million in additional SG&A expensesaforementioned accrual and subsequent reversal of a potential liability associated with the relocationactions of our terminated employees of our Chinese subsidiaries.  In addition, there was a favorable difference of approximately $71,000 in the Irvington Facility; (2)provision for income tax expense increased by approximately $1.3 million due to non-recurring benefits related to our foreign jurisdictions and the adjustment to the valuation allowance on our U.S. deferred tax assets, all of which favorably impacted fiscal 2018; (3) new product development expenses increased by approximately $397,000; and (4) an unfavorable difference in foreign exchange transaction gains and losses of $577,000.

taxes.

Weighted-average shares of Class A common stock shares outstanding were 25,794,669,27,019,534 for both basic and diluted in fiscal 2019,year 2022, compared to 26,314,025 for both basic and diluted shares of 25,006,467 and 26,811,468, respectively, in fiscal 2018.year 2021.  The increase in the weighted-average basic weighted-average common stock shares was primarily due to the 967,208issuance of shares of Class A common stock issued during the third quarter of fiscal 2018 in conjunction with the satisfaction of the Sellers Note, and, to a lesser extent, shares of Class A common stock issued under the 2014 Employee Stock Purchase Plan (“ESPP”),ESPP and uponunderlying vested RSUs.  Potential dilutive common stock equivalents were excluded from the exercisescalculation of stock optionsdiluted shares for fiscal years 2022 and restricted stock units (“RSUs”).

2021, as their effects would have been anti-dilutive due to the net loss in those periods.

Liquidity and Capital Resources

At June 30, 2019,2022, we had working capital of approximately $13.3$10.4 million and total cash and cash equivalents of approximately $4.6$5.5 million. Approximately $3.3 millionGreater than 50% of our total cash and cash equivalents was held by our foreign subsidiaries in China and Latvia.

Cash and cash equivalents held by our foreign subsidiaries in China and Latvia were generated in Chinain-country as a result of foreign earnings.  BeforeHistorically, we considered unremitted earnings held by our foreign subsidiaries to be permanently reinvested.  However, during fiscal year 2020, we began declaring intercompany dividends to remit a portion of the earnings of our foreign subsidiaries to us, as the U.S. parent company.  It is still our intent to reinvest a significant portion of earnings generated by our foreign subsidiaries, however we also plan to repatriate a portion of their earnings.

27

Table of Contents

In China, before any funds can be repatriated, the retained earnings in Chinaof the legal entity must equal at least 150%50% of the registered capital.  During fiscal years 2022 and 2021, we repatriated approximately $2.8 million and $4 million, respectively, from LPOIZ.  As of June 30, 2019,2022, LPOIZ had approximately $3.9 million in retained earnings available for repatriation, and LPOI did not have any earnings available for repatriation, based on earnings accumulated through December 31, 2021, the end of the most recent statutory tax year, that remained undistributed as of June 30, 2022.  Based on our previous intent, we had retained earnings of $3.3 million and we need to have retained earnings of $11.3 million before repatriation will be allowed. We currently intend to permanently invest earnings from our foreign Chinese operations and, therefore, we have not previouslyhistorically provided for future Chinese withholding taxes on the related earnings.  However, if, induring fiscal year 2020 we began to accrue for these taxes on the future,portion of earnings that we change such intention, we would provide for and pay additional foreign taxes, if any, at that time.

intend to repatriate.

Loans payable as of June 30, 2019 consist of the BankUnited Term Loan. As of June 30, 2019, the outstanding balance on the BankUnited Term Loan was approximately $5.7 million, and we had no borrowings outstanding on the BankUnited Revolving Line. The Amended Loan Agreement (as defined below) includes certain customary covenants. We were in compliance with all covenants as of June 30, 2019.


Avidbank Loan
Until February 26, 2019, loans payable2022 consisted of the Term II Loan payable to Avidbank, pursuant to the Second Amended and Restated Loan and Security Agreement (the “LSA”) entered into on December 21, 2016, as amended by the First Amendment to the LSA dated December 20, 2017 (the “First Amendment”), the Second Amendment to the LSA dated January 16, 2018 (the “Second Amendment”), the Third Amendment to the LSA dated May 11, 2018 (the “Third Amendment”), the Fourth Amendment to the LSA dated September 7, 2018 (the “Fourth Amendment”), and the Fifth Amendment to the LSA dated October 30, 2018 (the “Fifth Amendment” and, together with the LSA, First Amendment, the Second Amendment, the Third Amendment, and the Fourth Amendment, the “Amended LSA”). The Amended LSA also provided for a working capital revolving line of credit (the “Revolving Line”).
Pursuant to the Amended LSA, Avidbank agreed to, in its discretion, maketerm loan advances under the Revolving Line to us up to a maximum aggregate principal amount outstanding not to exceed the lesser of (i) One Million Dollars ($1,000,000), or (ii) eighty percent (80%) (the “Maximum Advance Rate”) of the aggregate balance of our eligible accounts receivable, as determined by Avidbank in accordance with the Amended LSA. Amounts borrowed under the Revolving Line could be repaid and re-borrowed at any time prior to the Revolving Maturity Date (as defined below), at which time all amounts were immediately due and payable. There were no borrowings under the Revolving Line during the year ended June 30, 2019. As of February 26, 2019, the date on which we terminated the Amended LSA, there was no outstanding balance under the Revolving Line.
On January 16, 2018, we entered into the Second Amendment, which established the Term II Loan in the original principal amount of $7,294,000, the proceedsapproximately $5.8 million (the “BankUnited Term Loan”) issued in favor of which were used to pay in full the previously outstanding acquisition termBankUnited, N.A. (“BankUnited”) and an equipment loan andwith a portionthird party.  Details of the Sellers Note. Contemporaneous with this transaction, the Sellers Note was satisfied in full with the issuance of 967,208 shares of our Class A common stock, with the remaining balance paid in cash. The Term II Loan was for a five-year term, and bore interest at a per annum rate equal to two percent (2.0%) above the Prime Rate; provided, however, that at no time would the applicable rate be less than five-and-one-half percent (5.50%) per annum.
As discussed in more detail below, on February 26, 2019, we entered into the Loan Agreement with loans are as follows:

BankUnited and used the proceeds from the BankUnited Term Loan to pay in full, all outstanding amounts owed pursuant to the Term II Loan. Accordingly, as of February 26, 2019, there was no outstanding balance under the Term II Loan.

BankUnited Loan
Loans.

On February 26, 2019, we entered into the Loan Agreement (the “Loan Agreement”) with BankUnited for (i) the BankUnited Revolving Line up to maximum amount of $2,000,000, (ii) the BankUnited Term Loan, in the amounta revolving line of up to $5,813,500, and (iii) the Guidance Linecredit up to a maximum amount of $10,000,000. Each$2 million (the “BankUnited Revolving Line”), and a non-revolving guidance line of credit up to a maximum amount of $10 million (the “Guidance Line” and together with the BankUnited Loans is evidenced by a promissory note in favor ofRevolving Line and BankUnited (theTerm Loan, the “BankUnited Notes”Loans”).

On May 6, 2019, we entered into that certain First Amendment to Loan Agreement, effective February 26, 2019, with BankUnited (the “Amendment” and, together with the Loan Agreement, the “Amended Loan Agreement”).  On September 9, 2021, we entered into a letter agreement with BankUnited (the “Letter Agreement”).  The Amendment amended the definition ofLetter Agreement:  (i) reduced the fixed charge coverage ratio to more accurately reflect1.0 for the parties’ understandings at the time the Loan Agreement was executed.
BankUnited Revolving Line
Pursuant to the Amended Loan Agreement, BankUnited will make loan advances under the BankUnited Revolving Line to us up to a maximum aggregate principal amount outstanding not to exceed $2,000,000, which proceeds will be used for working capital and general corporate purposes. Amounts borrowed under the BankUnited Revolving Line may be repaid and re-borrowed at any time prior to February 26, 2022, at which time all amounts will be immediately due and payable.  The advances under the BankUnited Revolving Line bear interest, on the outstanding daily balance, at a per annum rate equal to 2.75% above the 30-day LIBOR.  Interest payments are due and payable, in arrears, on the first day of each month.  
BankUnited Term Loan
Pursuant to the Amended Loan Agreement, BankUnited advanced us $5,813,500 to satisfy in full the amounts owed to Avidbank, including the Term II Loan,quarter ending September 30, 2021 and to pay1.1 for the feesquarter ended December 31, 2021; (ii) modified the calculation for both the fixed charge coverage ratio and the total leverage ratio to provide for adjustments related to expenses incurred in connection with closing of the events at LPOI and LPOIZ, which expenses must be approved by BankUnited; (iii) terminated the Guidance Line; and (iv) required approval from BankUnited Loans. The BankUnited Term Loan is for a 5-year term, but co-terminusprior to our being able to draw upon the Revolving Line, subject to our compliance with the BankUnited Revolving Line.fixed charge coverage ratio for the quarters ending September 30, 2021 and December 31, 2021.  The BankUnited Term Loan bears interest atLetter Agreement also granted us a per annum rate equalwaiver of default arising prior to 2.75% above the 30-day LIBOR. Equal monthly principal payments of $48,445.83, plus accrued interest, are due and payable, in arrears,Letter Agreement for our failure to comply with the fixed charge coverage ratio measured on June 30, 2021.  Based on the first daywaiver, we were no longer in default of each month during the term. Upon maturity, all principal and interest shall be immediately due and payable. As of June 30, 2019, the applicable interest rate was 5.19%.

Guidance Line
Pursuant to the Amended Loan Agreement.  Finally, in connection with the Letter Agreement, we paid BankUnited in its sole discretion, may make loan advances to us under the Guidance Line up to a maximum aggregate principal amount outstanding not to exceed $10,000,000, which proceeds will be used for capital expenditures and approved business acquisitions. Such advances must be in minimum amounts of $1,000,000 for acquisitions and $500,000 for capital expenditures, and will be limited to 80% of cost or as otherwise determined by BankUnited. Amounts borrowed under the Guidance Line may not re-borrowed. The advances under the Guidance Line bear interest, on the outstanding daily balance, at a per annum ratefee equal to 2.75% above$10,000.

On November 5, 2021, we entered into a letter agreement with BankUnited (the “Second Letter Agreement”). In accordance with the 30-day LIBOR. Interest payments are due and payable, in arrears, onSecond Letter Agreement, the first day of each month. On each anniversaryparties agreed to initiate discussions regarding a possible modification, forbearance, or other resolution of the Amended Loan Agreement (as defined below), which resolution would occur on or before December 31, 2021. On December 20, 2021, we entered into the Second Amendment to the Loan Agreement dated February 26, 2019 (the “Second Amendment”), which further amended the Loan Agreement with BankUnited. In accordance with the Second Amendment, the parties agreed to the following terms, among others: (i) a maturity date of April 15, 2023 with respect to the Term Loan (as defined in the Amended Loan Agreement); (ii) an increased monthly payment amount of $100,000 commencing on November 1, 2022; (iii) beginning on December 20, 2021, each facility will bear interest at BankUnited’s then-prime rate of interest minus fifty (50) basis points (4.25% as of June 30, 2022), as adjusted from time to time, (iv) the Term Loan will bear a higher interest rate commencing on August 1, 2022; (v) an exit fee equal to 4% of the outstanding principal payments becomebalance of the Term Loan on April 15, 2023 (to the extent the Term Loan is still outstanding on such date and has not been refinanced with another lender); and (vi) a fee of $50,000 payable amortized basedupon execution of the Second Amendment. The Second Amendment also granted us a waiver of compliance for the Financial Covenants (as set forth in the Amended Loan Agreement) for the periods ended December 31, 2021, March 31, 2022 and June 30, 2022.

On May 11, 2022, we entered into the Third Amendment to the Loan Agreement dated February 26, 2019 (the “Third Amendment”; and, together with the First Amendment, the Letter Agreement and the Second Letter Agreement, the “Amended Loan Agreement”), which further amended the Loan Agreement with BankUnited. In accordance with the Third Amendment, the parties agreed to the following terms, among others: (i) an amended maturity date of April 15, 2024 with respect to the Term Loan (as defined in the Amended Loan Agreement); and (ii) an amended exit fee equal to (a) 2% of the outstanding principal balance of the Term Loan on a ten-year term.

SecuritySeptember 30, 2022, (b) 1% of the outstanding principal balance on December 31, 2022, (c) 1% of the outstanding principal balance on March 31, 2023, and Guarantees
(d) 4% of the outstanding principal balance on April 15, 2024 (to the extent the Term Loan is still outstanding on the respective dates and has not been refinanced with another lender).

We have commenced discussions with other lenders, with the intent of refinancing our credit facility prior to maturity with reasonable commercial terms, of which there can be no assurance. If we are unable to refinance the credit facility with other commercial lenders prior to maturity, we may need to raise additional equity financing, source financing through non-commercial lenders or further reduce certain operating expenses and capital expenditures in order to repay our credit facility and all charges related thereto upon its maturity on April 15, 2024. For additional information on liquidity, see Note 13, Loans Payable, to the Notes to the Consolidated Financial Statements to this Annual Report on Form 10-K.

28

Table of Contents

Our obligations under the Amended Loan Agreement are collateralized by a first priority security interest (subject to permitted liens) in all of our assets and the assets of our U.S. subsidiaries, GelTech, Inc. (“GelTech”) and ISP, pursuant to a Security Agreement granted by GelTech, ISP, and us in favor of BankUnited. Our equity interests in, and the assets of, our foreign subsidiaries are excluded from the security interest.  In addition, all of our subsidiaries have guaranteed our obligations under

BankUnited Revolving Line

Pursuant to the Amended Loan Agreement, BankUnited agreed to make loan advances under the BankUnited Revolving Line to us up to a maximum aggregate principal amount outstanding not to exceed $2,000,000, which proceeds could have been used for working capital and related documents,general corporate purposes. The BankUnited Revolving Line expired on February 26, 2022.  No amounts were outstanding under the BankUnited Revolving Line on June 30, 2021 or on February 26, 2022.

BankUnited Term Loan

Pursuant to the Amended Loan Agreement, BankUnited advanced us $5,813,500 to satisfy in full the amounts owed to Avidbank, including the outstanding principal amount and all accrued interest under the acquisition term loan and to pay the fees and expenses incurred in connection with closing of the BankUnited Loans. The Term Loan was for a 5-year term, but co-terminus with the BankUnited Revolving Line should the BankUnited Revolving Line not be renewed beyond February 26, 2022.  Pursuant to the Second Amendment, the maturity date of the Term Loan was April 15, 2023, and pursuant to Guaranty Agreements executed bythe Third Amendment, the maturity date of the Term Loan is April 15, 2024. The Term Loan initially bore interest at a per annum rate equal to 2.75% above the 30-day LIBOR. However, pursuant to the Second Amendment, beginning on December 20, 2021, each facility bears interest at BankUnited’s then-prime rate of interest minus fifty (50) basis points (4.25% as of June 30, 2022), as adjusted from time to time. Equal monthly principal payments of approximately $48,446, plus accrued interest, are due and payable, in arrears, on the first day of each month during the term. Pursuant to the Second Amendment, the monthly payment, including principal and interest, will increase to $100,000, commencing November 1, 2022. Upon maturity, all principal and interest shall be immediately due and payable.

As of June 30, 2022, the applicable interest rate was 4.25% and the outstanding balance on the BankUnited Term Loan was approximately $3.9 million.

Guidance Line

The Amended Loan Agreement provided that BankUnited, in its sole discretion, could make loan advances to us under the Guidance Line up to a maximum aggregate principal amount outstanding not to exceed $10,000,000, which proceeds could have been used for capital expenditures and our subsidiariesapproved business acquisitions.  The Guidance Line terminated on September 9, 2021 in favor of BankUnited.

accordance with the Letter Agreement.  There were no amounts outstanding under the Guidance Line at June 30, 2021 or upon its termination at September 9, 2021.

General Terms

The Amended Loan Agreement contains customary covenants, including, but not limited to: (i) limitations on the disposition of property; (ii) limitations on changing our business or permitting a change in control; (iii) limitations on additional indebtedness or encumbrances; (iv) restrictions on distributions; and (v) limitations on certain investments. The Amended Loan Agreement also containsto certain financial covenants, including obligations tocovenants.  Generally, we must maintain a fixed charge coverage ratio of 1.25 to 1.00 and a total leverage ratio of 4.00 to 1.00.  The Letter Agreement granted us a waiver of default arising prior to the Letter Agreement from our failure to comply with the fixed charge coverage ratio measured on June 30, 2021.  The Second Amendment to the Amended Loan Agreement granted us a waiver of compliance for the Financial Covenants (as set forth in the Amended Loan Agreement) through June 30, 2022.  Based on the waivers, we are no longer in default of the Amended Loan Agreement.  As of June 30, 2019,2022, we were in compliance with all requiredother covenants.

We may prepay any or all of

Equipment Loan.

In December 2020, ISP Latvia entered into an equipment loan with a third party (the “Equipment Loan”), which party is also a significant customer. The Equipment Loan is subordinate to the BankUnited Loans and is collateralized by certain equipment. The initial advance under the Equipment Loan was 225,000 EUR (or USD $275,000), payable in whole or in part at any time, without penalty or premium. Late payments are subjectequal installments over 60 months, the proceeds of which were used to make a prepayment to a late fee equalvendor for equipment to five percent (5%) of the unpaid amount. Amounts outstanding during an event of default accruebe delivered at a future date.  The Equipment Loan bears interest at a fixed rate of five percent (5%) above the 30-day LIBOR applicable immediately prior3.3%. An additional 225,000 EUR (or USD $267,000) was drawn in September 2021, which proceeds were paid to the occurrencevendor for the equipment, payable in equal installments over 52 months.  As of June 30, 2022, the event of default.  The Amendedoutstanding balance on the Equipment Loan Agreement contains other customary provisions with respect to events of default, expense reimbursement, and confidentiality.

was 335,000 EUR (or USD $352,000).

For additional information regarding the BankUnited Loans and the Equipment Loan, see Note 18, 13, Loans Payable and Note 19, Note Satisfaction and Securities Purchase Agreement,, to the Notes to the Consolidated Financial Statements to this Annual Report on Form 10-K.

29

Table of Contents

In February 2022, we filed a shelf registration statement to facilitate the issuance of our Class A common stock, warrants exercisable for shares of our Class A common stock, and/or units up to an aggregate offering price of $75.8 million from time to time. In connection with the filing of the shelf registration statement, we also included a prospectus supplement relating to an at-the-market equity program under which we may issue and sell shares of our Class A common stock up to an aggregate offering price of $25.2 million from time to time, decreasing the aggregate offering price available under our shelf registration statement to $50.6 million. The shelf registration statement was declared effective by the SEC on March 1, 2022.  We have not issued any shares of our Class A common stock pursuant to the at-the-market equity program.

We believe we have adequate financial resources to sustain our current and anticipated operations in the coming year.  We have established milestones that will be tracked to ensure that as funds are expended we are achieving results before additional funds are committed.  We anticipate sales growth in future years, primarily from infrared products. We structured our sales teamthe engineered solutions we plan to enhance our incremental organic growth position for our core aspheric lens business, prime our operations for the anticipated high growth of our new infrared products, and allow for the integration of strategic acquisitions. We are also seeing a substantial increase in revenue-generating opportunities and broader market applications as a result of our investments in technologies that decreased our lens production costs and expanded our production capacity.

focus on.

We generally rely on cash from operations and equity offerings, and commercial debt, offerings, to the extent available, to satisfy our liquidity needs and to maintain our ability to repaymeet our payment obligations, including payments due under the BankUnited Term Loan and Equipment Loan.  There are a number of factors that could result in the need to raise additional funds, including a decline in revenue or a lack of anticipated sales growth, increased material costs, increased labor costs, planned production efficiency improvements not being realized, increases in property, casualty, benefit and liability insurance premiums, and increases in other costs.  We will also continue efforts to keep costs under control as we seek renewed sales growth.  Our efforts are directed toward generating positive cash flow and profitability.  If these efforts are not successful, we may need to raise additional capital.  Should capital not be available to us at reasonable terms, other actions may become necessary in addition to cost control measures and continued efforts to increase sales.  These actions may include exploring strategic options for the sale of the Company, the sale of certain product lines, the creation of joint ventures or strategic alliances under which we will pursue business opportunities, the creation of licensing arrangements with respect to our technology, or other alternatives.

Cash Flows – Financings:

Net cash used in financing activities was approximately $1.4 million in fiscal 2019, compared to $1.3 million in fiscal 2018. In fiscal 2019, net repayments on debt and capital leases were $1.4 million. In fiscal 2018, net repayments on debt and capital leases were $2.1 million, including approximately $600,000 related to the satisfaction of the Sellers Note. These repayments were offset by net proceeds of approximately $534,000 from the exercise of the June 2012 Warrants, as well as proceeds from exercises of stock options of approximately $226,000 during fiscal 2018.

Cash Flows – Operating and Investing:
Operating.

Cash flow provided by operations was approximately $411,000$1.5 million for thefiscal year ended June 30, 2019,2022, compared to approximately $2.6$4.7 million for thefiscal year ended June 30, 2018.2021.  The decrease in cash flowflows from operations during fiscal year 2022 is primarily the result of the net loss, including the non-recurring costs associated with the relocation of the Irvington Facility, as well as the increases in inventory and accounts receivable. The increase in inventory is primarily to support the growth in sales of infrared products, particularly as related to our new BD6-based product line. With respect to accounts receivable, one of our larger customers modified its payment cycle during the fourth quarter of fiscal 2019, which contributeddue to the increase in net loss, decrease in accounts payable and accrued liabilities, and an increase in accounts receivable, year-over-year. We did not grant extendedpartially offset by a reduction in inventory. The decrease in accounts payable and accrued liabilities was primarily due to the previously described events that occurred at our Chinese subsidiaries, for which certain expenses were accrued as of June 30, 2021, many of which were paid during fiscal year 2022, as well as payment termsof certain bonuses paid to our executive officers and other employees which were earned during fiscal year 2021.   During fiscal year 2022 we also made the first installment payment of payroll taxes deferred in conjunction with this change, andfiscal year 2020 under the collection cycle for this customer remains at 30 days or less.

CARES Act.

We anticipate continued improvement in our cash flows provided by operations in future years, basedas we continue to focus on managing our forecastedreceivables, payables and inventory, while continuing to grow our sales growth and anticipated margin improvements based on production efficiencies, including the relocation of our Irvington Facility, partially offset by marginalimprove gross margins, with moderate increases in general, administrative, sales and marketing and new product development expenditures.

costs.

Cash Flows – Investing.

During fiscal 2019,year 2022, we expended approximately $1.9$1.6 million for capital equipment, as compared to approximately $2.5$3.2 million during fiscal 2018. In fiscal 2019, we initiated capital leases in the amount of approximately $530,000 for manufacturing equipment, compared to $760,000 in fiscal 2018.year 2021.  Our capital expenditures during fiscal 2019year 2022 were primarily related to upgradesthe continued expansion of equipment and facilities in conjunction with relocating the Irvington Facility,our infrared coating capacity as well as expandingincreasing our productionlens diamond turning capacity for infrared glass, particularly our new BD6 material.to meet current and forecasted demand.  During fiscal 2018, the majority ofyear 2021, our capital expenditures were primarily related to the purchasecontinued expansion of equipment usedour infrared coating capacity as well as increasing our lens pressing and dicing capacity to enhance or expand our production capacity in alignment with sales growth opportunities, including facility improvements for our Zhenjiang and Riga Facilities.

meet demand.

We anticipate a similar level of capital expenditures during fiscal 2020;year 2023; however, the total amount expended will depend on sales growth opportunities and other circumstances.

Cash Flows – Financings.

Net cash used in financing activities was approximately $636,000 in fiscal year 2022, compared to $843,000 in fiscal year 2021.  Cash used in financing activities for fiscal year 2022 reflects approximately $894,000 in principal payments on our loans and finance leases and $61,000 in loan costs, offset by proceeds of approximately $267,000 from the Equipment Loan and approximately $52,000 in proceeds from the sale of Class A common stock under the 2014 ESPP.  Cash used in financing activities for fiscal year 2021 reflects approximately $1.3 million in principal payments on our loans and finance leases, offset by proceeds of approximately $275,000 from the Equipment Loan, and approximately $173,000 in proceeds from the exercise of stock options and from the sale of Class A common stock under the 2014 ESPP.

30

Table of Contents

How We Operate:

Operate

We have continuing sales of two basic types:  sales via ad-hoc purchase orders of mostly standard product configurations (our “turns” business) and the more challenging and potentially more rewarding business of customer product development.  In this latter type of business, we work with customers to help them determine optical specifications and even create certain optical designs for them, including complex multi-component designs that we call “engineered assemblies.solutions.”  This is followed by “sampling” small numbers of the product for the customers’ test and evaluation.  Thereafter, should a customer conclude that our specification or design is the best solution to their product need; we negotiate and “win” a contract (sometimes called a “design win”) – whether of a “blanket purchase order” type or a supply agreement.  The strategy is to create an annuity revenue stream that makes the best use of our production capacity, as compared to the turns business, which is unpredictable and uneven.  This annuity revenue stream can also generate low-cost, high-volume type orders.  A key business objective is to convert as much of our business to the design win and annuity model as is possible.  We face several challenges in doing so:

● 
Maintaining an optical design and new product sampling capability, including a high-quality and responsive optical design engineering staff;
● 
The fact that as our customers take products of this nature into higher volume, commercial production (for example, in the case of molded optics, this may be volumes over one million pieces per year) they begin to work seriously to reduce costs – which often leads them to turn to larger or overseas producers, even if sacrificing quality; and
● 
Our small business mass means that we can only offer a moderate amount of total productive capacity before we reach financial constraints imposed by the need to make additional capital expenditures – in other words, because of our limited cash resources and cash flow, we may not be able to service every opportunity that presents itself in our markets without arranging for such additional capital expenditures.

·

Maintaining an optical design and new product sampling capability, including a high-quality and responsive optical design engineering staff;

·

The fact that as our customers take products of this nature into higher volume, commercial production (for example, in the case of molded optics, this may be volumes over one million pieces per year) they begin to work seriously to reduce costs – which often leads them to turn to larger or overseas producers, even if sacrificing quality; and

·

Our small business mass means that we can only offer a moderate amount of total productive capacity before we reach financial constraints imposed by the need to make additional capital expenditures – in other words, because of our limited cash resources and cash flow, we may not be able to service every opportunity that presents itself in our markets without arranging for such additional capital expenditures.

Despite these challenges to winning more “annuity” business, we nevertheless believe we can be successful in procuring this business because of our unique capabilities in optical design engineering that we make available on the merchant market, a market that we believe is underserved in this area of service offering.  Additionally, we believe that we offer value to some customers as a source of supply in the U.S. should they be unwilling to commit to purchase their supply of a critical component from foreign merchant production sources.  For information regarding revenue recognition related to our various revenue streams, refer to Critical Accounting Policies and Estimates in this Annual Report on Form 10-K.


Our Key Performance Indicators:

Indicators

Usually on a weekly basis, management reviews a number ofseveral performance indicators.  Some of these indicators are qualitative and others are quantitative.  These indicators change from time to time as the opportunities and challenges in the business change.  They are mostly non-financial indicators, such as units of shippable output by product line, production yield rates by major product line, and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product.  These indicators can be used to calculate such other related indicators as fully yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time.  Higher unit production per shift means lower unit cost, and, therefore, improved margins or improved ability to compete, where desirable, for price sensitive customer applications.  The data from these reports is used to determine tactical operating actions and changes.  We believe that our non-financial production indicators, such as those noted, are proprietary information.

Financial indicators that are usually reviewed at the same time include the major elements of the micro-level business cycle:

● 
sales backlog;
● 
revenue dollars and units by product group;
● 
inventory levels;
● 
accounts receivable levels and quality; and
● 
other key indicators.

·

sales backlog;

·

revenue dollars and units by product group;

·

inventory levels;

·

accounts receivable levels and quality; and

·

other key indicators.

These indicators are similarly used to determine tactical operating actions and changes and are discussed in more detail below.

  Management will evaluate these key indicators as we transition to our new strategic plan to determine whether any changes or updates to our key indicators are warranted.

31

Table of Contents

Sales Backlog:

Backlog.

We believe our sales growth has been and continues to be our best indicator of success.  Our best view into the efficacy of our sales efforts is in our “order book.”  Our order book equates to sales “backlog.”  It has a quantitative and a qualitative aspect:  quantitatively, our backlog’s prospective dollar value and qualitatively, what percent of the backlog is scheduled by the customer for date-certain delivery.  We defineHistorically, we evaluated our “12-month backlog” as thatbacklog on a 12-month basis, which is requestedexamined orders required by thea customer for delivery within onea one-year period.  To better align with our strategic focus on longer-term customer orders and relationships, beginning in fiscal year and2021, management began evaluating our total backlog, which isincludes all firm orders requested by a customer that are reasonably likelybelieved to remain in the backlog and be converted into revenues.  This includes customer purchase orders and may include amounts under supply contracts if they meet the aforementioned criteria.  Generally, a higher 12-monthtotal backlog is better for us.

Our 12-month

Quarterly backlog grew 33% in comparison to the prior year, while we also increased our sales by 4%, compared to the prior year, maintaining our strong booking performance. Our 12-month backlog at June 30, 2019 was approximately $17.1 million, compared to $12.8 million as of June 30, 2017. Backlog growth rateslevels for fiscal 2019years 2022 and 2018 are:

 
Quarter
 
 
Backlog ($ 000)
 
 
Change From Prior Year End
 
 
Change From Prior Quarter End
 
  Q1 2018 
 $8,618 
  -8%
  -8%
  Q2 2018 
 $12,306 
  32%
  43%
  Q3 2018 
 $12,898 
  38%
  5%
  Q4 2018 
 $12,828 
  38%
  -1%
  Q1 2019 
 $13,994 
  9%
  9%
  Q2 2019 
 $18,145 
  41%
  30%
  Q3 2019 
 $17,137 
  34%
  -6%
  Q4 2019 
 $17,121 
  33%
  0%
2021 are as follows:

Quarter

 

Total Backlog 

($ 000)

 

 

Change From Prior Year End

 

 

Change From Prior Quarter End

 

Q1 2021

 

$20,866

 

 

 

-5%

 

 

-5%

Q2 2021

 

$23,835

 

 

 

9%

 

 

14%

Q3 2021

 

$19,498

 

 

 

-11%

 

 

-18%

Q4 2021

 

$21,329

 

 

 

-3%

 

 

9%

Q1 2022

 

$19,265

 

 

 

-10%

 

 

-10%

Q2 2022

 

$21,929

 

 

 

3%

 

 

14%

Q3 2022

 

$19,678

 

 

 

-8%

 

 

-10%

Q4 2022

 

$17,767

 

 

 

-17%

 

 

-10%

The increase in our 12-monthtotal backlog from the first quarter to the second quarter of both fiscal 2019years 2022 and 20182021 was largely due to the renewal of a large annual contract during the second quarter of the respective fiscal year, which we began shipping against during the third quarter of the respective fiscal year.  DuringThe timing of this renewal is similar to the remainderprior fiscal year.  The decrease in our total backlog from June 30, 2021 to June 30, 2022 is primarily due to the timing of other annual and multi-year contract renewals.  These renewals may substantially increase backlog levels at the time the orders are received, and backlog will subsequently be drawn down as shipments are made against these orders.  Our annual and multi-year contracts are expected to renew in future quarters. For example, in August 2022 we announced a $4 million supply agreement for PMO, with a long time European customer of precision motion control systems and OEM assemblies. The new supply agreement will go into effect in the second half of our fiscal 2019, bookingsyear 2023 and shipments remained fairly consistent, yielding a continued strong level of backlog.


We have experienced strongis expected to run for around 12-18 months.

Markets continue to experience growing demand for infrared products used in the industrial, defense and first responder sectors. Demand for infrared products is being furthercontinues to be fueled by interest in lenses made with our new BD6 material. With the global supply of germanium currently sourced from Russia and China, recent global events are generating renewed interest in BD6 as an alternative to germanium. We expect to maintain moderate growth in our visible PMO product group by continuing to diversify and offer new applications, with a cost competitive structure. Overstructure; however, we believe that, although necessary, the past several years,terminations of certain of our management employees in our China subsidiaries, LPOIZ and LPOI, and transition to new management personnel has adversely impacted the domestic sales in China of these subsidiaries through fiscal year 2022. Our former employees, including management personnel, maintained relationships with certain of our customers in China and we expect that until our new sales and management personnel establish relationships with these customers, of which there can be no assurance, domestic sales in China may be adversely impacted. Although the recovery has taken longer than initially expected, we have broadened our capabilitiesbegun to include additional glass typesrecapture some customers. Our sales and the abilitymanagement team in China was enhanced in October 2021 with two key new hires, and we are beginning to make much larger lenses, providing long-term opportunities for our technology roadmap and market share expansion. Based on our backlog and recent quote activity, we expect increasessee more progress in revenue from sales of both molded and turned infrared products as we enter fiscal 2020.

this area.

32

Table of Contents

Revenue Dollars and Units by Product Group:

Group.

The following table sets forth revenue dollars and units by our three product groups for the three and twelve months ended June 30, 20192022 and 2018:

 
 
Three Months Ended June 30,
 
 
Quarter
 
 
Years Ended June 30,
 
 
Year-to-date
 
 
 
2019
 
 
2018
 
 
% Change
 
 
2019
 
 
2019
 
 
% Change
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PMO
 $3,508,046 
 $3,377,942 
  4%
 $14,098,157 
 $13,522,458 
  4%
Infrared Products
  4,746,849 
  3,992,511 
  19%
  17,271,590 
  15,979,888 
  8%
Specialty Products
  490,383 
  717,924 
  -32%
  2,379,341 
  3,023,125 
  -21%
Total revenue
 $8,745,278 
 $8,088,377 
  8%
 $33,749,088 
 $32,525,471 
  4%
 
    
    
    
    
    
    
Units
    
    
    
    
    
    
PMO
  641,006 
  566,399 
  13%
  2,287,631 
  2,206,378 
  4%
Infrared Products
  87,428 
  44,293 
  97%
  232,081 
  145,433 
  60%
Specialty Products
  17,383 
  11,369 
  53%
  69,554 
  69,854 
  0%
Total units
  745,817 
  622,061 
  20%
  2,589,266 
  2,421,665 
  7%
2021:

 

 

(unaudited)

Three Months Ended

June 30,

 

 

Year Ended June 30,

 

 

Quarter

 

 

Year-to-date

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

% Change

 

% Change

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PMO

 

$3,411,877

 

 

$2,941,270

 

 

$15,020,542

 

 

$15,882,189

 

 

 

16%

 

 

-5%

Infrared Products

 

 

5,046,555

 

 

 

4,975,947

 

 

 

18,735,325

 

 

 

20,971,080

 

 

 

1%

 

 

-11%

Specialty Products

 

 

448,799

 

 

 

415,099

 

 

 

1,803,293

 

 

 

1,611,552

 

 

 

8%

 

 

12%

Total revenue

 

$8,907,231

 

 

$8,332,316

 

 

$35,559,160

 

 

$38,464,821

 

 

 

7%

 

 

-8%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PMO

 

 

398,064

 

 

 

323,404

 

 

 

1,999,200

 

 

 

3,139,774

 

 

 

23%

 

 

-36%

Infrared Products

 

 

100,715

 

 

 

122,127

 

 

 

438,508

 

 

 

579,563

 

 

 

-18%

 

 

-24%

Specialty Products

 

 

4,079

 

 

 

8,901

 

 

 

18,948

 

 

 

32,980

 

 

 

-54%

 

 

-43%

Total units

 

 

502,858

 

 

 

454,432

 

 

 

2,456,656

 

 

 

3,752,317

 

 

 

11%

 

 

-35%

Three months ended June 30, 20192022 compared to three months ended June 30, 2018

2021.

Our revenue increased by 8%7% in the fourth quarter of fiscal 2019,year 2022, as compared to the same period inquarter of the prior fiscal year, primarily as a result of an increase in demand for infrared products, with a moderate increase in sales of PMO products and a significant decrease in sales of specialty products.

Revenue from the PMO product group for the fourth quarter of fiscal 2019year 2022 was $3.5$3.4 million, an increase of approximately $130,000, or 4%16%, as compared to the same periodquarter of the prior fiscal year.  The increase in revenue is primarily attributed to increases in sales to customers in the industrial and telecommunications markets, partially offset by a decrease in sales through our catalog and distribution channels.  The decrease in sales through our catalog and distribution channels is primarily due to the termination of our distribution agreement in Europe.  European customers now order directly from our enhanced direct sales force in the region.  This transition will continue through the third quarter of fiscal year 2023.  Sales of PMO units increased by 13%, as compared to the prior period, however, the average selling prices decreased 8% due to the mix of products shipped. For the fourth quarter of fiscal 2019, revenue from PMO products included more sales to customers in the telecommunications and industrial markets, which are typically higher in volume and lower in average selling prices.

Revenue generated by the infrared product group during the fourth quarter of fiscal 2019 was $4.7 million, an increase of approximately $754,000, or 19%, as compared to the same period of the prior fiscal year. Sales of infrared units increased 97%23%, as compared to the prior year period, and average selling prices decreased 6%.  The slight decrease in average selling prices is due to a higher mix of telecommunications products unit sales, which typically have higher volumes and lower average selling prices. 

Revenue generated by 40%. These changes arethe infrared product group for the fourth quarter of fiscal year 2022 was $5.0 million, an increase of 1%, as compared to same quarter of the prior fiscal year.  The increase in revenue is primarily driven by ansales diamond-turned infrared products, while sales of BD6-based molded infrared products decreased. The increase in sales of moldeddiamond-turned infrared products was primarily driven by a new annual contract for a customer in the industrial market, for which we shipped full production volume in the fourth quarter of fiscal 2022.  Demand for BD6-based infrared products has leveled off, particularly for temperature sensing applications, demand for which was previously accelerated by COVID-19.  Demand for industrial applications, firefighting and other public safety applications continues to be strong.  Molded infrared products are higher in volume and lower in average selling prices than diamond-turned infrared products. Industrial applications, firefighting cameras and other public safety applications are the primary drivers of the

Our specialty products revenue increased demand for infrared products, particularly our thermal imaging assemblies.

In the fourth quarter of fiscal 2019, our specialty product revenue decreased by 32%8%, as compared to the same period of the prior fiscal year. This decrease isyear, and represented 5% of total revenue for both the fourth quarters of fiscal years 2022 and 2021.  The increase was primarily due to lower sales to customersdriven by NRE project revenue in the medical and industrial markets, with fewer NRE projects. The decrease in sales to customers in the medical market is due to the timingfourth quarter of customer orders. The decrease in sales to customers in the industrial market is primarily due to a slowdown in LIDAR development projects and the related assemblies. NRE revenue is project-based and the timing of any such projects is wholly dependent on our customers and their project activity.
fiscal year 2022.

Year ended June 30, 20192022 compared to year ended June 30, 2018

2021.

Our revenue increaseddecreased by 4% inapproximately $2.9 million, or 8%, for fiscal 2019,year 2022, as compared to fiscal 2018, primarily driven by significant growthyear 2021, with decreases in theboth infrared and PMO product group, with a moderate increase in sales of PMO products, partially offset by a decrease in sales of specialty products.


sales.

Revenue from the PMO product group for fiscal 2019year 2022 was approximately $14.1$15.0 million, an increasea decrease of approximately $576,000, or 4%5%, as compared to fiscal 2018.year 2021.  The decrease in revenue is primarily attributed to a reduction in orders from a key customer in the telecommunications market, in China, due to a decrease in that customer’s market share. This decrease was partially offset by an increase in sales through our catalog and distribution channels, as well as increases in sales to customers in the industrial and medical industries. Sales of PMO units increaseddecreased by 4%36%, as compared to the same period of the prior fiscal year, and average selling prices increased 1%by 49%. The increase in sales isvolume decrease was largely driven by salesa lower mix of telecommunications products, which typically have lower average selling prices. The unit volume for telecommunications products decreased by approximately 62% for fiscal year 2022, as compared to customers in the telecommunications market, partially offset by a decrease in sales to customers insame period of the commercial market.

prior fiscal year.

33

Table of Contents

Revenue generated by the infrared product group duringfor fiscal 2019year 2022 was $18.7 million, a decrease of approximately $17.3 million, an increase of $1.3 million, or 8%11%, as compared to the prior fiscal year.  SalesThe decrease in revenue is primarily driven by sales to customers in the industrial market, particularly for our BD6-based molded infrared products. During fiscal year 2022, sales of infrared units increaseddecreased by 60%24%, as compared to the prior fiscal year and average selling prices decreased by 34%. These changes areperiod. The decrease in units is due primarily due to the following shiftsmix of products shipped, as the prior year period included more molded infrared lenses which are lower in volume and higher in price than the larger diamond-turned lenses. Industrial applications, firefighting cameras, and other public safety applications continue to be the primary drivers of demand for infrared revenue mix: (i)products, including thermal imaging assemblies.  During fiscal years 2020 and 2021, we saw an increase in a large-volume order of diamond turned infrared products, resulting in a lower mix ofdemand for medical and temperature sensing applications, such as fever detection. Demand for temperature sensing applications were accelerated by COVID-19, and although the typically higher-priced custom infrared diamond-turned products, and (ii) an increase in sales of molded infrared products, which are higher in volume and lower in price than diamond-turned infrared products.

Specialtydemand has leveled off since the initial spike, it remains elevated.

In fiscal year 2022, our specialty products revenue was approximately $2.4 million for fiscal 2019, a decrease of approximately $644,000,increased by $192,000, or 21%12%, as compared to the prior fiscal year. This decrease is largely relatedyear, primarily due to revenues generated fromhigher NRE projects and related lenses and assemblies, primarily for customersproject revenue in the industrial market related to LIDAR applications.fiscal year 2022.  NRE revenue is project based and the timing of any such projects is wholly dependent on our customers and their project activity. Fiscal 2018 included a large NRE project, which was not repeated in fiscal 2019. The remainder of the decrease is due to lower sales to customers in the defense market, due to timing of government contracts.

Inventory Levels:

Levels.

We manage inventory levels to minimize investment in working capital but still have the flexibility to meet customer demand to a reasonable degree.  We review our inventory for obsolete items quarterly.  While the mix of inventory is an important factor, including adequate safety stocks of long lead-time materials, an important aggregate measure of inventory in all phases of production is the quarter’s ending inventory expressed as a number of days’ worth of the quarter’s cost of sales, also known as “days cost of sales in inventory,” or “DCSI.”  It is calculated by dividing the quarter’s ending inventory by the quarter’s cost of goods sold, multiplied by 365 and divided by 4.  Generally, a lower DCSI measure equates to a lesser investment in inventory, and, therefore, more efficient use of capital.  The table below shows our DCSI for the immediately preceding eight fiscal quarters:

Fiscal

Quarter

Ended

DCSI (days)

Q4-2019

Q4-2022

6/30/20192022

119

104

Q3-2019

Q3-2022

3/31/20192022

122

132

Q2-2019

Q2-2022

12/31/20182021

117

104

Q1-2019

Q1-2022

9/30/20182021

106

134

Fiscal 2019 averageYear 2022 Average

116

118

Q4-2018

Q4-2021

6/30/20182021

103

126

Q3-2018

Q3-2021

3/31/20182021

112

119

Q2-2018

Q2-2021

12/31/20172020

113

142

Q1-2018

Q1-2021

9/30/20172020

109

154

Fiscal 2018 averageYear 2021 Average

135

109

Our average DCSI for fiscal 2019year 2022 was 116,118, compared to 109135 for fiscal 2018.year 2021.  The increasedecrease in DCSI is driven by the decrease in partinventory levels, due to an increased focus on inventory management.  Despite these efforts, we have experienced inventory increases at times driven by strategic buysshifts in customer activity due to COVID-19, where we are sometimes given short notice to delay shipments of certain raw materialssome products and accelerate the manufacturing and shipment of other products.  As the COVID-19 impacts begin to reduce lead timeslevel off, and meetwith increasing demand for both infrared glass. As we continue to see increasing demand for infraredand PMO products, particularly molded infrared, we expect DCSI to remainmaintain an average of between 110 andto 120.

Accounts Receivable Levels and Quality:

Quality.

Similarly, we manage our accounts receivable to minimize investment in working capital.  We measure the quality of receivables by the proportions of the total that are at various increments past due from our normally extended terms, which are generally 30 days.  The most important aggregate measure of accounts receivable is the quarter’s ending balance of net accounts receivable expressed as a number of days’ worth of the quarter’s net revenues, also known as “days sales outstanding,” or “DSO.”  It is calculated by dividing the quarter’s ending net accounts receivable by the quarter’s net revenues, multiplied by 365 and divided by 4.  Generally, a lower DSO measure equates to a lesser investment in accounts receivable and, therefore, more efficient use of capital.  The table below shows our DSO for the preceding eight fiscal quarters:


Fiscal

Quarter

Ended

DSO (days)

Q4-2019

Q4-2022

6/30/20192022

65

54

Q3-2019

Q3-2022

3/31/20192022

68

55

Q2-2019

Q2-2022

12/31/20182021

66

49

Q1-2019

Q1-2022

9/30/20182021

56

59

Fiscal 2019 averageYear 2022 Average

64

54

Q4-2018

Q4-2021

6/30/20182021

61

51

Q3-2018

Q3-2021

3/31/20182021

61

53

Q2-2018

Q2-2021

12/31/20172020

62

63

Q1-2018

Q1-2021

9/30/20172020

62

60

Fiscal 2018 average

Year 2021 Average

57

 
6234

Table of Contents

Our average DSO for fiscal 2019year 2022 was 64,54, compared to 6257 for fiscal 2018. During the fourth quarteryear 2021.  The improvement in fiscal year 2022 reflects our increased focus on collections, and tightening of fiscal 2019, one of our larger customers modified its payment cycle, which has caused a slight increase in our DSO; however, the average days outstanding for this customer is still less than 30 days.terms policies.  We strive to havemaintain a DSO no higherof less than 65.

60.

Other Key Indicators:

Indicators.

Other key indicators include various operating metrics, some of which are qualitative and others are quantitative.  These indicators change from time to time as the opportunities and challenges in the business change.  They are mostly non-financial indicators, such as on time delivery trends, units of shippable output by major product line, production yield rates by major product line, and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product.  These indicators can be used to calculate such other related indicators as fully-yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time.  Higher unit production per shift means lower unit cost, and, therefore, improved margins or improved ability to compete where desirable for price sensitive customer applications.  The data from these reports is used to determine tactical operating actions and changes.  Management also assesses business performance and makes business decisions regarding our operations using certain non-GAAP measures.  These non-GAAP measures are described in more detail below under the heading “Non-GAAP Financial Measures”.

Non-GAAP Financial Measures

We report our historical results in accordance with GAAP; however, our management also assesses business performance and makes business decisions regarding our operations using certain non-GAAP financial measures.  We believe these non-GAAP financial measures provide useful information to management and investors that is supplementary to our financial condition and results of operations computed in accordance with GAAP; however, we acknowledge that our non-GAAP financial measures have a number of limitations.  As such, you should not view these disclosures as a substitute for results determined in accordance with GAAP, and they are not necessarily comparable to non-GAAP financial measures that other companies use.

Adjusted Net Income:
Adjusted net income

EBITDA.

EBITDA is a non-GAAP financial measure used by management, lenders, and certain investors as a supplemental measure in the evaluation of some aspects of a corporation's financial position and core operating performance. Management uses adjusted net income to evaluate our underlying operating performance and for planning and forecasting future business operations. We believe adjusted net income may be helpful for investors as one means of evaluating our operational performance.

We calculate adjusted net income by excluding the change in the fair value of the June 2012 Warrants from net income. The fair value of the June 2012 Warrants was re-measured each reporting period until the warrants were exercised or expired on December 11, 2017. In each reporting period during the term of the June 2012 Warrants, the change in the fair value of the June 2012 Warrants was either recognized as non-cash expense or non-cash income. The change in the fair value of the June 2012 Warrants was not impacted by our actual operations but was instead strongly tied to the change in the market value of our Class A common stock. The following table reconciles net income to adjusted net income for the three and twelve months ended June 30, 2019 and 2018:

 
 
(unaudited)
 
 
 
 
 
 
 
 
 
Quarter Ended:
 
 
   Year Ended:
 
 
 
June 30, 2019
 
 
June 30, 2018
 
 
June 30, 2019
 
 
June 30, 2018
 
Net income (loss)
 $(1,761,690)
 $(807,220)
 $(2,680,323)
 $1,060,104 
Change in fair value of warrant liability
   
   
   
  194,632 
Adjusted net income (loss)
 $(1,761,690)
 $(807,220)
 $(2,680,323)
 $1,254,736 
% of revenue
  -20%
  -10%
  -8%
  4%
Our adjusted net loss for the quarter ended June 30, 2019 was approximately $1.8 million, as compared to $807,000 for the quarter ended June 30, 2018. The decrease in net income is due to the following: (1) the quarter ended June 30, 2019 includes approximately $845,000 in additional SG&A expenses associated with the relocation of the Irvington Facility, (2) a $1.0 million increase in income tax expense, primarily due to adjustments to net deferred tax assets in the U.S. jurisdiction; and (3) an unfavorable difference in foreign exchange gains and losses of $600,00 for the quarter ended June 30, 2019, as compared to the quarter ended June 30, 2019.
Our adjusted net loss for fiscal 2019 was approximately $2.7 million, as compared to net income of approximately $1.3 million for fiscal 2018. The approximately $3.9 million decrease is primarily due to the following: (1) fiscal 2019 includes approximately $1.2 million in additional SG&A expenses associated with the relocation of the Irvington Facility, (2) a $1.3 million increase in income tax expense, due to non-recurring benefits related to our foreign jurisdictions, as well as an adjustment to the valuation allowance on our U.S. deferred tax assets, which all favorably impacted fiscal 2018; (3) a $397,000 increase in new product development expenses; and (4) an unfavorable difference in foreign exchange gains and losses of $577,00 for fiscal 2019, as compared to fiscal 2018.
EBITDA and Adjusted EBITDA:
EBITDA and adjusted EBITDA are non-GAAP financial measures used by management, lenders, and certain investors as a supplemental measure in the evaluation of some aspects of a corporation'scorporation’s financial position and core operating performance.  Investors sometimes use EBITDA as it allows for some level of comparability of profitability trends between those businesses differing as to capital structure and capital intensity by removing the impacts of depreciation and amortization.  EBITDA also does not include changes in major working capital items, such as receivables, inventory, and payables, which can also indicate a significant need for, or source of, cash.  Since decisions regarding capital investment and financing and changes in working capital components can have a significant impact on cash flow, EBITDA is not a good indicator of a business'sbusiness’s cash flows.  We use EBITDA for evaluating the relative underlying performance of our core operations and for planning purposes.  We calculate EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization, thus the term “Earnings Before Interest, Taxes, Depreciation and Amortization” and the acronym “EBITDA.”
We also calculate an adjusted EBITDA, which excludes the effect of the non-cash income or expense associated with the mark-to-market adjustments, related to our June 2012 Warrants. The fair value of the June 2012 Warrants was re-measured each reporting period until the warrants were either exercised or expired on December 11, 2017. Each reporting period, the change in the fair value of the June 2012 Warrants was either recognized as a non-cash expense or non-cash income. The change in the fair value of the June 2012 Warrants was not impacted by our actual operations but was instead strongly tied to the change in the market value of our Class A common stock. Management uses adjusted EBITDA to evaluate our underlying operating performance and for planning and forecasting future business operations. We believe this adjusted EBITDA is helpful for investors to better understand our underlying business operations.

The following table adjusts net income to EBITDA and adjusted EBITDA for the three and twelve months ended June 30, 20192022 and 2018:


 
 
(unaudited)
 
 
 
 
 
 
 
 
 
 Quarter Ended:
 
 
 Year Ended:
 
 
 
June 30, 2019
 
 
June 30, 2018
 
 
June 30, 2019
 
 
June 30, 2018
 
Net income (loss)
 $(1,761,690)
 $(807,220)
 $(2,680,323)
 $1,060,104 
Depreciation and amortization
  923,195 
  911,577 
  3,464,156 
  3,403,581 
Income tax provision (benefit)
  495,699 
  (508,399)
  455,206 
  (827,077)
Interest expense
  123,578 
  134,736 
  697,113 
  186,948 
EBITDA
  (219,218)
  (269,306)
 $1,936,152 
 $3,823,556 
Change in fair value of warrant liability
   
   
   
  194,632 
Adjusted EBITDA
 $(219,218)
 $(269,306)
 $1,936,152 
 $4,018,188 
% of revenue
  -3%
  -3%
  6%
  12%
2021:

 

 

(unaudited)

Quarter Ended June 30,

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net loss

 

$(1,359,790)

 

$(2,913,210)

 

$(3,542,181)

 

$(3,185,251)

Depreciation and amortization

 

 

854,123

 

 

 

900,964

 

 

 

3,617,743

 

 

 

3,509,436

 

Income tax provision

 

 

534,579

 

 

 

(49,671)

 

 

862,907

 

 

 

933,915

 

Interest expense

 

 

78,411

 

 

 

48,863

 

 

 

229,475

 

 

 

215,354

 

EBITDA

 

$107,323

 

 

$(2,013,054)

 

$1,167,944

 

 

$1,473,454

 

% of revenue

 

 

1%

 

 

-24%

 

 

3%

 

 

4%

35

Table of Contents

Our adjusted EBITDA for the quarter ended June 30, 20192022 was approximately $107,000, compared a loss of approximately $219,000, compared to a loss of $269,000$2.0 million for the quarter ended June 30, 2018. The slight improvement in adjusted EBITDA is primarily the result of the increase in gross margin, coupled with an approximately $600,000 decrease in foreign exchange losses for the fourth quarter of fiscal 2019, as compared to the same period of the prior fiscal year.  These favorable changes were offset by approximately $845,000The increase in restructuring costs related to the relocation of the Irvington Facility duringEBITDA in the fourth quarter of fiscal 2019.

year 2022 was primarily attributable to the increase in revenue and gross margin, coupled with the decreases in SG&A and Other expenses incurred related to the previously described events that occurred in our Chinese subsidiaries, as well as certain director and personnel matters that occurred during fiscal year 2021.  In addition, there was a favorable difference of approximately $68,000 in foreign exchange gains and losses.

Our adjusted EBITDA for fiscal 2019year 2022 was approximately $1.9$1.2 million, compared to approximately $4.0$1.5 million for fiscal 2018.year 2021.  The decrease in adjusted EBITDA betweenfor fiscal year 2022 is primarily attributable to lower revenue and gross margin, partially offset by decreased SG&A and Other expenses, due to the periods was principally caused by restructuring costs of approximately $1.2 milliondecreases in expenses incurred during fiscal 2019 related to the relocation of the Irvington Facility. In addition, foreign exchange losses increased by approximately $577,000previously described events that occurred in our Chinese subsidiaries, as well as certain officer, director, and personnel matters that occurred during fiscal 2019,year 2021, as compared to fiscal 2018.

discussed above.

Off Balance Sheet Arrangements

We do not engage in any activities involving variable interest entities or off balance sheet arrangements.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of income and expense during the reporting periods presented.  Our critical estimates include the allowance for trade receivables, which is made up of allowances for bad debts, allowances for obsolete inventory, valuation of compensation expense on stock-based awards and accounting for income taxes.  Although we believe that these estimates are reasonable, actual results could differ from those estimates given a change in conditions or assumptions that have been consistently applied.  We also have other policies that we consider key accounting policies, such as our policy for revenue recognition, however, the application of these policies does not require us to make significant estimates or judgments that are difficult or subjective.

Management has discussed the selection of critical accounting policies and estimates with our Board, of Directors (the “Board”), and the Board has reviewed our disclosure relating to critical accounting policies and estimates in this prospectus.Annual Report on Form 10-K.  The critical accounting policies used by management and the methodology for its estimates and assumptions are as follows:

Allowance for accounts receivableis calculated by taking 100% of the total of invoices that are over 90 days past due from the due date and 10% of the total of invoices that are over 60 days past due from the due date for U.S.- and Latvia-based accounts and 100% on invoices that are over 120 days past due for China-based accounts without an agreed upon payment plan.  Accounts receivable are customer obligations due under normal trade terms.  We perform continuing credit evaluations of our customers’ financial condition.  Recovery of bad debt amounts which were previously written off is recorded as a reduction of bad debt expense in the period the payment is collected.  If our actual collection experience changes, revisions to our allowance may be required.  After attempts to collect a receivable have failed, the receivable is written off against the allowance.  To date, our actual results have been materially consistent with our estimates, and we expect such estimates to continue to be materially consistent in the future.


Inventory obsolescence allowanceis calculated by reserving 100% for items that have not been sold in two years or that have not been purchased in two years, or items for which we have more than a two-year supply.years.  These items, as identified, are allowed for at 100%, as well as allowing 50% for other items deemed to be slow moving within the last twelve months and allowing 25% for items deemed to have low material usage within the last six months.  Items of which we have greater than a two-year supply are also reserved at 25% to 100%, depending on usage rates.  The parts identified are adjusted for recent order and quote activity to determine the final inventory allowance.  To date, our actual results have been materially consistent with our estimates, and we expect such estimates to continue to be materially consistent in the future.

Revenueis generally recognized upon transfer of control, including the risks and rewards of ownership, of products or services to customers in an amount that reflects the consideration we expect to receive in exchange for those products or services.  The performance obligations for the sale of optical components and assemblies are satisfied at a point in time.  We generally bear all costs, risk of loss, or damage and retain title to the goods up to the point of transfer of control of products to customers.  Shipping and handling costs are included in the cost of goods sold.  Revenues from product development agreements are recognized as performance obligations are met in accordance with the terms of the agreements and upon transfer of control of products, reports or designs to the customer.  Product development agreements are generally short term in nature, with revenue recognized upon satisfaction of the performance obligation, and transfer of control of the agreed-upon deliverable.  Invoiced amounts for value-added taxes (“VAT”)VAT related to sales are posted to the balance sheet and are not included in revenue.

36

Table of Contents

Stock-based compensationis measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period.  We estimate the fair value of each stock option as of the date of grant using the Black-Scholes-Merton pricing model.  Our directors, officers, and key employees were granted stock-based compensation through our Amended and Restated Omnibus Incentive Plan, as amended (the “Omnibus Plan”), through October 2018 and after that date, the 2018 Stock and Incentive Compensation Plan (the “SICP”). Most options granted under the Omnibus Plan and the SICP vest ratably over two to four years and generally have ten-year contract lives.  The volatility rate is based on four-year historical trends in common stock closing prices and the expected term was determined based primarily on historical experience of previously outstanding options.  The interest rate used is the U.S. Treasury interest rate for constant maturities.  The likelihood of meeting targets for option grants that are performance based are evaluated each quarter.  If it is determined that meeting the targets is probable, then the compensation expense will be amortized over the remaining vesting period.

Goodwill and intangible assetsacquired in a business combination are recognized at fair value using generally accepted valuation methods appropriate for the type of intangible asset and reported separately from goodwill.  Purchased intangible assets other than goodwill are amortized over their useful lives unless these lives are determined to be indefinite.  Purchased intangible assets are carried at cost, less accumulated amortization.  Amortization is computed over the estimated useful lives of the respective assets, generally two to fifteen years.  We periodically reassess the useful lives of intangible assets when events or circumstances indicate that useful lives have significantly changed from the previous estimate.  Definite-lived intangible assets consist primarily of customer relationships, know-how/trade secrets and trademarks.  They are generally valued as the present value of estimated cash flows expected to be generated from the asset using a risk-adjusted discount rate.  When determining the fair value of our intangible assets, estimates and assumptions about future expected revenue and remaining useful lives are used.  Goodwill and intangible assets are tested for impairment on an annual basis and during the period between annual tests if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable.

We assess the qualitative factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment analysis.  If we determine that it is more likely than not that its fair value is less than its carrying amount, then the goodwill impairment test is performed.  The fair value of the reporting unit is compared to its carrying amount, and if the carrying amount exceeds its fair value, then an impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value, up to the total amount of goodwill allocated to that reporting unit.

Accounting for income taxes requires estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, benefits, and deductions, and in the calculation of certain tax assets and liabilities, which arise from differences in the timing of the recognition of revenue and expense for tax and financial statement purposes.  We assessed the likelihood of the realization of deferred tax assets and concluded that a valuation allowance is needed to reserve the amount of the deferred tax assets that may not be realized due to the uncertainty of the timing and amount of taxable income in certain jurisdictions.  In reaching our conclusion, we evaluated certain relevant criteria, including the amount of pre-tax income generated during the current and prior two years, as adjusted for non-recurring items, the existence of deferred tax liabilities that can be used to realize deferred tax assets, the taxable income in prior carryback years in the impacted jurisdictions that can be used to absorb net operating losses and taxable income in future years.  Our judgments regarding future profitability may change due to future market conditions, changes in U.S. or international tax laws and other factors.  These changes, if any, may require material adjustments to these deferred tax assets, resulting in a reduction in net income or an increase in net loss in the period when such determinations are made, which, in turn, may result in an increase or decrease to our tax provision in a subsequent period.


In the ordinary course of global business, there are many transactions and calculations where the ultimate tax outcome is uncertain.  Some of these uncertainties arise as a consequence of cost reimbursement and royalty arrangements among related entities, which could impact our income or loss in each jurisdiction in which we operate.  Although we believe our estimates are reasonable, no assurance can be given that the final tax outcome of these matters will not be different than that which is reflected in our historical income tax provisions and accruals.  In the event our assumptions are incorrect, the differences could have a material impact on our income tax provision and operating results in the period in which such determination is made.  In addition to the factors described above, our current and expected effective tax rate is based on then-current tax law.  Significant changes during the year in enacted tax law could affect these estimates.

Impact of recently issued accounting pronouncements that have recently been issued but have not yet been implemented by us are described in Note 2, Summary of Significant Accounting Policies, to the Notes to the Consolidated Financial Statements to this Annual Report on Form 10-K, which describes the potential impact that these pronouncements are expected to have on our financial condition, results of operations and cash flows.

Item 8. Financial Statements and Supplementary Data.

Data.

The information required by this Item is incorporated herein by reference to the consolidated financial statements and supplementary data set forth in Item 15. Exhibits, Financial Statement Schedules of Part IV of this Annual Report on Form 10-K.

37

Table of Contents

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

Disclosure.

None.

Item 9A. Controlsand Procedures.

Procedures.

Evaluation of Disclosure Controls and Procedures

As of the end of the fiscal year ended June 30, 2019,2022, we carried out an evaluation, under the supervision and with the participation of members of our management, including our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15(b) of the Exchange Act.  Our CEO and our CFO have concluded, based on their evaluation, that as of June 30, 2019,2022, our disclosure controls and procedures were effective at the end of the fiscal year to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit with the SEC under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act).  Internal control over financial reporting is a process, including policies and procedures, designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.  Our management assessed our internal control over financial reporting based on the Internal Control—Integrated Framework (2013(2013 Framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).  Based on the results of this assessment, our management concluded that our internal control over financial reporting was effective as of June 30, 20192022 based on such criteria.

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met under all potential conditions, regardless of how remote, and may not prevent or detect all errors and all fraud.  Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within LightPath have been prevented or detected.  Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.


Auditor’s Report on Internal Control over Financial Reporting

This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting.  Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to rules of the Securities and Exchange Commission (the “SEC”) that permit us to provide only management’s report in this Annual Report.

Changes in Internal Controls over Financial Reporting

In connection with our continued monitoring and maintenance of our controls procedures as part of the implementation of Section 404 of the Sarbanes-Oxley Act, we continue to review, test, and improve the effectiveness of our internal controls.  ThereIn connection with the events that occurred at our Chinese subsidiaries, we have adopted additional policies and procedures designed to improve our internal controls, including, without limitation, revising the reporting structure for our foreign-based finance directors, adopting Codes of Conduct applicable to our subsidiaries’ foreign-based employees, adopting an internal authority approval matrix, and hiring additional staff for our accounting departments at LPOI and LPOIZ to improve segregation of duties, among other items.  Other than these modifications, there have not been any significant changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fourth quarter and since the year ended June 30, 20192022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information.

Information.

None.


PART

38

Table of Contents

PART III

Item 10. Directors, Executive Officers and Corporate Governance.

Governance.

The information required under this item is incorporated herein by reference to our proxy statement for our fiscal 2020year 2023 Annual Stockholders’ Meeting to be filed with the SEC not later than 120 days after the end of fiscal 2019.

year 2022.

Item 11. Executive Compensation.

Compensation.

The information required under this item is incorporated herein by reference to our proxy statement for our fiscal 2020year 2023 Annual Stockholders’ Meeting to be filed with the SEC not later than 120 days after the end of fiscal 2019.

year 2022.

Item 12. Security Ownership of Certain Beneficial Owners and Management.

Management.

The information required under this item is incorporated herein by reference to our proxy statement for our fiscal 2020year 2023 Annual Stockholders’ Meeting to be filed with the SEC not later than 120 days after the end of fiscal 2019,year 2022, with the exception of those items listed below.

Securities Authorized for Issuance Under Equity Compensation Plans

Plans.

The following table sets forth information with respect to compensation plans under which our equity securities are authorized for issuance as of the end of fiscal 2019:

Plan category
 
Number of securities to be issued upon exercise of outstanding options, warrants and rights
 
 
Weighted average exercise and grant price of outstanding options, warrants and rights
 
 
Number of securities remaining available for future issuance
 
Equity compensation plans approved by security holders
  2,844,451 
 $1.82 
  1,416,691 
Equity compensation plans not approved by security holders
   
   
   
year 2022:

Plan category

 

Number of securities to be issued upon exercise of outstanding options, warrants and rights

 

 

Weighted average exercise and grant price of outstanding options, warrants and rights

 

 

Number of securities remaining available for future issuance

 

Equity compensation plans approved by security holders

 

 

2,614,131

 

 

$1.81

 

 

 

365,324

 

Equity compensation plans not approved by security holders

 

 

 

 

 

 

 

 

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

Independence.

The information required under this item is incorporated herein by reference to our proxy statement for our fiscal 2020year 2023 Annual Stockholders’ Meeting to be filed with the SEC not later than 120 days after the end of fiscal 2019.

year 2022.

Item 14. Principal Accountant Fees and Services.

Services.

The information required under this item is incorporated herein by reference to our proxy statement for our fiscal 2020year 2023 Annual Stockholders’ Meeting to be filed with the SEC not later than 120 days after the end of fiscal 2019.


PARTyear 2022.

39

Table of Contents

PART IV

Item 15. Exhibits, Financial Statement Schedules.

Schedules.

(a) The following documents are filed as part of this Annual Report on Form 10-K:

(1) Financial Statements – See Index on page F-1 of this report

(2) Financial Statement Schedules - None

(b) The following exhibits are filed herewith as a part of this report

Exhibit

Number  

Description

3.1.1

Certificate of Incorporation of LightPath Technologies, Inc., filed June 15, 1992 with the Secretary of State of Delaware, which was filed as an exhibitExhibit 3.1.1 to our Registration StatementAnnual Report on Form SB-210-K (File No: 33-80119)No. 000-25748) filed with the Securities and Exchange Commission on December 7, 1995,September 10, 2020, and is incorporated herein by reference thereto.

��

3.1.2

Certificate of Amendment to Certificate of Incorporation of LightPath Technologies, Inc., filed October 2, 1995 with the Secretary of State of Delaware, which was filed as an exhibit 3.1.2 to our Registration StatementAnnual Report on Form SB-210-K (File No: 33-80119)No. 000-25748) filed with the Securities and Exchange Commission on December 7, 1995,September 10, 2020, and is incorporated herein by reference thereto.

3.1.3

Certificate of Designations of Class A common stock and Class E-1 common stock, Class E-2 common stock, and Class E-3 common stock of LightPath Technologies, Inc., filed November 9, 1995 with the Secretary of State of Delaware, which was filed as an exhibitExhibit 3.1.3 to our Registration StatementAnnual Report on Form SB-210-K (File No: 33-80119)No. 000-25748) filed with the Securities and Exchange Commission on December 7, 1995,September 10, 2020, and is incorporated herein by reference thereto.

Certificate of Designation of Series A Preferred Stock of LightPath Technologies, Inc., filed July 9, 1997 with the Secretary of State of Delaware, which was filed as Exhibit 3.4 to our Annual Report on Form 10-KSB40 filed with the Securities and Exchange Commission on September 11, 1997, and is incorporated herein by reference thereto.

Certificate of Designation of Series B Stock of LightPath Technologies, Inc., filed October 2, 1997 with the Secretary of State of Delaware, which was filed as Exhibit 3.2 to our Quarterly Report on Form 10-QSB (File No. 000-27548) filed with the Securities and Exchange Commission on November 14, 1997, and is incorporated herein by reference thereto.


Certificate of Amendment of Certificate of Incorporation of LightPath Technologies, Inc., filed November 12, 1997 with the Secretary of State of Delaware, which was filed as Exhibit 3.1 to our Quarterly Report on Form 10-QSB (File No. 000-27548) filed with the Securities and Exchange Commission on November 14, 1997, and is incorporated herein by reference thereto.

Certificate of Designation of Series C Preferred Stock of LightPath Technologies, Inc., filed February 6, 1998 with the Secretary of State of Delaware, which was filed as Exhibit 3.2 to our Registration Statement on Form S-3 (File No. 333-47905) filed with the Securities and Exchange Commission on March 13, 1998, and is incorporated herein by reference thereto.

Certificate of Designation, Preferences and Rights of Series D Participating Preferred Stock of LightPath Technologies, Inc. filed April 29, 1998 with the Secretary of State of Delaware, which was filed as Exhibit 1 to our Registration Statement on Form 8-A (File No. 000-27548) filed with the Securities and Exchange Commission on April 28, 1998, and is incorporated herein by reference thereto.

Certificate of Designation of Series F Preferred Stock of LightPath Technologies, Inc., filed November 2, 1999 with the Secretary of State of Delaware, which was filed as Exhibit 3.2 to our Registration Statement on Form S-3 (File No: 333-94303) filed with the Securities and Exchange Commission on January 10, 2000, and is incorporated herein by reference thereto.

Certificate of Amendment of Certificate of Incorporation of LightPath Technologies, Inc., filed February 28, 2003 with the Secretary of State of Delaware, which was filed as Appendix A to our Proxy Statement (File No. 000-27548) filed with the Securities and Exchange Commission on January 24, 2003, and is incorporated herein by reference thereto.

 
40

Table of Contents

3.1.11

Certificate of Amendment of Certificate of Incorporation of LightPath Technologies, Inc., filed March 1, 2016 with the Secretary of State of Delaware, which was filed as Exhibit 3.1.11 to our Quarterly Report on Form 10-Q (File No: 000-27548) filed with the Securities and Exchange Commission on November 14, 2016, and is incorporated herein by reference thereto.

Certificate of Amendment of Certificate of Incorporation of LightPath Technologies, Inc., filed October 30, 2017 with the Secretary of State of Delaware, which was filed as Exhibit 3.1 to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on October 31, 2017, and is incorporated herein by reference thereto.

Certificate of Amendment of Certificate of Designations of Class A Common Stock and Class E-1 Common Stock, Class E-2 Common Stock, and Class E-3 Common Stock of LightPath Technologies, Inc., filed October 30, 2017 with the Secretary of State of Delaware, which was filed as Exhibit 3.2 to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on October 31, 2017, and is incorporated herein by reference thereto.

Certificate of Amendment of Certificate of Designation, Preferences and Rights of Series D Participating Preferred Stock of LightPath Technologies, Inc., filed January 30, 2018 with the Secretary of State of Delaware, which was filed as Exhibit 3.1 to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on February 1, 2018, and is incorporated herein by references thereto.

Second Amended and Restated Bylaws of LightPath Technologies, Inc., which was filed as Exhibit 3.1 to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on February 3, 2015,2, 2021, and is incorporated herein by reference thereto.

First Amendment to Amended and Restated Bylaws

Description of LightPath Technologies, Inc., which was filed as Exhibit 3.1 to our Current Report on Form 8-K (File No: 000-27548) filed withSecurities Registered under Section 12 of the Securities and Exchange Commission on September 21, 2017, and is incorporated herein by reference thereto.Act of 1934, as amended.*


4.1Rights Agreement dated May 1, 1998, between LightPath Technologies, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent, which was filed as Exhibit 1 to Registration Statement on Form 8-A filed with the Securities and Exchange Commission on April 28, 1998, and is incorporated herein by reference thereto.

4.2First Amendment to Rights Agreement dated February 25, 2008 between LightPath Technologies, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent, which was filed as Exhibit 2 to Amendment No. 1 to Form 8-A filed with the Securities and Exchange Commission on February 25, 2008, and is incorporated herein by reference thereto.
4.3Second Amendment to Rights Agreement dated January 30, 2018 between LightPath Technologies, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent, which was filed as Exhibit 4.1 to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on February 1, 2018, and is incorporated herein by reference thereto.

Amended and Restated Omnibus Incentive Plan dated October 15, 2002, as amended, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on October 31, 2017, and is incorporated herein by reference thereto.

Employee Letter Agreement dated June 12, 2008, between LightPath Technologies, Inc., and J. James Gaynor, its Chief Executive Officer & President, which was filed as Exhibit 99.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on June 17, 2008, and is incorporated herein by reference thereto.
LightPath Technologies, Inc. Employee Stock Purchase Plan effective January 30, 2015, which was filed as Appendix A to our Definitive Proxy Statement on Schedule 14A (File No.: 000-27548) filed with the Securities and Exchange Commission on December 19, 2014, and is incorporated herein by reference thereto.

Second Amended and Restated Loan and Security Agreement dated December 21, 2016 by and between LightPath Technologies, Inc. and Avidbank Corporate Finance, a division of Avidbank, which was filed as Exhibit 10.2 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on December 27, 2016, and is incorporated herein by reference thereto.
Sixth Amendment to Lease dated as of July 2, 2014 between LightPath Technologies, Inc. and Challenger Discovery LLC, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on July 8, 2014, and is incorporated herein by reference thereto.

Unsecured Promissory Note dated December 21, 2016 in favor of Joseph Menaker and Mark Lifshotz, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on December 27, 2016, and is incorporated herein by reference thereto.
Joinder Agreement dated December 22, 2016 by and between ISP Optics Corporation and Avidbank Corporate Finance, a division of Avidbank, which was filed as Exhibit 10.4 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on December 27, 2016, and is incorporated herein by reference thereto.
First Amendment to Second Amended and Restated Loan and Security Agreement dated December 20, 2017 by and between LightPath Technologies, Inc. and Avidbank Corporate Finance a division of Avidbank, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 00027548) filed with the Securities and Exchange Commission on December 22, 2017, and is incorporated herein by reference thereto.
Note Satisfaction and Securities Purchase Agreement dated January 16, 2018, by and between LightPath Technologies, Inc., Joseph Menaker, and Mark Lifshotz, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on January 17, 2018, and is incorporated herein by reference thereto.
Second Amendment to Second Amended and Restated Loan and Security Agreement dated December 20, 2017 by and between LightPath Technologies, Inc. and Avidbank Corporate Finance, a division of Avidbank, which was filed as Exhibit 10.3 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on January 17, 2018, and is incorporated herein by reference thereto.

Affirmation of Guarantee of GelTech, Inc., which was filed as Exhibit 10.4 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on January 17, 2018, and is incorporated herein by reference thereto.
Amendment No. 8 to the Amended and Restated LightPath Technologies, Inc. Omnibus Incentive Plan dated February 8, 2018, which was filed as Exhibit 10.7 to our Quarterly Report on Form 10-Q (File No.: 000-27548) filed with the Securities and Exchange Commission on February 13, 2018, and is incorporated herein by reference thereto.

Lease dated April 20, 2018, by and between LightPath Technologies, Inc. and CIO University Tech, LLC, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on April 26, 2018, and is incorporated herein by reference thereto.

Third Amendment to Second Amended and Restated Loan and Security Agreement dated May 11, 2018, by and between LightPath Technologies, Inc. and Avidbank, which was filed as Exhibit 10.7 to our Quarterly Report on Form 10-Q (File No.: 000-27548) filed with the Securities and Exchange Commission on May 14, 2018, and is incorporated herein by reference thereto.
Affirmation of Guarantee of Geltech, Inc., which was filed as Exhibit 10.8 to our Quarterly Report on Form 10-Q (File No.: 000-27548) filed with the Securities and Exchange Commission on May 14, 2018, and is incorporated herein by reference thereto.
Offer Letter between LightPath Technologies, Inc. and Donald O. Retreage, Jr., dated May 31, 2018, which was filed as Exhibit 10.1 to our Currently Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on June 5, 2018, and is incorporated herein by reference thereto.
Fourth Amendment to the Second Amended and Restated Loan and Security Agreement dated September 7, 2018, by and between LightPath Technologies, Inc. and Avidbank, which was filed as Exhibit 10.21 to our Annual Report on Form 10-K (File No.: 000-27548) filed with the Securities and Exchange Commission on September 13, 2018, and is incorporated herein by reference thereto.
First Amendment to Lease, dated January 9, 2019, by and between LightPath Technologies, Inc. and CIO University Tech, LLC, which was filed as Exhibit 10.3 to our Quarterly Report on Form 10-Q (File No.: 000-27548) filed with the Securities and Exchange Commission on February 7, 2019, and is incorporated herein by reference thereto.

Loan Agreement dated February 26, 2019 by and between LightPath Technologies, Inc. and BankUnited, N.A., which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on March 1, 2019, and is incorporated herein by reference thereto.

 
41

10.20Table of Contents

10.8

Term Loan Note dated February 26, 2019 by LightPath Technologies, Inc. in favor of BankUnited, N.A., which was filed as Exhibit 10.2 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on March 1, 2019, and is incorporated herein by reference thereto.

Revolving Credit Note dated February 26, 2019 by LightPath Technologies, Inc. in favor of BankUnited, N.A., which was filed as Exhibit 10.3 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on March 1, 2019, and is incorporated herein by reference thereto.

Guidance Line Note dated February 26, 2019 by LightPath Technologies, Inc. in favor of BankUnited, N.A., which was filed as Exhibit 10.4 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on March 21, 2019, and is incorporated herein by reference thereto.

Security Agreement dated February 26, 2019 by LightPath Technologies, Inc. in favor of BankUnited, N.A., and joined by GelTech, Inc. and ISP Optics Corporation, which was filed as Exhibit 10.5 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on March 1, 2019, and is incorporated herein by reference thereto.

Guaranty Agreement (Term Loan) dated February 26, 2019 by GelTech Inc., ISP Optics Corporation, LightPath Optical Instrumentation (Shanghai) Co., Ltd., LightPath Optical Instrumentation (Zhenjiang) Co., Ltd., and ISP Optics Latvia, SIA in favor of BankUnited, N.A., which was filed as Exhibit 10.6 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on March 1, 2019, and is incorporated herein by reference thereto.

Guaranty Agreement (Revolving Credit) dated February 26, 2019 by GelTech Inc., ISP Optics Corporation, LightPath Optical Instrumentation (Shanghai) Co., Ltd., LightPath Optical Instrumentation (Zhenjiang) Co., Ltd., and ISP Optics Latvia, SIA in favor of BankUnited, N.A., which was filed as Exhibit 10.7 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on March 1, 2019, and is incorporated herein by reference thereto.


Guaranty Agreement (Guidance Line) dated February 26, 2019 by GelTech Inc., ISP Optics Corporation, LightPath Optical Instrumentation (Shanghai) Co., Ltd., LightPath Optical Instrumentation (Zhenjiang) Co., Ltd., and ISP Optics Latvia, SIA in favor of BankUnited, N.A., which was filed as Exhibit 10.8 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on March 1, 2019, and is incorporated herein by reference thereto.

First Amendment to Loan Agreement dated May 6, 2019, and effective February 26, 2019, by and between LightPath Technologies, Inc. and BankUnited, N.A., which was filed as Exhibit 10.10 to our Quarterly Report on Form 10-Q (File No.: 000-27548) filed with the Securities and Exchange Commission on May 9, 2019, and is incorporated herein by reference thereto.

Fifth Amendment to Second Amended and Restated Loan and Security Agreement dated October 30, 2018, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on November 2, 2018, and is incorporated herein by reference thereto.
Affirmation of Guarantee of Geltech, Inc., which was filed as Exhibit 10.2 to our Quarterly Report on Form 10-Q (File No.: 000-27548) filed with the Securities and Exchange Commission on November 1, 2018, and is incorporated herein by reference thereto.
LightPath Technologies, Inc. 2018 Stock and Incentive Compensation Plan, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on November 8, 2018, and is incorporated herein by reference thereto.

Separation

Employment Agreement between the CompanyLightPath Technologies, Inc. and Dorothy M. Cipolla, effective as of July 27, 2019,Mr. Sam Rubin, which was filed as Exhibit 10.1 to Amendment No. 1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on AugustFebruary 26, 2019,2020, and is incorporated herein by reference thereto.

10.18

Letter Agreement, dated November 13, 2020, by and between the Company and J. James Gaynor which was filed as Exhibit 10.1 to our Quarterly Report on Form 10-Q (File No.: 000-27548) filed with the Securities and Exchange Commission on February 3, 2021, and is incorporated herein by reference thereto.

10.19

Employment Agreement between LightPath Technologies, Inc. and Mr. Albert Miranda, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on April 22, 2021, and is incorporated herein by reference thereto.

10.20

Eighth Amendment to Lease Agreement between LightPath Technologies, Inc. and Challenger-Discovery, LLC which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on May 17, 2021, and is incorporated herein by reference thereto.

 
42

Table of Contents

10.21

Ninth Amendment to Lease dated as of September 21, 2021, between LightPath Technologies, Inc. and Challenger Discovery LLC, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on September 27, 2021, and is incorporated herein by reference thereto.

10.22

Notice of Default and Waiver dated November 8, 2021 between LightPath Technologies, Inc. and BankUnited, N.A., which was filed as Exhibit 10.3 to our Quarterly Report on Form 10-Q (File No: 000-27548) filed with the Securities and Exchange Commission on November 9, 2021, and is incorporated herein by reference thereto.

10.23

Second Amendment to Loan Agreement dated as of December 20, 2021, between LightPath Technologies, Inc. and BankUnited N.A., which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on December 23, 2021, and is incorporated herein by reference thereto.

10.24

Sales Agreement, dated February 15, 2022, by and between LightPath Technologies, Inc. and A.G.P./Alliance Global Partners, which was filed as Exhibit 10.1 to our Current Report on Form 8-K (File No: 000-27548) filed with the Securities and Exchange Commission on February 16, 222, and is incorporated herein by reference thereto.

10.25

Investor Relations Consulting Agreement, dated April 11, 2022, by and between LightPath Technologies, Inc. and MZHCI, LLC, which was filed as Exhibit 10.2 to our Quarterly Report on Form 10-Q (File No: 000-27548) filed with the Securities and Exchange Commission on May 12, 2022, and is incorporated herein by reference thereto.

10.26

Third Amendment to Loan Agreement, dated May 11, 2022, by and between LightPath Technologies, Inc. and BankUnited, N.A., which was filed as Exhibit 10.3 to our Quarterly Report on Form 10-Q (File No: 000-27548) filed with the Securities and Exchange Commission on May 12, 2022, and is incorporated herein by reference thereto.

14.1

Code of Business Conduct and Ethics, which was filed as Exhibit 14.1 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on May 3, 2016, and is incorporated herein by reference thereto.

Code of Business Conduct and Ethics for Senior Financial Officers, which was filed as Exhibit 14.2 to our Current Report on Form 8-K (File No.: 000-27548) filed with the Securities and Exchange Commission on May 3, 2016, and is incorporated herein by reference thereto.

Subsidiaries of the Registrant*

Consent of Moore Stephens Lovelace,MSL, P.A.*

Power of Attorney*

31.1

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934*

31.2

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934*

32.1

32.2

101.INS   

XBRL Instance Document*

101.SCH   

XBRL Taxonomy Extension Schema Document*

101.CAL   

XBRL Taxonomy Extension Calculation Linkbase Document*

101.DEF  

XBRL Taxonomy Extension Definition Linkbase Document*

101.LAB   

XBRL Taxonomy Extension Label Linkbase Document*

101.PRE   

XBRL Taxonomy Presentation Linkbase Document*

104        

The cover page from the Company’s Annual Report on Form 10-K for thefiscal year ended June 30, 2022, formatted in iXBRL.

101.INS   XBRL Instance Document*
101.SCH   XBRL Taxonomy Extension Schema Document*
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF  XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB   XBRL Taxonomy Extension Label Linkbase Document*
101.PRE   XBRL Taxonomy Presentation Linkbase Document*

*filed herewith

Item 16. Form 10-K Summary.

Summary.

None.


43

Table of Contents

LightPath Technologies, Inc.

Index to Consolidated Financial Statements

Statements

Report of Independent Registered Public Accounting Firm – Moore Stephens Lovelace,MSL, P.A. (MSL PCAOB #569)

F-1

F-2

Consolidated Financial Statements:

Consolidated Balance Sheets as of June 30, 20192022 and 20182021

F-2

F-3

Consolidated Statements of Comprehensive Income (Loss) for the years ended June 30, 20192022 and 20182021

F-3

F-4

Consolidated Statements of Changes in Stockholders’ Equity for the years ended June 30, 20192022 and 20182021 

F-4

F-5

Consolidated Statements of Cash Flows for the years ended June 30, 20192022 and 20182021

F-5

F-6

Notes to Consolidated Financial Statements

F-7

 
F-6F-1

Table of Contents

Report of Independent Registered Public Accounting Firm

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders

of LightPath Technologies, Inc.

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of LightPath Technologies, Inc. (the “Company”) as of June 30, 20192022 and 2018,2021, and the related consolidated statements of comprehensive income (loss), changes in stockholders’ equity, and cash flows for each of the years ended June 30, 20192022 and 2018,2021, and the related notes (collectively referred to as the consolidated“consolidated financial statements)statements”).  In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 20192022 and 2018,2021, and the results of its operations and its cash flows for each of the years ended June 30, 20192022 and 2018,2021, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits.  We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federalFederal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB.  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As a part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.  Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.  Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.  We believe that our audits provide a reasonable basis for our opinion.

/s/ MOORE STEPHENS LOVELACE, P.A.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments.  The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.

Inventory Allowance

As disclosed in Notes 2 and 4 of the notes to the consolidated financial statements, the Company records an estimated inventory allowance to state the Company’s inventories at the lower of cost or net realizable value.  The Company relies on, among other things, past usage, sales experience, recent order and quote activity, future sales forecasts, and its strategic business plan to develop the estimate.  As a result of management’s assessment, the Company recorded an inventory allowance of approximately $1,330,000 as of June 30, 2022.

Auditing management’s estimate of the inventory allowance involved subjective evaluation and high degree of auditor judgement due to significant assumptions involved in estimating future inventory turnover and sales.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements.  We obtained an understanding and evaluated the design of internal controls that address the risks of material misstatement relating to recording inventory at the lower of cost or net realizable value.  We tested the accuracy and completeness of the underlying data used in calculating the inventory allowance, including testing of a sample of inventory usage transactions, and recomputed the allowance calculation.  We also evaluated the Company’s ability to accurately estimate the assumptions used to develop the estimate by comparing historical allowance amounts to the history of actual inventory write-offs.  Furthermore, we reviewed management’s business plan and forecasts of future sales.

We have served as the Company’s auditor since 2017.

/s/ MSL, P.A.

Orlando, Florida

September 12, 2019


 
LIGHTPATH TECHNOLOGIES, INC.
 
 
Consolidated Balance Sheets
 
 
 
 
 
 
 
 
 
 
 
 
 
June 30,
 
 
June 30,
 
Assets
 
2019
 
 
2018
 
Current assets:
 
 
 
 
 
 
Cash and cash equivalents
 $4,604,701 
 $5,508,620 
Restricted cash
  - 
  1,000,000 
Trade accounts receivable, net of allowance of $29,406 and $13,364
  6,210,831 
  5,370,508 
Inventories, net
  7,684,527 
  6,404,741 
Other receivables
  353,695 
  46,574 
Prepaid expenses and other assets
  754,640 
  1,058,610 
Total current assets
  19,608,394 
  19,389,053 
 
    
    
Property and equipment, net
  11,731,084 
  11,809,241 
Intangible assets, net
  7,837,306 
  9,057,970 
Goodwill
  5,854,905 
  5,854,905 
Deferred tax assets, net
  652,000 
  624,000 
Other assets
  289,491 
  381,945 
Total assets
 $45,973,180 
 $47,117,114 
Liabilities and Stockholders’ Equity
    
    
Current liabilities:
    
    
Accounts payable
 $2,227,768 
 $2,032,834 
Accrued liabilities
  871,912 
  685,430 
Accrued payroll and benefits
  1,730,658 
  1,228,120 
Deferred rent, current portion
  539,151 
  86,560 
Loans payable, current portion
  581,350 
  1,458,800 
Capital lease obligation, current portion
  404,424 
  307,199 
Total current liabilities
  6,355,263 
  5,798,943 
 
    
    
Capital lease obligation, less current portion
  640,284 
  550,127 
Deferred rent, less current portion
  518,364 
  290,804 
Loans payable, less current portion
  5,000,143 
  5,119,796 
Total liabilities
  12,514,054 
  11,759,670 
 
    
    
Commitments and Contingencies
    
    
 
    
    
Stockholders’ equity:
    
    
Preferred stock: Series D, $.01 par value, voting;
    
    
500,000 shares authorized; none issued and outstanding
   
   
Common stock: Class A, $.01 par value, voting;
    
    
    
44,500,000 shares authorized; 25,813,895 and 25,764,544
 
    
shares issued and outstanding
  258,139 
  257,645 
Additional paid-in capital
  230,321,324 
  229,874,823 
Accumulated other comprehensive income
  808,518 
  473,508 
Accumulated deficit
  (197,928,855)
  (195,248,532)
Total stockholders’ equity
  33,459,126 
  35,357,444 
Total liabilities and stockholders’ equity
 $45,973,180 
 $47,117,114 

15, 2022

F-2

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Consolidated Balance Sheets

 

 

 

June 30,

 

 

June 30,

 

Assets

 

2022

 

 

2021

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$5,507,891

 

 

$6,774,694

 

Trade accounts receivable, net of allowance of $36,313 and $45,643

 

 

5,211,292

 

 

 

4,656,354

 

Inventories, net

 

 

6,985,427

 

 

 

8,659,587

 

Other receivables

 

 

 

 

 

137,103

 

Prepaid expenses and other assets

 

 

464,804

 

 

 

475,364

 

Total current assets

 

 

18,169,414

 

 

 

20,703,102

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

11,640,463

 

 

 

13,279,867

 

Operating lease right-of-use assets

 

 

10,420,604

 

 

 

9,015,498

 

Intangible assets, net

 

 

4,457,798

 

 

 

5,582,881

 

Goodwill

 

 

5,854,905

 

 

 

5,854,905

 

Deferred tax assets, net

 

 

143,000

 

 

 

147,000

 

Other assets

 

 

27,737

 

 

 

27,737

 

Total assets

 

$50,713,921

 

 

$54,610,990

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$3,073,933

 

 

$2,924,333

 

Accrued liabilities

 

 

558,750

 

 

 

1,067,265

 

Accrued payroll and benefits

 

 

2,081,212

 

 

 

2,810,043

 

Operating lease liabilities, current

 

 

965,622

 

 

 

799,507

 

Loans payable, current portion

 

 

998,692

 

 

 

634,846

 

Finance lease obligation, current portion

 

 

55,348

 

 

 

212,212

 

Total current liabilities

 

 

7,733,557

 

 

 

8,448,206

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities, net

 

 

541,015

 

 

 

 

Finance lease obligation, less current portion

 

 

11,454

 

 

 

66,801

 

Operating lease liabilities, noncurrent

 

 

9,478,077

 

 

 

8,461,133

 

Loans payable, less current portion

 

 

3,218,580

 

 

 

4,057,365

 

Total liabilities

 

 

20,982,683

 

 

 

21,033,505

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock: Series D, $.01 par value, voting; 500,000 shares authorized; none issued and outstanding

 

 

 

 

 

 

Common stock: Class A, $.01 par value, voting; 44,500,000 shares authorized; 27,046,790 and 26,985,913 shares issued and outstanding

 

 

270,468

 

 

 

269,859

 

Additional paid-in capital

 

 

232,315,003

 

 

 

231,438,651

 

Accumulated other comprehensive income

 

 

935,125

 

 

 

2,116,152

 

Accumulated deficit

 

 

(203,789,358)

 

 

(200,247,177)

Total stockholders’ equity

 

 

29,731,238

 

 

 

33,577,485

 

Total liabilities and stockholders’ equity

 

$50,713,921

 

 

$54,610,990

 

The accompanying notes are an integral part of these consolidated financial statements.

F-2
 
LIGHTPATH TECHNOLOGIES, INC.
 
 
Consolidated Statements of Comprehensive Income (Loss)
 
 
 
 
 
 
 
Years Ended June 30,
 
 
 
2019
 
 
2018
 
Revenue, net
 $33,749,088 
 $32,525,471 
Cost of sales
  21,230,168 
  19,997,740 
Gross margin
  12,518,920 
  12,527,731 
Operating expenses:
    
    
Selling, general and administrative
  10,498,651 
  9,218,346 
New product development
  2,016,615 
  1,618,994 
Amortization of intangibles
  1,220,664 
  1,317,082 
Gain on disposal of property and equipment
  (77,047)
  (258)
Total operating costs and expenses
  13,658,883 
  12,154,164 
Operating income (loss)
  (1,139,963)
  373,567 
Other income (expense):
    
    
Interest expense, net
  (697,113)
  (186,948)
Change in fair value of warrant liability
   
  (194,632)
Other income (expense), net
  (388,041)
  241,040 
Total other income (expense), net
  (1,085,154)
  (140,540)
Income (loss) before income taxes
  (2,225,117)
  233,027 
Income tax provision (benefit)
  455,206 
  (827,077)
Net income (loss)
 $(2,680,323)
 $1,060,104 
Foreign currency translation adjustment
  335,010 
  178,112 
Comprehensive income (loss)
 $(2,345,313)
 $1,238,216 
Earnings (loss) per common share (basic)
 $(0.10)
 $0.04 
Number of shares used in per share calculation (basic)
  25,794,669 
  25,006,467 
Earnings (loss) per common share (diluted)
 $(0.10)
 $0.04 
Number of shares used in per share calculation (diluted)
  25,794,669 
  26,811,468 

F-3

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Consolidated Statements of Comprehensive Income (Loss)

 

 

 

Year Ended

 

 

 

June 30,

 

 

 

2022

 

 

2021

 

Revenue, net

 

$35,559,160

 

 

$38,464,821

 

Cost of sales

 

 

23,744,524

 

 

 

25,017,051

 

Gross margin

 

 

11,814,636

 

 

 

13,447,770

 

Operating expenses:

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

11,221,866

 

 

 

11,989,597

 

New product development

 

 

2,085,686

 

 

 

2,165,951

 

Amortization of intangible assets

 

 

1,125,083

 

 

 

1,125,083

 

Loss on disposal of property and equipment

 

 

9,235

 

 

 

8,951

 

Total operating expenses

 

 

14,441,870

 

 

 

15,289,582

 

Operating loss

 

 

(2,627,234)

 

 

(1,841,812)

Other income (expense):

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(229,475)

 

 

(215,354)

Other income (expense), net

 

 

177,435

 

 

 

(194,170)

Total other income (expense), net

 

 

(52,040)

 

 

(409,524)

Loss before income taxes

 

 

(2,679,274)

 

 

(2,251,336)

Income tax provision

 

 

862,907

 

 

 

933,915

 

Net loss

 

$(3,542,181)

 

$(3,185,251)

Foreign currency translation adjustment

 

 

(1,181,027)

 

 

1,380,260

 

Comprehensive loss

 

$(4,723,208)

 

$(1,804,991)

Loss per common share (basic)

 

$(0.13)

 

$(0.12)

Number of shares used in per share calculation (basic)

 

 

27,019,534

 

 

 

26,314,025

 

Loss per common share (diluted)

 

$(0.13)

 

$(0.12)

Number of shares used in per share calculation (diluted)

 

 

27,019,534

 

 

 

26,314,025

 

The accompanying notes are an integral part of these consolidated financial statements.

F-3
 
LIGHTPATH TECHNOLOGIES, INC.
 
 
Consolidated Statements of Changes in Stockholders' Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated
 
 
 
 
 
 
 
 
 
Class A
 
 
 
 
 
Additional
 
 
Other
 
 
 
 
 
Total
 
 
 
Common Stock
 
 
 
 
 
Paid-in
 
 
Comphrehensive
 
 
Accumulated
 
 
Stockholders’
 
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Income
 
 
Deficit
 
 
Equity
 
Balances at June 30, 2017
  24,215,733 
 $242,157 
 $225,492,252 
 $295,396 
 $(196,308,636)
 $29,721,169 
Issuance of common stock for:
    
    
    
    
    
    
Exercise of warrants
  433,810 
  4,338 
  529,980 
   
   
  534,318 
Employee Stock Purchase Plan
  19,980 
  200 
  48,391 
   
   
  48,591 
Exercise of stock options, net
  127,813 
  1,278 
  224,723 
   
   
  226,001 
Settlement of Sellers Note
  967,208 
  9,672 
  2,237,392 
    
    
  2,247,064 
Reclassification of warrant liability upon exercise
   
   
  685,132 
   
   
  685,132 
Stock-based compensation on stock options & RSUs
   
   
  656,953 
   
   
  656,953 
Foreign currency translation adjustment
   
   
   
  178,112 
   
  178,112 
Net income
   
   
   
   
  1,060,104 
  1,060,104 
Balances at June 30, 2018
  25,764,544 
  257,645 
  229,874,823 
  473,508 
  (195,248,532)
  35,357,444 
Issuance of common stock for:
    
    
    
    
    
    
Employee Stock Purchase Plan
  20,871 
  209 
  38,229 
   
   
  38,438 
Exercise of stock options, net
  28,480 
  285 
  13,482 
   
   
  13,767 
Stock-based compensation on stock options & RSUs
   
   
  394,790 
   
   
  394,790 
Foreign currency translation adjustment
   
   
   
  335,010 
   
  335,010 
Net loss
   
   
   
   
  (2,680,323)
  (2,680,323)
Balances at June 30, 2019
  25,813,895 
 $258,139 
 $230,321,324 
 $808,518 
 $(197,928,855)
 $33,459,126 

F-4

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Consolidated Statements of Changes in Stockholders' Equity

 

 

 

Class A

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

Common

 

 

 

 

Additional

 

 

Other

 

 

 

 

Total

 

 

 

Stock

 

 

 

 

Paid-in

 

 

Comphrehensive

 

 

Accumulated

 

 

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income

 

 

Deficit

 

 

Equity

 

Balances at June 30, 2020

 

 

25,891,885

 

 

$258,919

 

 

$230,634,056

 

 

$735,892

 

 

$(197,061,926)

 

$34,566,941

 

Issuance of common stock for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee Stock Purchase Plan

 

 

8,145

 

 

 

81

 

 

 

29,897

 

 

 

 

 

 

 

 

 

29,978

 

Exercise of Stock Options & RSUs, net

 

 

1,085,883

 

 

 

10,859

 

 

 

131,833

 

 

 

 

 

 

 

 

 

142,692

 

Stock-based compensation on stock options & RSUs

 

 

 

 

 

 

 

 

642,865

 

 

 

 

 

 

 

 

 

642,865

 

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

1,380,260

 

 

 

 

 

 

1,380,260

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,185,251)

 

 

(3,185,251)

Balances at June 30, 2021

 

 

26,985,913

 

 

$269,859

 

 

$231,438,651

 

 

$2,116,152

 

 

$(200,247,177)

 

$33,577,485

 

Issuance of common stock for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee Stock Purchase Plan

 

 

21,012

 

 

 

210

 

 

 

51,501

 

 

 

 

 

 

 

 

 

51,711

 

Exercise of Stock Options & RSUs, net

 

 

39,865

 

 

 

399

 

 

 

(399)

 

 

 

 

 

 

 

 

-

 

Stock-based compensation on stock options & RSUs

 

 

 

 

 

 

 

 

825,250

 

 

 

 

 

 

 

 

 

825,250

 

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(1,181,027)

 

 

 

 

 

(1,181,027)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,542,181)

 

 

(3,542,181)

Balances at June 30, 2022

 

 

27,046,790

 

 

$270,468

 

 

$232,315,003

 

 

$935,125

 

 

$(203,789,358)

 

$29,731,238

 

The accompanying notes are an integral part of these consolidated financial statements.


F-4
 
LIGHTPATH TECHNOLOGIES, INC.
 
 
Consolidated Statements of Cash Flows
 
 
 
 
 
 
 
 
 
 
Years Ended June 30,
 
 
 
2019
 
 
2018
 
Cash flows from operating activities:
 
 
 
 
 
 
Net (loss) income
 $(2,680,323)
 $1,060,104 
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
    
    
       Depreciation and amortization
  3,464,156 
  3,403,581 
       Interest from amortization of debt costs
  117,261 
  19,685 
       Gain on disposal of property and equipment
  (77,047)
  (258)
       Stock-based compensation on stock options & RSUs, net
  394,790 
  373,554 
       Provision for doubtful accounts receivable
  (6,658)
  (16,417)
       Change in fair value of warrant liability
   
  194,632 
       Change in fair value of Sellers Note
   
  (396,163)
       Deferred rent amortization
  370,701
  (81,475)
       Inventory write-offs to reserve
  125,234 
  187,547 
       Deferred tax benefit
  (28,000)
  (533,806)
Changes in operating assets and liabilities:
    
    
Trade accounts receivable
  (833,665)
  618,393 
Other receivables
  (306,348)
  (15,997)
Inventories
  (1,405,020)
  (1,330,994)
    Prepaid expenses and other assets
  392,925
  (685,260)
    Accounts payable and accrued liabilities
  883,179
  (178,138)
                  Net cash provided by operating activities
 411,185
  2,618,988 
 
    
    
Cash flows from investing activities:
    
    
   Purchase of property and equipment
  (1,931,835)
  (2,517,685)
   Proceeds from sale of equipment
  683,250 
   
                  Net cash used in investing activities
  (1,248,585)
  (2,517,685)
 
    
    
Cash flows from financing activities:
    
    
Proceeds from exercise of stock options
  13,767 
  226,001 
Proceeds from sale of common stock from Employee Stock Purchase Plan
  38,438 
  48,591 
Loan costs
  (92,860)
  (61,253)
Borrowings on loan payable
  5,813,500 
  2,942,583 
Proceeds from exercise of warrants, net of costs
   
  534,318 
    Payments on loan payable
  (6,831,503)
  (4,716,536)
    Payments on capital lease obligations
  (342,871)
  (287,354)
                 Net cash used in financing activities
  (1,401,529)
  (1,313,650)
Effect of exchange rate on cash and cash equivalents
 335,010
  (364,048)
Change in cash and cash equivalents and restricted cash
  (1,903,919)
  (1,576,395)
Cash and cash equivalents and restricted cash, beginning of period
  6,508,620 
  8,085,015 
Cash and cash equivalents, end of period
 $4,604,701 
 $6,508,620 
 
    
    
Supplemental disclosure of cash flow information:
    
    
 Interest paid in cash
 $500,985 
 $546,306 
 Income taxes paid
 $406,526 
 $386,471 
 Supplemental disclosure of non-cash investing & financing activities:
    
    
 Purchase of equipment through capital lease arrangements
 $530,253 
 $763,247 
 Landlord credits for leasehold improvements
 $309,450 
   
 Reclassification of warrant liability upon exercise
   
 $685,132 
 Derecognition of liability associated with stock option grants
   
 $283,399 
 Conversion of Sellers Note to Common Stock
   
 $2,247,064 
 
    
    

F-5

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Consolidated Statements of Cash Flows

 

 

 

Year Ended

June 30,

 

 

 

2022

 

 

2021

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$(3,542,181)

 

$(3,185,251)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

3,617,743

 

 

 

3,509,436

 

Interest from amortization of debt costs

 

 

51,974

 

 

 

18,572

 

Loss on disposal of property and equipment

 

 

9,235

 

 

 

8,951

 

Stock-based compensation on stock options & RSUs, net

 

 

825,250

 

 

 

642,865

 

Provision for doubtful accounts receivable

 

 

7,713

 

 

 

(35,799)

Change in operating lease assets and liabilities

 

 

(222,047)

 

 

(187,616)

Inventory write-offs to allowance

 

 

456,538

 

 

 

157,399

 

Deferred taxes

 

 

545,015

 

 

 

512,000

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Trade accounts receivable

 

 

(562,651)

 

 

1,568,171

 

Other receivables

 

 

137,103

 

 

 

(5,052)

Inventories

 

 

1,217,622

 

 

 

167,496

 

Prepaid expenses and other assets

 

 

10,560

 

 

 

137,810

 

Accounts payable and accrued liabilities

 

 

(1,087,746)

 

 

1,423,042

 

Net cash provided by operating activities

 

 

1,464,128

 

 

 

4,732,024

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(1,626,614)

 

 

(3,158,784)

Net cash used in investing activities

 

 

(1,626,614)

 

 

(3,158,784)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from exercise of stock options

 

 

 

 

 

142,692

 

Proceeds from sale of common stock from Employee Stock Purchase Plan

 

 

51,711

 

 

 

29,978

 

Loan costs

 

 

(61,223)

 

 

 

Borrowings on loans payable

 

 

266,850

 

 

 

275,377

 

Payments on loans payable

 

 

(681,301)

 

 

(1,013,014)

Repayment of finance lease obligations

 

 

(212,211)

 

 

(278,462)

Net cash used in financing activities

 

 

(636,174)

 

 

(843,429)

Effect of exchange rate on cash and cash equivalents

 

 

(468,143)

 

 

657,495

 

Change in cash and cash equivalents

 

 

(1,266,803)

 

 

1,387,306

 

Cash and cash equivalents, beginning of period

 

 

6,774,694

 

 

 

5,387,388

 

Cash and cash equivalents, end of period

 

$5,507,891

 

 

$6,774,694

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Interest paid in cash

 

$157,407

 

 

$199,524

 

Income taxes paid

 

$267,585

 

 

$1,054,232

 

The accompanying notes are an integral part of these consolidated financial statements.


F-5

F-6

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

1.

Organization and History

LightPath Technologies, Inc. (“LightPath”, the “Company”, “we”, “us” or “our”) was incorporated in Delaware in 1992.  It was the successor to LightPath Technologies Limited Partnership formed in 1989, and its predecessor, Integrated Solar Technologies Corporation formed in 1985.  The Company completed its initial public offering during fiscal year 1996.  On April 14, 2000, the Company acquired Horizon Photonics, Inc. (“Horizon”).  On September 20, 2000, the Company acquired Geltech, Inc. (“Geltech”). The Company completed its initial public offering during fiscal 1996.  In November 2005, we formed LightPath Optical Instrumentation (Shanghai) Co., Ltd (“LPOI”), a wholly-owned subsidiary located in Jiading, People’s Republic of China.  In December 2013, we formed LightPath Optical Instrumentation (Zhenjiang) Co., Ltd (“LPOIZ”), a wholly-owned subsidiary located in Zhenjiang, Jiangsu Province, People’s Republic of China.  In December 2016, we acquired ISP Optics Corporation, a New York corporation (“ISP”), and its wholly-owned subsidiary, ISP Optics Latvia, SIA, a limited liability company founded in 1998 under the Laws of the Republic of Latvia (“ISP Latvia”).

LightPath is a manufacturer of optical components and higher-level assemblies, including precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses, and other optical components used to produce products that manipulate light.  LightPath designs, develops, manufactures, and distributes optical components and assemblies utilizing advanced optical manufacturing processes. LightPath products are incorporated into a variety of applications by customers in many industries, including defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors, among others.

As used herein, the terms “LightPath,” the “Company,” “we,” “us” or “our,” refer to LightPath individually or, as the context requires, collectively with its subsidiaries on a consolidated basis.

2.

Summary of Significant Accounting Policies

Consolidated Financial Statementsinclude the accounts of the Company and its wholly-owned subsidiaries.  All significant intercompany balances and transactions have been eliminated in consolidation.

Reclassifications.The classification of certain prior-year amounts have been adjusted in our Consolidated Financial Statements to conform to current-year classifications. Reclassifications include the addition of the line item “Deferred rent, current portion” to the Consolidated Balance Sheet, to classify as current the amount of the liability expected to be relieved within a one-year period.

Management estimates.Management makes estimates and assumptions during the preparation of the Company’s Consolidated Financial Statements that affect amounts reported in the Consolidated Financial Statements and accompanying notes.  Such estimates and assumptions could change in the future as more information becomes available, which, in turn, could impact the amounts reported and disclosed herein.

Cash and cash equivalentsconsist of cash in the bank and cash equivalents with maturities of 90 days or less when purchased. The Company maintains its cash accounts in various institutions, generally with high credit ratings. The Company’s domestic cash accounts are maintained in one financial institution, and balances may exceed federalFederal insured limits at times.  The Company’s foreign cash accounts are not insured.

Restricted cashconsists of amounts held in restricted accounts as collateral associated with our debt covenants. See Note 18, Loans Payable, to these Consolidated Financial Statements for additional information. Our  The Company did not have any restricted cash was invested in a money market account. During fiscal year 2018, the Company adopted ASU 2016-18, “Statement of Cash Flows (Topic 320): Restricted Cash” (“ASU 2016-18”), which provides guidance on the presentation of restricted cash and restricted cash equivalents in the statement of cash flows. Cash and cash equivalents and restricted cash presented in the Consolidated Balance Sheet as of June 30, 2018 are combined in the Consolidated Statements of Cash Flows for the years ended June 30, 2019 and 2018.
2022 or 2021.

Allowance for accounts receivableis calculated by taking 100% of the total of invoices that are over 90 days past due from the due date and 10% of the total of invoices that are over 60 days past due from the due date for U.S.- and Latvia-based accounts and 100% of invoices that are over 120 days past due for Chinese-based accounts.  Accounts receivable are customer obligations due under normal trade terms.  The Company performs continuing credit evaluations of its customers’ financial condition.  If the Company’s actual collection experience changes, revisions to its allowance may be required.  After all attempts to collect a receivable have failed, the receivable is written off against the allowance.

F-6

Inventories,which consist principally of raw materials, tooling, work-in-process and finished lenses, collimators and assemblies are stated at the lower of cost or net realizable value, on a first-in, first-out basis.  Inventory costs include materials, labor and manufacturing overhead.  Acquisition of goods from our vendors has a purchase burden added to cover customs, shipping and handling costs.  Fixed costs related to excess manufacturing capacity are expensed when incurred.  The Company looks at the following criteria for parts to consider for the inventory allowance: (i) items that have not been sold in two years and (ii) items that have not been purchased in two years, or (iii) items of which we have more than a two-year supply.years. These items, as identified, are allowed for at 100%, as well as allowing 50% for other items deemed to be slow moving within the last twelve months and allowing 25% for items deemed to have low material usage within the last six months. Items of which we have greater than a two-year supply are also reserved at 25% to 100%, depending on usage rates.  The parts identified are adjusted for recent order and quote activity to determine the final inventory allowance.

F-7

Table of Contents

Property and equipmentare stated at cost and depreciated using the straight-line method over the estimated useful lives of the related assets ranging from one to ten years.  Leasehold improvements are amortized over the shorter of the lease term or the estimated useful lives of the related assets using the straight-line method.  Construction in process represents the accumulated costs of assets not yet placed in service and primarily relates to manufacturing equipment.

Long-lived assets, such as property, plant, and equipment and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to its estimated undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.  The Company did not record any impairment of long-lived assets during the fiscal years ended June 30, 2022 and 2021.  Assets to be disposed of would be separately presented in the Consolidated Balance Sheet and reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.  The assets and liabilities of a disposed group classified as held for sale would be presented separately in the appropriate asset and liability sections of the Consolidated Balance Sheet.

Goodwill and Intangible Assetsacquired in a business combination are recognized at fair value using generally accepted valuation methods appropriate for the type of intangible asset and reported separately from goodwill.  Purchased intangible assets other than goodwill are amortized over their useful lives unless these lives are determined to be indefinite.  Purchased intangible assets are carried at cost, less accumulated amortization.  Amortization is computed over the estimated useful lives of the respective assets, generally two to fifteen years.  The Company periodically reassesses the useful lives of its intangible assets when events or circumstances indicate that useful lives have significantly changed from the previous estimate.  Definite-lived intangible assets consist primarily of customer relationships, know-how/trade secrets and trademarks.  They are generally valued as the present value of estimated cash flows expected to be generated from the asset using a risk-adjusted discount rate.  When determining the fair value of our intangible assets, estimates and assumptions about future expected revenue and remaining useful lives are used.  Goodwill and intangible assets are tested for impairment on an annual basis and during the period between annual tests if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable.

The Company will assess the qualitative factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment analysis.  If the Company determines that it is more likely than not that its fair value is less than its carrying amount, then the goodwill impairment test is performed.  The first step, identifying a potential impairment, compares the fair value of the reporting unit with its carrying amount. If the carrying amount exceeds its fair value, the second step would need to be performed; otherwise, no further steps are required.  The second step, measuring the impairment loss, compares the implied fair value of the goodwill with the carrying amount of the goodwill.  Any excess of the goodwill carrying amount over the implied fair value is recognized as an impairment loss, and the carrying value of goodwill is written down to fair value.  During fiscal year 2018, the Company adopted ASU 2017-4, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” (“ASU 2017-4”), which amends the goodwill impairment test to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, up to the total amount of goodwill allocated to that reporting unit. The Company did not record any goodwill impairment during the fiscal years ended June 30, 20192022 or 2018.

Deferred rentrelates to certain2021.

Leases. The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use ("ROU") assets, other current liabilities and operating lease liabilities on the Company's consolidated balance sheet. Finance leases are included in property, plant and equipment, current portion of long-term debt and long-term debt, net of current portion on the consolidated balance sheets.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the Company’s operating leases containing predetermined fixed increases of the base rental rate duringfuture minimum lease payments over the lease term beingat commencement date. As most of our leases do not provide an implicit rate, the Company uses an estimate of its incremental borrowing rate based on observed market data and other information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. The Company does not record leases on the consolidated balance sheet with a term of one year or less. The Company does not separate lease and non-lease components but rather accounts for each separate component as a single lease component for all underlying classes of assets. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. Variable lease payments primarily include reimbursements of costs incurred by lessors for common area maintenance and utilities. Lease expense for minimum operating lease payments is recognized as rental expense on a straight-line basis over the lease term, as well as applicable leasehold improvement incentives provided by the landlord. The Company has recorded the difference between the amounts charged to operations and amounts payable under the leases as deferred rent in the accompanying Consolidated Balance Sheets.

term.

Income taxesare accounted for under the asset and liability method.  Deferred income tax assets and liabilities are computed on the basis of differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based upon enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.  Valuation allowances have been established to reduce deferred tax assets to the amount expected to be realized.

F-7

F-8

Table of Contents

The Company has not recognized a liability for uncertain tax positions.  A reconciliation of the beginning and ending amount of unrecognized tax benefits or penalties has not been provided since there has been no unrecognized benefit or penalty.  If there were an unrecognized tax benefit or penalty, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

The Company files United States (“U.S.”) Federal income tax returns, as well as tax returns in various states and foreign jurisdictions.  Open tax years subject to examination by the Internal Revenue Service generally remain open for three years from the filing date. Tax years subject to examination by the state jurisdictions generally remain open for up to four years from the filing date. In Latvia, tax years subject to examination remain open for up to five years from the filing date and, in China, tax years subject to examination remain open for up to ten years from the filing date.

Our cash, cash equivalents totaled $4.6approximately $5.5 million at June 30, 2019.2022.  Of this amount, approximately 71%greater than 50% was held by our foreign subsidiaries in China and Latvia.  These foreign funds were generated in China and Latvia as a result of foreign earnings.  Historically, we considered unremitted earnings held by our foreign subsidiaries to be permanently reinvested.  However, during fiscal 2020, we began declaring intercompany dividends to remit a portion of the earnings of our foreign subsidiaries to the U.S. parent company.  It is still our intent to reinvest a significant portion of earnings generated by our foreign subsidiaries, however we also plan to repatriate a portion of their earnings.

With respect to the funds generated by our foreign subsidiaries in China, the retained earnings in Chinaof the legal entity must equal at least 150%50% of the registered capital before any funds can be repatriated.  During fiscal 2022 and 2021, we repatriated approximately $2.8 million and $4 million, respectively, from LPOIZ.  As of June 30, 2019, we have2022, LPOIZ had approximately $3.9 million in retained earnings available for repatriation, and LPOI did not have any earnings available for repatriation, based on earnings accumulated through December 31, 2021, the end of the most recent statutory tax year, that remained undistributed as of June 30, 2022.  During fiscal year 2020 we began to accrue for the applicable Chinese withholding taxes on the portion of earnings that we intend to repatriate.  As of June 30, 2022 and 2021, accrued and unpaid withholding taxes were $40,000 and $100,000, respectively.

Beginning in China of approximately $3.3 million and we need to have $11.3 million before repatriation will be allowed.

Accumulatedfiscal year 2019, earnings from the Company’s non-U.S. subsidiaries were subject to the global intangible low-taxed income (“GILTI”) inclusion in the Company’s current periodpursuant to U.S. and state income tax returns as a result of the impact of the U.S. tax law changes. However, no income tax was due on the inclusion of these earnings due to utilization of net operating losses.rules.  See Note 9, 8, Income Taxes, to these Consolidated Financial Statements for additional information.
The Company currently intends to permanently invest earnings generated from its foreign Chinese operations and, therefore, has not previously provided for future Chinese withholding taxes on such related earnings. However, if in the future the Company changes such intention, the Company would provide for and pay additional foreign taxes, if any, at that time.

Revenue recognition– See Note 3, Revenue, to these Consolidated Financial Statements for additional information.

VATis computed on the gross sales price on all sales of the Company’s products sold in the People’s Republic of China and Latvia.  The VAT rates range up to 21%, depending on the type of products sold.  The VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost of producing or acquiring its finished products.  The Company recorded VAT receivables and payables on a VAT receivable, net of payables,basis in the accompanying Consolidated Financial Statements.

  These amounts were not significant as of June 30, 2022 and 2021.

New product developmentcosts are expensed as incurred.

Stock-based compensationis measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period.  We estimate the fair value of each restricted stock unit or stock option as of the date of grant using the Black-Scholes-Merton pricing model.  Our directors, officers, and key employees were granted stock-based compensation through our Amended and Restated Omnibus Incentive Plan, as amended (the “Omnibus Plan”), through October 2018 and after that date, the 2018 Stock and Incentive Compensation Plan (the “SICP”). Most options granted under the Omnibus Plan and the SICP vest ratably over two to four years and generally have four to ten-year contract lives.  The volatility rate is based on historical trends in common stock closing prices and the expected term was determined based primarily on historical experience of previously outstanding awards.  The interest rate used is the U.S. Treasury interest rate for constant maturities.  The likelihood of meeting targets for option grants that are performance based are evaluated each quarter.  If it is determined that meeting the targets is probable, then the compensation expense will be amortized over the remaining vesting period.

F-9

Table of Contents

Fair value of financial instruments.The Company accounts for financial instruments in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification Topic 820, “Fair Value Measurements and Disclosures” (“ASC 820”), which provides a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities.  ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.  The standard describes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable.

Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

F-8

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management.  

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values.  These financial instruments include receivables,accounts receivable, accounts payable and accrued liabilities.  Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair values or they are receivable or payable on demand.  The fair value of the Company’s capitalfinance lease obligations and loans payable approximate their carrying values, based upon current rates available to us.  On January 16, 2018, the Company satisfied in full a note payable to the sellers of ISP, in the aggregate original principal amount of $6 million (the “Sellers Note”). Therefore, the Sellers Note was not included in loans payable as of June 30, 2018. The carrying value of the Sellers Note included a fair value premium based on a risk-adjusted discount rate, a Level 2 fair value measurement. Upon satisfaction of the Sellers Note, the fair value adjustment liability was reversed and is included in interest expense, net, in the Consolidated Statement of Operations for the year ended June 30, 2018. See Note 18, 13, Loans Payable to these Consolidated Financial Statements for additional information.

The Company valued its warrant liabilities based on open-form option pricing models which, based on the relevant inputs, render the fair value measurement at Level 3. The Company based its estimates of fair value for warrant liabilities on the amount it would pay a third-party market participant to transfer the liability and incorporated inputs, such as equity prices, historical and implied volatilities, dividend rates and prices of convertible securities issued by comparable companies, maximizing the use of observable inputs when available. See Note 17, Derivative Financial Instruments (Warrant Liability), to these Consolidated Financial Statements for additional information.
  Management considers these fair value estimates to be level 2 fair value measurements.

The Company does not have any other financial or non-financial assets or liabilities that would be characterized as Level 1, Level 2 or Level 3 instruments.

Debt issuance costsare recorded as a reduction to the carrying value of the related notes payable, by the same amount, and are amortized ratably over the term of the related note.

Derivative financial instruments.The Company accounts for derivative instruments in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic 815, “Derivatives and Hedging” (“ASC 815”), which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements.
The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk.  Terms of convertible debt instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract, and recorded on the balance sheet at fair value.  The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. The Company issued warrants in connection with our June 2012 private placement (the “June 2012 Warrants”). The fair value of the June 2012 Warrants was estimated using the Lattice option-pricing model. See Note 17, Derivative Financial Instruments (Warrant Liability), to these Consolidated Financial Statements for additional information.
Freestanding warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments.  Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.

Comprehensive incomeis defined as the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owner sources.  It includes all changes in equity during a period, except those resulting from investments by owners and distributions to owners.  Comprehensive income has two components, net income, and other comprehensive income, and is included on the Consolidated Statements of Comprehensive Income.  Our other comprehensive income consists of foreign currency translation adjustments made for financial reporting purposes.

Business segments.As the Company only operates in principally one business segment, no additional reporting is required.

Recent accounting pronouncements.There are no new accounting pronouncements issued by the Financial Accounting Standards Board (“FASB”)FASB that are not yet effective for the Company for the year ended June 30, 2019.

Leases – In February 2016, the FASB issued a new lease standard2022 that supersedes existing lease guidance under GAAP. This standard requires, among other things, the recognition of right-of-use assets and liabilities on the balance sheet for most lease arrangements and disclosure of certain information about leasing arrangements. The new standard currently allows two transition methods with certain practical expedients available. Companies may elect to use the modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements or to initially apply this standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. This standard is effective for fiscal years, and interim reporting periods within those years, beginning after December 15, 2018, which for the Company is its fiscal 2020.
F-9
The Company expects to adopt the new lease standard on July 1, 2019 by applying the standard at the adoption date and recognizing a cumulative-effect adjustment, if any, to the opening balance of retained earnings. The Company also intends to elect the package of practical expedients permitted by the standard, which, among other things, allows it to carry forward the historical lease classification. The Company’s current real estate lease arrangements are classified as operating leases under existing GAAP lease guidance, and the Company expects they will continue to be classified as operating leases under the new standard. The Company’s current capital lease arrangements are expected to be classified as finance leases under the new standard. The Company has made progress in executing its implementation plan, and it is in the process of measuring the right-of-use assets and liabilities for leases in effect at the adoption date. The adoption of this guidance is expected to have a material impact on the Company's consolidated balance sheets and disclosures in consolidated financial statements. The Company does not expect that the adoption of this standard will have a material impact on its results of operations, cash flows, or debt covenant compliance.
No other new accounting pronouncement recently issued or newly effective had or is expected to have a material impact on the Consolidated Financial Statements.

3.

Revenue
On July 1, 2018, the Company adopted ASU 2014-9 using the modified retrospective method, which required a cumulative effect adjustment, if any, to be recorded at the date of adoption. The adoption did not have a material impact on the Company’s Consolidated Financial Statements and, as a result, no changes were made to prior reporting periods presented.

Product Revenue

The Company manufactures optical components and higher-level assemblies, including precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses, and other optical components used to produce products that manipulate light.  The Company designs, develops, manufactures, and distributes optical components and assemblies utilizing advanced optical manufacturing processes.  The Company also performs research and development for optical solutions for a wide range of optics markets.  Revenue is derived primarily from the sale of optical components and assemblies.

Revenue Recognition

Revenue is generally recognized upon transfer of control, including the risks and rewards of ownership, of products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services.  The Company generally bears all costs, risk of loss, or damage and retains title to the goods up to the point of transfer of control of products to customers.  Shipping and handling costs are included in the cost of goods sold.  Revenue is presented net of sales taxes and any similar assessments.

F-10

Table of Contents

Customary payment terms are granted to customers, based on credit evaluations.  The Company does not have any contracts where revenue is recognized, but the customer payment is contingent on a future event.  Deferred revenue is recorded when cash payments are received or due in advance of the Company’s performance.  Deferred revenue was immaterialnot significant as of June 30, 20192022 and 2018.

2021.

Nature of Products

Revenue from the sale of optical components and assemblies is recognized upon transfer of control, including the risks and rewards of ownership, to the customer.  The performance obligations for the sale of optical components and assemblies are satisfied at a point in time.  Product development agreements are generally short term in nature, with revenue recognized upon satisfaction of the performance obligation, and transfer of control of the agreed-upon deliverable.  The Company has organized its products in three groups: precision molded optics (“PMO”), infrared, and specialty products.  Revenues from product development agreements are included in specialty products.  The Company’s revenue by product group for the years ended June 30, 20192022 and 20182021 was as follows:

 
 
Years Ended June 30,
 
 
 
2019
 
 
2018
 
PMO
 $14,098,157 
 $13,522,458 
Infrared Products
  17,271,590 
  15,979,888 
Specialty Products
  2,379,341 
  3,023,125 
Total revenue
 $33,749,088 
 $32,525,471 
F-10

 

 

Year Ended

June 30,

 

 

 

2022

 

 

2021

 

PMO

 

$15,020,542

 

 

$15,882,189

 

Infrared Products

 

 

18,735,325

 

 

 

20,971,080

 

Specialty Products

 

 

1,803,293

 

 

 

1,611,552

 

Total revenue

 

$35,559,160

 

 

$38,464,821

 

4.

Inventories, net

The components of inventories include the following:

 
 
June 30, 2019
 
 
June 30, 2018
 
Raw materials
 $3,467,105 
 $2,309,454 
Work in process
  2,288,226 
  2,506,891 
Finished goods
  2,704,471 
  2,263,121 
Allowance for obsolescence
  (775,275)
  (674,725)
 
 $7,684,527 
 $6,404,741 

 

 

June 30,

2022

 

 

June 30,

2021

 

Raw materials

 

$3,019,156

 

 

$3,908,630

 

Work in process

 

 

2,243,907

 

 

 

2,473,070

 

Finished goods

 

 

3,052,001

 

 

 

3,467,105

 

Allowance for obsolescence

 

 

(1,329,637)

 

 

(1,189,218)

 

 

$6,985,427

 

 

$8,659,587

 

During fiscal 20192022 and 2018,2021, the Company evaluated all allowed items and disposed of approximately $125,000$457,000 and $188,000,$157,000, respectively, of inventory parts and wrote them off against the allowance for obsolescence.

The value of tooling in raw materials, net of the related allowance for obsolescence, was approximately $2.2$1.6 million and $1.6$2.0 million at June 30, 20192022 and 2018,2021, respectively.

5.

Property and Equipment, net

Property and equipment consist of the following:

 
 
Estimated
 
 
June 30,
 
 
June 30,
 
 
 
Lives (Years)
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Manufacturing equipment
  5 - 10 
 $17,412,136 
 $16,534,124 
Computer equipment and software
  3 - 5 
  706,840 
  513,681 
Furniture and fixtures
  5 
  293,582 
  199,872 
Leasehold improvements
  5 - 7 
  2,074,069 
  1,350,482 
Construction in progress
    
  697,126 
  954,317 
     Total property and equipment
    
  21,183,753 
  19,552,476 
 
    
    
    
Less accumulated depreciation and amortization
    
  (9,452,669)
  (7,743,235)
            Total property and equipment, net
    
 $11,731,084 
 $11,809,241 

 

 

Estimated Lives

(Years)

 

 

June 30,

2022

 

 

June 30,

2021

 

Manufacturing equipment

 

5 - 10

 

 

$22,058,636

 

 

$21,465,402

 

Computer equipment and software

 

3 - 5

 

 

 

978,348

 

 

 

918,679

 

Furniture and fixtures

 

 

5

 

 

 

352,060

 

 

 

362,944

 

Leasehold improvements

 

5 - 7

 

 

 

3,043,867

 

 

 

2,944,543

 

Construction in progress

 

 

 

 

 

 

943,793

 

 

 

1,529,452

 

Total property and equipment

 

 

 

 

 

 

27,376,704

 

 

 

27,221,020

 

Less accumulated depreciation and amortization

 

 

 

 

 

 

(15,736,241)

 

 

(13,941,153)

Total property and equipment, net

 

 

 

 

 

$11,640,463

 

 

$13,279,867

 

During fiscal 2015, the Company extended the term of its Orlando lease and received a tenant improvement allowance from the landlord of $420,014.  During fiscal 2019, the Company received a tenant improvement allowance from the landlord related to the new portion of the Orlando facility in the amount of $309,450. These allowances were used to construct improvements and were initially recorded as leasehold improvements and deferred rent liability.  The balances are being amortized over the corresponding lease terms.

terms, and are included in leasehold improvements and operating lease liabilities as of June 30, 2022 and 2021.

F-11

Table of Contents

6. Goodwill and Intangible Assets

In connection with the December 2016 acquisition of ISP, the Company identified intangible assets, which were recorded at fair value and are being amortized on a straight-line basis over their useful lives.  The excess purchase price over the fair values of all identified assets and liabilities was recorded as goodwill, attributable primarily to expected synergies and the assembled workforce of ISP.

There were no changes in the net carrying value of goodwill during the years ended June 30, 20192022 and 2018,2021, and there have been no events or changes in circumstances that indicate the carrying value of goodwill may not be recoverable.

F-11

Identifiable intangible assets were comprised of:

 
 
 Useful
 
 
 June 30,
 
 
 June 30,
 
 
 
 Lives (Years)
 
 
 2019
 
 
 2018
 
 Customer relationships
  15 
 $3,590,000 
 $3,590,000 
 Backlog
  2 
  366,000 
  366,000 
 Trade secrets
  8 
  3,272,000 
  3,272,000 
 Trademarks
  8 
  3,814,000 
  3,814,000 
 Non-compete agreement
  3 
  27,000 
  27,000 
 Total intangible assets
    
  11,069,000 
  11,069,000 
 
 Less accumulated amortization
 
  (3,231,694)
  (2,011,030)
 Total intangible assets, net
    
 $7,837,306 
 $9,057,970 

 

 

 Useful Lives

(Years)

 

 

 June 30,

2022

 

 

 June 30,

2021

 

Customer relationships

 

 

15

 

 

$3,590,000

 

 

$3,590,000

 

Trade secrets

 

 

8

 

 

 

3,272,000

 

 

 

3,272,000

 

Trademarks

 

 

8

 

 

 

3,814,000

 

 

 

3,814,000

 

Total intangible assets

 

 

 

 

 

 

10,676,000

 

 

 

10,676,000

 

Less accumulated amortization

 

 

 

 

 

 

(6,218,202)

 

 

(5,093,119)

Total intangible assets, net

 

 

 

 

 

$4,457,798

 

 

$5,582,881

 

Future amortization of identifiable intangibles is as follows:

Fiscal year ending:
 June 30, 2020
$1,129,342
 June 30, 2021
1,125,083
 June 30, 2022
1,125,083
 June 30, 2023
1,125,083
 June 30, 2024 and later
3,332,715
$7,837,306

Fiscal year ending:

 

 

 

June 30, 2023

 

 

1,125,083

 

June 30, 2024

 

 

1,125,083

 

June 30, 2025

 

 

658,398

 

June 30, 2026

 

 

239,334

 

After June 30, 2026

 

 

1,309,900

 

 

 

$4,457,798

 

7. Accounts Payable

The accounts payable balance includes $91,000 and $82,000 of earned but unpaid board of directors’ fees, as of June 30, 2019 and 2018, respectively.
8. Stockholders’ Equity

The Company’s authorized capital stock consists of 55,000,000 shares, comprised of 50,000,000 shares of common stock, par value $0.01 per share, and 5,000,000 shares of preferred stock, par value $0.01 per share.

Of the 5,000,000 shares of preferred stock authorized, the board of directors has previously designated:

● 
250 shares of preferred stock as Series A Preferred Stock, all previously outstanding shares of which have been previously redeemed or converted into shares of our Class A common stock and may not be reissued;
● 
300 shares of preferred stock as Series B Preferred Stock, all previously outstanding shares of which have been previously redeemed or converted into shares of our Class A common stock and may not be reissued;
● 
500 shares of preferred stock as Series C Preferred Stock, all previously outstanding shares of which have been previously redeemed or converted into shares of our Class A common stock and may not be reissued;
● 
500,000 shares of preferred stock as Series D Preferred Stock, none of which have been issued; however, in 1998, the board of directors declared a dividend distribution as a right to purchase one share of Series D Preferred Stock for each outstanding share of Class A common stock upon occurrence of certain events. The rights will be exercisable only if a person or group acquires twenty percent (20%) or more of the Class A common stock or announces a tender offer, the consummation of which would result in ownership by a person or group of twenty percent (20%) or more of the Class A common stock. As of the date of the filing of this Annual Report on Form 10-K, no such triggering event has occurred. If, in the future, any shares of Series D Preferred Stock are issued, the stockholders of Series D Preferred Stock are entitled to one vote for each share held; and
● 
500 shares of our preferred stock as Series F Preferred Stock, all previously outstanding shares of which have been previously redeemed or converted into shares of our Class A common stock and may not be reissued.

·

250 shares of preferred stock as Series A Preferred Stock, all previously outstanding shares of which have been previously redeemed or converted into shares of our Class A common stock and may not be reissued;

·

300 shares of preferred stock as Series B Preferred Stock, all previously outstanding shares of which have been previously redeemed or converted into shares of our Class A common stock and may not be reissued;

·

500 shares of preferred stock as Series C Preferred Stock, all previously outstanding shares of which have been previously redeemed or converted into shares of our Class A common stock and may not be reissued;

·

500,000 shares of preferred stock as Series D Preferred Stock, none of which have been issued; and

·

500 shares of our preferred stock as Series F Preferred Stock, all previously outstanding shares of which have been previously redeemed or converted into shares of our Class A common stock and may not be reissued.

F-12

Table of Contents

Of the 50,000,000 shares of common stock authorized, the board of directors has previously designated 44,500,000 shares authorized as Class A common stock. The stockholders of Class A common stock are entitled to one vote for each share held. The remaining 5,500,000 shares of authorized common stock were designated as Class E-1 common stock, Class E-2 common stock, or Class E-3 common stock, all previously outstanding shares of which have been previously redeemed or converted into shares of Class A common stock.

F-12
During fiscal 2018, the Company received approximately $534,000 in net proceeds from the exercise of the June 2012 Warrants. The Company issued 433,810 shares of Class A common stock during fiscal 2018, in connection with these exercises. The June 2012 Warrants expired on December 11, 2017. There were no oustanding warrants as of June 30, 2019 or 2018.
9.            

8. Income Taxes

For financial reporting purposes, income (loss) before income taxes includes the following components:

 
 
Year Ended June 30,
 
 
 
2019
 
 
2018
 
Pretax income:
 
 
 
 
 
 
United States
 $(4,649,593)
 $359,027 
Foreign
  2,424,476 
  (126,000)
Income before income taxes
 $(2,225,117)
 $233,027 

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

Pretax income (loss):

 

 

 

 

 

 

United States

 

$(5,129,955)

 

$(5,265,803)

Foreign

 

 

2,450,681

 

 

 

3,014,467

 

Loss before income taxes

 

$(2,679,274)

 

$(2,251,336)

The components of the provision for income taxes are as follows:

 
 
Year Ended June 30,
 
 
 
2019
 
 
2018
 
Current:
 
 
 
 
 
 
Federal tax
 $(9,352)
 $57,315 
State
  23,423 
  - 
Foreign
  469,135 
  (117,852)
Total current
  483,206 
  (60,537)
 
    
    
Deferred:
    
    
Federal tax
  21,803 
  (510,125)
State
  (49,803)
  (72,875)
Foreign
  - 
  (183,540)
Total deferred
  (28,000)
  (766,540)
 
    
    
Total income tax (benefit)
 $455,206 
 $(827,077)
F-13

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

Federal tax

 

$-

 

 

$-

 

State

 

 

3,829

 

 

 

18,563

 

Foreign

 

 

314,063

 

 

 

403,352

 

Total current

 

 

317,892

 

 

 

421,915

 

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

Federal tax

 

 

4,000

 

 

 

510,069

 

State

 

 

-

 

 

 

1,931

 

Foreign

 

 

541,015

 

 

 

-

 

Total deferred

 

 

545,015

 

 

 

512,000

 

 

 

 

 

 

 

 

 

 

Total income tax provision

 

$862,907

 

 

$933,915

 

F-13

Table of Contents

The reconciliation of income tax computed at the U.S. federal statutory rates to the total income tax expenseprovision is as follows:

 
 
Year Ended June 30,
 
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
U.S. federal statutory tax rate
  21.0%
  27.5%
 
    
    
Income tax provision reconciliation:
    
    
Tax at statutory rate:
 $(467,275)
 $64,082 
Net foreign income subject to lower tax rate
  (303,288)
  25,927 
State income taxes, net of federal benefit
  (26,380)
  (107,997)
Valuation allowance
  652,262 
  (11,763,000)
Changes in statutory income tax rates
  - 
  9,114,886 
IRC 965 repatriation
  202,026 
  1,809,603 
GILTI
  251,869 
  - 
Federal research and development and other credits
  (84,440)
  (163,165)
Stock-based compensation
  3,034 
  43,818 
Change in fair value of derivative warrants
  - 
  53,524 
Other permanent differences
  74,099 
  30,758 
Other, net
  153,299 
  64,487 
 
 $455,206 
 $(827,077)
Tax Cuts

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

U.S. federal statutory tax rate

 

 

21.0%

 

 

21.0%

 

 

 

 

 

 

 

 

 

Income tax provision reconciliation:

 

 

 

 

 

 

 

 

Tax at statutory rate:

 

$(562,648)

 

$(472,782)

Net foreign income subject to lower tax rate

 

 

(297,049)

 

 

(169,276)

State income taxes, net of federal benefit

 

 

(159,950)

 

 

(196,719)

Valuation allowance

 

 

(1,255,273)

 

 

(1,400,450)

NOL expiration and adjustments

 

 

2,550,645

 

 

 

3,516,695

 

GILTI

 

 

138,611

 

 

 

310,431

 

Federal research and development and other credits

 

 

(121,990)

 

 

(74,288)

Stock-based compensation

 

 

20,472

 

 

 

(265,485)

Other permanent differences

 

 

11,387

 

 

 

(67,893)

Other, net

 

 

538,702

 

 

 

(246,318)

 

 

$862,907

 

 

$933,915

 

On March 27, 2020, the Coronavirus Aid, Relief, and Jobs Act

In December 2017, the U.S. enacted the Tax Cuts and JobsEconomic Security Act (the “TCJA”“CARES Act”), was signed into law, which, changes existing U.S. tax law and includes various provisions that are expected to affect companies. Amongamong other things, is intended to provide emergency assistance to qualifying businesses and individuals.  The CARES Act also suspends the TCJA: (i) changes U.S. corporatelimitation on the deduction of NOLs arising in taxable years beginning before January 1, 2021, permits a five-year carryback of NOLs arising in taxable years beginning after December 31, 2017 and before January 1, 2021, and generally modifies the limitation on the deduction for net interest expense to 50% of adjusted taxable income for taxable years beginning in 2019 and 2020.  During fiscal 2020, as a result of the CARES Act, the Company was able to accelerate the recovery of an income tax rates, (ii) generally reduces a company’s abilityreceivable related to utilize accumulated net operating losses, and (iii) requires the calculationpreviously paid alternative minimum tax. The receivable amount of a one-time transition tax on certain foreign earnings and profits (“foreign E&P”) that had not been previously repatriated.
Asapproximately $107,000 as of June 30, 2018,2020 was collected in July 2020.  In addition, the Company had not fully completed our accounting forelected to utilize the incomepayroll tax impactdeferral under the CARES Act, resulting in cash savings of enactmentapproximately $325,000, accrued as of the TCJA. In accordance with SEC Staff Accounting Bulletin No.118, the Company recognized provisional amounts for income tax effects of the TCJA that it was able to reasonably estimate.
Implementation of the TCJA required the Company to calculate a one-time transition tax on certain foreign E&P that had not been previously repatriated. During fiscal 2018, the Company provisionally determined its foreign E&P inclusion, and anticipated that it would not owe any one-time transition tax due to utilization of U.S. net operating loss (“NOL”) carryforward benefits against these earnings. During fiscal 2019, the Company completed its analysis of the TCJA, and although the Company did not owe any one-time transition tax, the deferred tax asset related to its NOL carryforwards was impacted by approximately $202,000. This amount is offset by a valuation allowance for a net impact of zero to its provision for income taxes for the year ended June 30, 2019.
2021.  Half of this amount was remitted on December 31, 2021, with the remainder deferred until December 31, 2022.

Income Tax Law of the People’s Republic of China

The Company’s Chinese subsidiaries, LPOI and LPOIZ, are governed by the Income Tax Law of the People’s Republic of China concerning the privately run and foreign invested enterprises, which are generally subject to tax at a statutory rate of 25% on income reported in the statutory financial statements after appropriate tax adjustments.  DuringFor both the three monthsyears ended December 31, 2017,June 30, 2022 and 2021, the statutory tax rate applicable tofor LPOIZ was lowered from 25% to 15%, in accordance with an incentive program for technology companies.  The lower rate applies to LPOIZ’s 2017Historically, no deferred tax year, beginning January 1, 2017. Accordingly, the Companyprovision was recorded a tax benefit of approximately $100,000for LPOIZ.  However, during the year ended June 30, 20182022, as a result of audits performed by the Chinese taxing authorities, and the Chinese subsidiaries’ statutory audits, it was determined that a net deferred tax liability was required. Accordingly, an approximately $541,000 net deferred tax liability related to this retroactive rate change. ForLPOIZ was recorded in the fiscalCompany’s Consolidated Financial Statements as of and for the year ended June 30, 2019, income taxes were accrued at2022.

Historically, the applicable rates. No deferred tax provision has been recorded for China, asCompany considered unremitted earnings held by its foreign subsidiaries to be permanently reinvested.  However, during fiscal year 2020, the effectCompany began declaring intercompany dividends to remit a portion of the historical earnings of its foreign subsidiaries to the U.S. parent company.  It is deemed de minimis.

The Company currently intendsstill the Company’s intent to permanently investreinvest a significant portion of the more recent earnings generated fromby its foreign Chinese operations and, therefore, hassubsidiaries, however the Company also plans to repatriate a portion of the historical earnings of its subsidiaries.  Based on its previous intent, the Company had not previouslyhistorically provided for future Chinese withholding taxes on suchthe related earnings.  However, if in the futureduring fiscal year 2020 the Company changes such intention,began to accrue for these taxes on the portion of historical earnings that it intends to repatriate.

During the years ended June 30, 2022 and 2021, the Company would providedeclared and paid intercompany dividends of $2.8 million and $4 million, respectively, from LPOIZ, payable to the Company as its parent company.  Accordingly, the Company paid Chinese withholding taxes of $280,000 and $400,000 associated with these dividends during fiscal years 2022 and 2021, respectively. Income tax expense associated with these dividends was $208,000 and $500,000 for fiscal year 2022 and pay additional foreign2021, respectively.  As of June 30, 2022 and 2021, accrued and unpaid withholding taxes if any, at that time.

F-14
were $40,000 and $100,000, respectively. Other than these withholding taxes, these intercompany dividends have no impact on the Consolidated Financial Statements.

F-14

Table of Contents

Law of Corporate Income Tax of Latvia

The Company’s Latvian subsidiary, ISP Latvia, is governed by the Law of Corporate Income Tax of Latvia.  Until December 31, 2017, ISP Latvia was subject to a statutory income tax rate of 15%.  Effective January 1, 2018, the Republic of Latvia enacted tax reform with the following key provisions:  (i) corporations are no longer subject to income tax, but are instead subject to a distribution tax on distributed profits (or deemed distributions, as defined), and (ii) the tax rate was changed to 20%; however, distribution amounts are first divided by 0.8 to arrive at the taxable amount of profit, resulting in an effective tax rate of 25%.  As a transitional measure, distributions made from earnings prior to January 1, 2018, distributed prior to December 31, 2019, are not subject to tax. As such, any distributions of profits fromtax if declared prior to December 31, 2019.  ISP Latvia has declared an intercompany dividend to be paid to ISP, its U.S. parent company, for the full amount of earnings accumulated prior to January 1, 2018.  Distributions of this dividend will be from earnings prior to January 1, 2018 and, therefore, will not be subject to tax. The Company currently does not intend to distribute any current earnings generated after January 1, 2018.  If, in the future, the Company changes such intention, distribution taxes, if any, will be accrued as profits are generated. With this change, the concept of taxable income and tax basis in assets and liabilities was eliminated and is no longer relevant for determining income taxes; therefore, the previously recorded net deferred tax liability related to ISP Latvia was adjusted to zero during the fiscal year ended June 30, 2018, resulting in a tax benefit of approximately $184,000.

The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are as follows at June 30:

 
 
2019
 
 
2018
 
Deferred tax assets:
 
 
 
 
 
 
Net operating loss and credit carryforwards
 $16,044,000 
 $16,282,000 
Stock-based compensation
  822,000 
  710,000 
R&D and other credits
  2,014,000 
  1,899,000 
Capitalized R&D expenses
  476,000 
  373,000 
Inventory
  156,000 
  143,000 
Accrued expenses and other
  111,000 
  83,000 
Gross deferred tax assets
  19,623,000 
  19,490,000 
Valuation allowance for deferred tax assets
  (16,725,000)
  (16,123,000)
Total deferred tax assets
  2,898,000 
  3,367,000 
Deferred tax liabilities:
    
    
Depreciation and other
  (277,000)
  (563,000)
Intangible assets
  (1,969,000)
  (2,180,000)
Total deferred tax liabilities
  (2,246,000)
  (2,743,000)
Net deferred tax asset
 $652,000 
 $624,000 
As of June 30, 2019, the Company has also recorded a non-current income tax receivable of $214,000 related to previously paid alternative minimum tax that is expected to be recovered within the next five years pursuant to certain provisions of the TCJA.

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$12,197,277

 

 

$13,585,000

 

Stock-based compensation

 

 

536,000

 

 

 

563,000

 

R&D and other credits

 

 

2,279,000

 

 

 

2,177,000

 

Capitalized R&D expenses

 

 

371,000

 

 

 

564,000

 

Inventories

 

 

263,973

 

 

 

253,000

 

Accrued expenses and other

 

 

267,000

 

 

 

347,000

 

Gross deferred tax  assets

 

 

15,914,250

 

 

 

17,489,000

 

Valuation allowance for deferred tax assets

 

 

(14,388,277)

 

 

(15,644,000)

Total deferred tax  assets

 

 

1,525,973

 

 

 

1,845,000

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Depreciation and other

 

 

(763,988)

 

 

(255,000)

Intangible assets

 

 

(1,160,000)

 

 

(1,443,000)

Total deferred tax liabilities

 

 

(1,923,988)

 

 

(1,698,000)

Net deferred tax assets (liabilities)

 

$(398,015)

 

$147,000

 

In assessing the potential future recognition of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.  Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment.  In order to fully realize the deferred tax asset, the Company will need to generate future taxable income of approximately $74$53 million prior to the expiration of federal NOL carry-forwards from 20202023 through 2035.2037.  Based on the level of historical taxable income, management has provided for a valuation adjustment against the deferred tax assets of $16,725,000approximately $14.4 million at June 30, 2019, an increase2022, a decrease of approximately $602,000$1.2 million as compared to June 30, 2018.2021.  The increasedecrease in the valuation allowance for deferred tax assets as compared to the prior year is primarily the result of the various movements in the current year deferred items.  The net deferred tax asset of $652,000$143,000 results from federal and state tax credits with indefinite carryover periods, and approximately $510,000 in federal NOL carryforwards that management expects to utilize in a future period. periods.  State income tax expense disclosed on the effective tax rate reconciliation above includes state deferred taxes that are offset by a full valuation allowance.

At June 30, 2019,2022, in addition to net operating loss carry forwards, the Company also has research and development and other credit carry forwards of approximately $2,014,000,$2.0 million, which will expire from 20222023 through 2039.2041. A portion of the NOL carry forwards may be subject to certain limitations of the Internal Revenue Code Sections 382 and 383, which would restrict the annual utilization in future periods due principally to changes in ownership in prior periods.

F-15
10.

F-15

Table of Contents

9. Compensatory Equity Incentive Plan and Other Equity Incentives

Share-based payment arrangements — The Company’s directors, officers, and key employees were granted stock-based compensation through the Omnibus Plan, through October 2018 and after that date, the SICP.  The awards include incentive stock options, non-qualified stock options and restricted stock unit (“RSU”) awards. Stock-based compensation is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period. The Company estimates the fair value of each stock option as of the date of grant using the Black-Scholes-Merton pricing model. Most options granted under the Omnibus Plan and the SICP vest ratably over two to four years and generally have ten-year contract lives. The volatility rate is based on four-year historical trends in common stock closing prices and the expected term was determined based primarily on historical experience of previously outstanding options. The interest rate used is the U.S. Treasury interest rate for constant maturities. The likelihood of meeting targets for option grants that are performance based are evaluated each quarter. If it is determined that meeting the targets is probable, then the compensation expense will be amortized over the remaining vesting period.

The LightPath Technologies, Inc. Employee Stock Purchase Plan (“2014 ESPP”) was adopted by the Company’s board of directors on October 30, 2014 and approved by the Company’s stockholders on January 29, 2015.  The 2014 ESPP permits employees to purchase Class A common stock through payroll deductions, which may not exceed 15% of an employee’s compensation, at a price not less than 85% of the market value of the Class A common stock on specified dates (June 30 and December 31).  In no event can any participant purchase more than $25,000 worth of shares of Class A common stock in any calendar year and an employee cannot purchase more than 8,000 shares on any purchase date within an offering period of 12 months and 4,000 shares on any purchase date within an offering period of six months.  This discount of approximately $3,900$5,000 and $4,900$3,000 for fiscal 2019years 2022 and 2018,2021, respectively, is included in the selling, general and administrative expense in the accompanying Consolidated Statements Comprehensive Income (Loss), which represents the value of the 10% discount given to the employees purchasing stock under the 2014 ESPP.

These plans are summarized below:

Equity Compensation Arrangement
 
Award Shares Authorized
 
 
Outstanding at June 30, 2019
 
 
Available for Issuance at June 30, 2019
 
SICP (or Omnibus Plan)
  5,115,625 
  2,844,451 
  1,416,691 
2014 ESPP
  400,000 
   
  337,137 
 
  5,515,625 
  2,844,451 
  1,753,828 

Equity Compensation Arrangement

 

Award Shares Authorized

 

 

Outstanding

at June 30,

2022

 

 

Available for

Issuance at

June 30,

2022

 

SICP (or Omnibus Plan)

 

 

5,115,625

 

 

 

2,614,131

 

 

 

365,324

 

2014 ESPP

 

 

400,000

 

 

 

 

 

 

277,443

 

 

 

 

5,515,625

 

 

 

2,614,131

 

 

 

642,767

 

Grant Date Fair Values and Underlying Assumptions; Contractual Terms—Terms —The Company estimates the fair value of each equity option as of the date of grant. The Company uses the Black-Scholes-Merton pricing model.  The 2014 ESPP fair value is the amount of the discount the employee obtains at the date of the purchase transaction.

For stock options and RSUs granted in the years ended June 30, 20192022 and 2018,2021, the Company estimated the fair value of each stock award as of the date of grant using the following assumptions:

 Year Ended June 30,
 20192018
Weighted-average expected volatility69.5%63% - 75%
Dividend yields0%0%
Weighted-average risk-free interest rate3.00%1.28% - 2.82%
Weighted-average expected term, in years7.507.27

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

Weighted-average expected volatility

 

 

80.8%

 

 

72.0%

Dividend yields

 

 

0%

 

 

0%

Weighted-average risk-free interest rate

 

 

2.09%

 

 

0.74%

Weighted-average expected term, in years

 

 

3.75

 

 

 

7.49

 

The assumed forfeiture rates used in calculating the fair value of options and restricted stock unit grants with both performance and service conditions were 20% for each of the years ended June 30, 20192022 and 2018.2021.  The volatility rate and expected term are based on seven-year historical trends in Class A common stock closing prices and actual forfeitures.  The interest rate used is the U.S. Treasury interest rate for constant maturities.

F-16

F-16

Table of Contents

Information Regarding Current Share-Based Payment Awards —A summary of the activity for share-based payment awards in the years ended June 30, 20192022 and 20182021 is presented below:  

 
 
 
 
 
 
 
 
 
 
 
 Restricted
 
 
 
Stock Options
 
 
Stock Units (RSUs)  
 
 
 
 
 
 
Weighted-
 
 
Weighted-
 
 
 
 
 
Weighted-
 
 
 
 
 
 
Average
 
 
Average
 
 
 
 
 
Average
 
 
 
 
 
 
Exercise
 
 
Remaining
 
 
 
 
 
Remaining
 
 
 
 Shares
 
 
 Price
 
 
 Contract
 
 
 Shares
 
 
 Contract
 
June 30, 2017
  1,096,186 
 $1.68 
  6.3 
  1,508,782 
  0.9 
 
    
    
    
    
    
Granted
  68,849 
 $3.88 
  9.4 
  140,571 
  2.2 
Exercised
  (127,813)
 $1.80 
  
   
  
Cancelled/Forfeited
  (32,093)
 $2.62 
 
   
  
June 30, 2018
  1,005,129 
 $1.77 
  6.3 
  1,649,353 
  0.9 
 
    
    
    
    
    
Granted
  13,058 
 $2.10 
  9.4 
  229,509 
  2.4 
Exercised
  (17,610)
 $1.08 
 
  (14,336)
  
Cancelled/Forfeited
  (20,652)
 $1.17 
  
   
  
June 30, 2019
  979,925 
 $1.80 
  5.5 
  1,864,526 
  0.9 
 
    
    
    
    
    
Awards exercisable/
    
    
    
    
    
vested as of
    
    
    
    
    
June 30, 2019
  869,230 
 $1.70 
  5.2 
  1,464,382 
   
 
    
    
    
    
    
Awards unexercisable/
    
    
    
    
    
unvested as of
    
    
    
    
    
June 30, 2019
  110,695 
 $2.56 
  7.7 
  400,144 
  0.9 
 
  979,925 
    
    
  1,864,526 
    

 

 

 Stock Options

 

 

 Restricted Stock Units (RSUs)

 

 

 

 

 

 

Weighted-

 

 

Weighted-

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

Average

 

 

 

 

 

Average

 

 

 

 

 

 

Exercise

 

 

Remaining

 

 

 

 

 

Remaining

 

 

 

 Shares

 

 

 Price

 

 

 Contract

 

 

 Shares

 

 

 Contract

 

June 30, 2020

 

 

942,575

 

 

$1.65

 

 

 

6.5

 

 

 

2,328,303

 

 

 

0.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

121,933

 

 

$2.97

 

 

 

9.7

 

 

 

296,386

 

 

 

2.3

 

Exercised

 

 

(225,137)

 

$1.50

 

 

 

 

 

 

 

(862,804)

 

 

 

 

Cancelled/Forfeited

 

 

(406,444)

 

$1.75

 

 

 

 

 

 

 

-

 

 

 

 

 

June 30, 2021

 

 

432,927

 

 

$2.01

 

 

 

8.8

 

 

 

1,761,885

 

 

 

0.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

125,000

 

 

$2.02

 

 

 

 

 

 

 

368,461

 

 

 

1.2

 

Exercised

 

 

-

 

 

$-

 

 

 

 

 

 

 

(45,143)

 

 

 

 

Cancelled/Forfeited

 

 

(23,465)

 

$1.67

 

 

 

 

 

 

 

(5,534)

 

 

 

 

June 30, 2022

 

 

534,462

 

 

$2.03

 

 

 

7.0

 

 

 

2,079,669

 

 

 

0.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Awards exercisable/

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

vested as of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2022

 

 

215,141

 

 

$1.87

 

 

 

7.1

 

 

 

1,334,978

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Awards unexercisable/

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

unvested as of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2022

 

 

319,321

 

 

$2.14

 

 

 

7.1

 

 

 

744,691

 

 

 

0.9

 

 

 

 

534,462

 

 

 

 

 

 

 

 

 

 

 

2,079,669

 

 

 

 

 

No stock options were exercised during the year ended June 30, 2022.  The total intrinsic value of stock options exercised for the yearsyear ended June 30, 2019 and 2018 was2021was approximately $580 and $1,000, respectively.

$344,000.

The total intrinsic value of stock options outstanding and exercisable at June 30, 20192022 and 20182021 was approximately $320$42,000 and $573,000,$285,000, respectively.

The total fair value of stock options vested during the years ended June 30, 20192022 and 20182021 was approximately $170,000$24,000 and $103,000,$142,000, respectively.

The total intrinsic value of RSUs exercised during the years ended June 30, 20192022 and 20182021 was approximately $26,000$77,000 and $0,$2.8 million, respectively.

The total intrinsic value of RSUs outstanding and exercisable at June 30, 20192022 and 20182021 was approximately $1.3$1.6 million and $3.0 million, respectively.

The total fair value of RSUs vested during the years ended June 30, 20192022 and 20182021 was approximately $393,000$395,000 and $320,000,$1.1 million, respectively.

F-17

F-17

Table of Contents

As of June 30, 2019,2022, there was approximately $523,000$1.1 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements, including share options and RSUs, granted under the Omnibus Plan.Plan, through October 2018 and after that date, the SICP.  The expected compensation cost to be recognized is as follows:

 
 
Stock
 
 
 
 
 
 
 
 
 
Options
 
 
RSUs
 
 
Total
 
Year ending June 30, 2020
 $8,926 
 $289,944 
 $298,870 
 
    
    
    
Year ending June 30, 2021
  5,939 
  169,978 
  175,917 
 
    
    
    
Year ending June 30, 2022
  2,021 
  46,654 
  48,675 
 
 $16,886 
 $506,576 
 $523,462 

Fiscal Year Ending:

 

Stock Options

 

 

RSUs

 

 

Total

 

June 30, 2023

 

$205,978

 

 

$531,850

 

 

$737,828

 

June 30, 2024

 

 

94,196

 

 

 

190,864

 

 

 

285,060

 

June 30, 2025

 

 

33,885

 

 

 

54,308

 

 

 

88,193

 

 

 

$334,059

 

 

$777,022

 

 

$1,111,081

 

The table above does not include shares under the Company’s 2014 ESPP, which has purchase settlement dates in the second and fourth fiscal quarters.

RSU awards vest immediately or from twoup to four years from the grant date.

The Company issues new shares of Class A common stock upon the exercise of stock options. The following table is a summary of the number and weighted-average grant date fair values, estimated using the Black-Scholes-Merton pricing model, regarding ourthe Company’s unexercisable/unvested awards as of June 30, 20192022 and 20182021 and changes during the two years then ended:

Unexercisable/Unvested Awards
 
Stock Options Shares 
 
 
RSU Shares 
 
 
Total Shares 
 
 
Weighted-Average
Grant Date Fair Values
(per share)
 
June 30, 2017
  244,511 
  438,912 
  683,423 
 $1.39 
Granted
  68,849 
  140,571 
  209,420 
 $3.61 
Vested
  (85,191)
  (217,500)
  (302,691)
 $3.78 
Cancelled/Forfeited
  (9,750)
  - 
  (9,750)
 $2.36 
June 30, 2018
  218,419 
  361,983 
  580,402 
 $1.53 
Granted
  13,058 
  229,509 
  242,567 
 $1.80 
Vested
  (118,282)
  (191,348)
  (309,630)
 $1.79 
Cancelled/Forfeited
  (2,500)
  - 
  (2,500)
 $0.97 
June 30, 2019
  110,695 
  400,144 
  510,839 
 $2.09 

Unexercisable/Unvested Awards

 

Stock Options

Shares 

 

 

RSU

Shares 

 

 

Total

Shares 

 

 

Weighted-Average

Grant Date Fair Values

(per share)

 

June 30, 2020

 

 

266,282

 

 

 

669,526

 

 

 

935,808

 

 

$1.10

 

Granted

 

 

121,933

 

 

 

296,386

 

 

 

418,319

 

 

$2.48

 

Vested

 

 

(64,636)

 

 

(367,325)

 

 

(431,961)

 

$1.39

 

Cancelled/Forfeited

 

 

(1,595)

 

 

-

 

 

 

(1,595)

 

$2.85

 

June 30, 2021

 

 

321,984

 

 

 

598,587

 

 

 

920,571

 

 

$1.59

 

Granted

 

 

125,000

 

 

 

368,461

 

 

 

493,461

 

 

$1.74

 

Vested

 

 

(118,696)

 

 

(216,823)

 

 

(335,519)

 

$1.42

 

Cancelled/Forfeited

 

 

(8,967)

 

 

(5,534)

 

 

(14,501)

 

$1.97

 

June 30, 2022

 

 

319,321

 

 

 

744,691

 

 

 

1,064,012

 

 

$1.71

 

Acceleration of Vesting —The Company does not generally accelerate the vesting of any stock options.

F-18
options or RSUs, however in the case of retirements, the Board of Directors may accelerate vesting. 

Financial Statement Effects and Presentation —The following table shows total stock-based compensation expense for the years ended June 30, 20192022 and 20182021, which is included in selling, general and administrative expenses in the accompanying Consolidated Statements of Comprehensive Income (Loss):

 
 
Year Ended June 30,
 
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
Stock options
 $36,461 
 $38,572 
RSUs
  358,329 
  334,982 
     Total
 $394,790 
 $373,554 
 
    
    
The amounts above were included in:
 
    
Selling, general & administrative
 $393,352 
 $366,407 
Cost of sales
  1,620 
  5,910 
New product development
  (182)
  1,237 
 
 $394,790 
 $373,554 
11.

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

Stock options

 

$144,682

 

 

$76,616

 

RSUs

 

 

680,568

 

 

 

566,249

 

Total

 

$825,250

 

 

$642,865

 

F-18

Table of Contents

10. Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of Class A common stock outstanding during each period presented. Diluted earnings (loss) per share is computed similarly to basic earnings (loss) per share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue shares of Class A common stock were exercised or converted into shares of Class A common stock.  The computations for basic and diluted earnings (loss) per common share are described in the following table:

 
 
Year Ended June 30,
 
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
Net income (loss)
 $(2,680,323)
 $1,060,104 
 
    
    
Weighted-average common shares outstanding:
 
    
Basic number of shares
  25,794,669 
  25,006,467 
 
    
    
Effect of dilutive securities:
    
    
Options to purchase common stock
  - 
  331,985 
RSUs
  - 
  1,387,348 
Common stock warrants
  - 
  85,668 
Diluted number of shares
  25,794,669 
  26,811,468 
 
    
    
Earnings (loss) per common share:
    
    
Basic
 $(0.10)
 $0.04 
Diluted
 $(0.10)
 $0.04 

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

Net loss

 

$(3,542,181)

 

$(3,185,251)

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

Basic number of shares

 

 

27,019,534

 

 

 

26,314,025

 

 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

Options to purchase common stock

 

 

-

 

 

 

-

 

RSUs

 

 

-

 

 

 

-

 

Diluted number of shares

 

 

27,019,534

 

 

 

26,314,025

 

 

 

 

 

 

 

 

 

 

Loss per common share:

 

 

 

 

 

 

 

 

Basic

 

$(0.13)

 

$(0.12)

Diluted

 

$(0.13)

 

$(0.12)

The following weighted-average potential dilutive shares were not included in the computation of diluted earnings (loss) per common share, as their effects would be anti-dilutive:

 
 
Year Ended June 30,
 
 
 
2019
 
 
2018
 
Options to purchase common stock
  999,612 
  739,864 
RSUs
  1,755,893 
  216,946 
Common stock warrants
  - 
  85,018 
 
  2,755,505 
  1,041,828 
F-19
12.            

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

Options to purchase common stock

 

 

445,397

 

 

 

490,703

 

RSUs

 

 

1,944,737

 

 

 

2,220,710

 

 

 

 

2,390,134

 

 

 

2,711,413

 

11. Defined Contribution Plan

The Company provides retirement benefits to its U.S.-based employees through a defined contribution retirement plan.  Until April 12, 2018, theseThese benefits wereare offered under the ADP Total Source 401(k) plan (the “ADP Plan”). The ADP Plan was a defined 401(k) contribution plan, administered by a third party, that all U.S. employees, over the age of 21, were eligible to participate in after three months of employment. Under the ADP Plan, annual discretionary contributions could be made by the Company to match a portion of the funds contributed by employees. Effective April 12, 2018, all plan assets were transferred to the Insperity 401(k) plan (the “Insperity Plan”).  The Insperity Plan is a defined 401(k) contribution plan that all employees, over the age of 21, are eligible to participate in after three months of employment.  Under the Insperity Plan, the Company matches 100% of the first 2% of employee contributions. As of June 30, 2019,2022, there were 5572 employees who are enrolled in this plan.  The Company made matching contributions of approximately $107,000$123,000 and $34,000$111,000 during the years ended June 30, 20192022 and 2018,2021, respectively.

13.            
Lease Commitments

F-19

Table of Contents

12. Leases

The Company has operating leases for its manufacturing and office space.  AtAs of June 30, 2019,2021, the Company hashad two lease agreements for its corporate headquarters and manufacturing facilities in Orlando, Florida.  The first lease (the “Orlando Lease”) is forwas amended effective April 30, 2021 to expand the space from approximately 26,000 square feet has a seven-year originalto approximately 58,500 square feet.  The lease term with renewal options, and expires inwas extended from April 2022.30, 2022, to that certain date that is one hundred twenty-seven (127) months after the date the landlord completes certain work to be done at the leased premises.  The commencement date is expected to be November 1, 2022, subject to completion of the build-out.  Minimum rental rates for the extension term were established based on annual increases of two- and one-halfapproximately three percent starting in the third year of the extension period.(3%).  Additionally, there is one five-year extension option exercisable by the Company.  The minimum rental rates for such additional extension option will be determined at the time an option is exercised and will be based on a “fair market rental rate,” as determined in accordance with the Orlando Lease, as amended.

On April 20, 2018, the Company  The second lease was entered into a lease agreementin April 2018 for an additional 12,378 square feet in Orlando, Florida (the “Orlando Lease II”). The Orlando Lease II, which provides additional manufacturing and office space near the Company’s corporate headquarters. The commencement date of the Orlando Lease II was NovemberDecember 1, 2018, and it has a four-year original term with one renewal option for an additional five-year term.
The Company received a $420,000 tenant improvement allowance  In October 2021, this lease was amended to reduce the square footage to approximately 3,700.  This lease will expire in fiscal 2015 with respectNovember 2022 and will not be renewed, as this manufacturing and office space will be relocated to the Orlando Lease. In fiscal 2019, the Company received a tenant improvement allowance of $309,450 with respect toexpanded space included in the Orlando Lease, II. These amounts are included in the property and equipment and deferred rent on the Consolidated Balance Sheets. Amortization of tenant improvements was approximately $284,000 as of June 30, 2019. The deferred rent is being amortized as a reduction in lease expense over the terms of the respective leases.
amended.

As of June 30, 2019,2021, the Company, through its wholly-owned subsidiary, LPOI, hashad a lease agreement for an office facility in Shanghai, China (the “Shanghai Lease”) for 1,900 square feet.  The Shanghai Lease commenced in October 2015.  During fiscal 2019,2020, the Shanghai Lease was renewed for an additional one-yearthree-year term, and now expires in October 2019.

2022.  We do not expect to renew this lease.

As of June 30, 2019,2021, the Company, through its wholly-owned subsidiary, LPOIZ, hashad three lease agreements for manufacturing and office facilities in Zhenjiang, China for an aggregate of 55,000 square feet.  The initial lease (the “Zhenjiang Lease I”) is for approximately 26,000 square feet, and had a five-year original term with renewal options.  In fiscal year 2019, the Company renewed the Zhenjiang Lease I and it now expireswas set to expire in June 2022.  During fiscal year 2018, another lease was executed for 13,000 additional square feet in this same facility (the “Zhenjiang Lease II”).  The Zhenjiang Lease II has a 54-month term,In January 2022, these leases were combined and expires inextended to December 2021. During fiscal 2019, LPOIZ entered into another lease agreement for manufacturing space near the existing facility, for an additional 16,000 square feet (the “Zhenjiang Lease III”). The Zhenjiang Lease III has a three-year term and expires in April 2022.

31, 2024.

At June 30, 2019, the Company, through its wholly-owned subsidiary ISP, has a lease agreement for a manufacturing and office facility in Irvington, New York (the “ISP Lease”) for 13,000 square feet. The ISP Lease, which is for a five-year original term with renewal options, expires in September 2020. As of June 30, 2019, the relocation of the operations formerly housed in this facility is complete and we have ceased use of this facility. See Note 20, Restructuring, to these Consolidated Financial Statements for additional information.

At June 30, 2019,2021, the Company, through ISP’s wholly-owned subsidiary ISP Latvia, hashad two lease agreements for a manufacturing and office facility in Riga, Latvia (the “Riga Leases”) for an aggregate of 23,00029,000 square feet.  The first lease (“Riga Leases, each of whichLease I”) was amended in August 2020, to expand the space to approximately 24,000 square feet.  The lease term was extended from December 31, 2022 to December 31, 2025.  The second lease (“Riga Lease II”), for approximately 5,000 square feet, had a five-year original term with renewal options, wereand was set to expire in December 2019.  During fiscal 2019,In January 2022, these leases were extended to December 31, 2030.

The Company’s facility leases are classified as operating leases, and the Riga Leases were renewed,Company also has finance leases related to certain equipment located in Orlando, Florida.  The operating leases for facilities are non-cancelable, expiring through 2024 to 2032.  The Company includes options to renew (or terminate) in the lease term, and now expire in December 2022.

Asas part of June 30, 2019,the ROU assets and lease liabilities, when it is reasonably certain that the Company will exercise that option.  The Company currently has obligations under five capitaltwo finance lease agreements, entered into during fiscal years 2016, 2017, 2018 andyear 2019, with terms ranging from three to five years. The leases are for computer and manufacturing equipment,equipment.

The Company’s operating lease ROU assets and the related lease liabilities are initially measured at the present value of future lease payments over the lease term.  Two of our operating leases include renewal options, which were not included in the measurement of the operating lease ROU assets and related lease liabilities.  As most of the Company’s leases do not provide an implicit rate, the Company used its collateralized incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Currently, none of the Company’s leases include variable lease payments that are dependent on an index or rate. The Company is responsible for payment of certain real estate taxes, insurance and other expenses on certain of its leases. These amounts are generally considered to be variable and are not included in the measurement of the ROU asset and lease liability. The Company generally accounts for non-lease components, such as maintenance, separately from lease components.  The Company’s lease agreements do not contain any material residual value guarantees or material restricted covenants.  Leases with a term of 12 months or less are not recorded on the Consolidated Balance Sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.

The Company received tenant improvement allowances for the Orlando Lease and for Orlando Lease II.  These allowances were used to construct improvements and are included in leasehold improvements and operating lease liabilities.  The balances are being amortized over the corresponding lease terms.

F-20

Table of Contents

The components of lease expense were as partfollows:

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

Operating lease cost

 

$668,054

 

 

$682,980

 

Finance lease cost:

 

 

 

 

 

 

 

 

Depreciation of lease assets

 

 

162,057

 

 

 

207,931

 

Interest on lease liabilities

 

 

19,571

 

 

 

44,248

 

Total finance lease cost

 

 

181,628

 

 

 

252,179

 

Total lease cost

 

$849,682

 

 

$935,159

 

Supplemental balance sheet information related to leases was as follows:

 

 

Classification

 

June 30,

2022

 

 

June 30,

2021

 

Assets:

 

 

 

 

 

 

 

 

Operating lease assets

 

Operating lease assets

 

$10,420,604

 

 

$9,015,498

 

Finance lease assets

 

Property and equipment, net(1)

 

 

61,566

 

 

 

477,102

 

Total lease assets

 

 

 

$10,482,170

 

 

$9,492,600

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

 

 

 

Operating leases

 

Operating lease liabilities, current

 

$965,622

 

 

$799,507

 

Finance leases

 

Finance lease liabilities, current

 

 

55,348

 

 

 

212,212

 

 

 

 

 

 

 

 

 

 

 

 

Noncurrent:

 

 

 

 

 

 

 

 

 

 

Operating leases

 

Operating lease liabilities, less current portion

 

 

9,478,077

 

 

 

8,461,133

 

Finance leases

 

Finance lease liabilities, less current portion

 

 

11,454

 

 

 

66,801

 

Total lease liabilities

 

 

 

$10,510,501

 

 

$9,539,653

 

(1)

Finance lease assets are recorded net of accumulated depreciation of approximately $418,000 and $477,000 as of June 30, 2022 and 2021, respectively.

Lease term and discount rate information related to leases was as follows:

Lease Term and Discount Rate

June 30,

2022

Weighted Average Remaining Lease Term (in years)

Operating leases

10.1

Finance leases

0.9

Weighted Average Discount Rate

Operating leases

3.0%

Finance leases

7.6%

F-21

Table of Contents

Supplemental cash flow information:

 

 

Year Ended June 30,

 

 

 

2022

 

 

2021

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

Operating cash used for operating leases

 

$870,911

 

 

$869,668

 

Operating cash used for finance leases

 

$19,571

 

 

$44,247

 

Financing cash used for finance leases

 

$212,211

 

 

$278,462

 

Future maturities of property and equipment in the accompanying Consolidated Balance Sheets. Assets under capital lease include approximately $2.0 million and $1.5 million in manufacturing equipment, with accumulated amortization of approximately $900,000 and $646,000liabilities were as follows as of June 30, 2019 and 2018, respectively. Amortization related to assets under capital leases is included in depreciation expense.

F-20
Rent expense totaled $1.7 million and $1.0 million during the years ended June 30, 2019 and 2018, respectively. For the year ended June 30, 2019, this includes an accrual of $467,000 in future lease payments due pursuant to the ISP Lease, which facility the Company ceased use of as of June 30, 2019. See Note 20, Restructuring, to these Consolidated Financial Statements for additional information.
The approximate future minimum lease payments under capital and operating leases at June 30, 2019, including the aforementioned accrued but unpaid lease obligation for the ISP Lease, were as follows:
 
 
Capital Leases
 
 
Operating Leases
 
Fiscal year ending June 30,
 
 
 
 
 
 
2020
 $482,598 
 $1,093,000 
2021
  407,954 
  907,000 
2022
  231,783 
  777,000 
2023
  59,647 
  157,000 
Total minimum payments
  1,181,982 
 $2,934,000 
   Less imputed interest
  (137,274)
    
Present value of minimum lease payments included in capital lease obligations
  1,044,708 
    
Less current portion
  404,424 
    
Non-current portion
 $640,284 
    
14.            
Contingencies
The Company from time to time is involved in various legal actions arising in the normal course of business. Management, after reviewing with legal counsel all of these actions and proceedings, believes that the aggregate losses, if any, will not have a material adverse effect on the Company’s financial position or results of operations.
15.            
Foreign Operations
Assets and liabilities denominated in non-U.S. currencies are translated at rates of exchange prevailing on the balance sheet date, and revenues and expenses are translated at average rates of exchange for the period. Gains or losses on the translation of the financial statements of a non-U.S. operation, where the functional currency is other than the U.S. dollar, are reflected as a separate component of equity, which was a cumulative gain of approximately $809,000 and $474,000 as of June 30, 2019 and 2018, respectively. During the years ended June 30, 2019 and 2018, we also recognized a net foreign currency transaction loss of approximately $436,000 and a net foreign currency transaction gain of approximately $141,000, respectively, included in the Consolidated Statements of Comprehensive Income (Loss) in the line item entitled “Other income (expense), net.”
Assets and net assets in foreign countries are as follows:
China
Latvia
June 30, 2019
June 30, 2018
June 30, 2019
June 30, 2018
Assets
$16.9 million
$14.7 million
$8.2 million
$6.4 million
Net assets
$14.5 million
$12.6 million
$7.8 million
$5.9 million
16.            
Supplier and Customer Concentrations
The Company utilizes a number of glass compositions in manufacturing its molded glass aspheres and lens array products. These glasses or equivalents are available from a large number of suppliers, including CDGM Glass Company Ltd., Ohara Corporation, and Sumita Optical Glass, Inc. Base optical materials, used in certain of the Company’s specialty products, are manufactured and supplied by a number of optical and glass manufacturers. ISP utilizes major infrared material suppliers located around the globe for a broad spectrum of infrared crystal and glass. The Company believes that a satisfactory supply of such production materials will continue to be available, at reasonable prices or, in some cases, at increased prices, although there can be no assurance in this regard.
F-21
In fiscal 2019, sales to three customers comprised an aggregate of approximately 32% of the Company’s annual revenue, and 40% of accounts receivable as of June 30, 2019, with one customer at 17% of sales, another customer at 8% of sales, and the third customer at 7% of sales. In fiscal 2018, sales to three customers comprised an aggregate of approximately 28% of the Company’s annual revenue, and 28% of accounts receivable as of June 30, 2018, with one customer at 16% of sales, another customer at 7% of sales, and the third customer at 5% of sales. The loss of any of these customers, or a significant reduction in sales to any such customer, would adversely affect the Company’s revenues.
In fiscal 2019, 62% of the Company’s net revenue was derived from sales outside of the U.S., with 94% of foreign sales derived from customers in Europe and Asia. In fiscal 2018, 58% of the Company’s net revenue was derived from sales outside of the U.S., with 84% of foreign sales derived from customers in Europe and Asia.
17.            
Derivative Financial Instruments (Warrant Liability)
On June 11, 2012, the Company executed a Securities Purchase Agreement with respect to a private placement of an aggregate of 1,943,852 shares of its Class A common stock at $1.02 per share and the June 2012 Warrants to purchase up to 1,457,892 shares of its Class A common stock at an initial exercise price of $1.32 per share, which was subsequently reduced to $1.26, and then to $1.22 on December 21, 2016 as a result of our public offering. The June 2012 Warrants were exercisable for a period of five years beginning on December 11, 2012. The Company accounted for the June 2012 Warrants issued to investors in accordance with ASC 815-10. ASC 815-10 provides guidance for determining whether an equity-linked financial instrument (or embedded feature) is indexed to an entity’s own stock. This applies to any freestanding financial instrument or embedded feature that has all the characteristics of a derivative under ASC 815-10, including any freestanding financial instrument that is potentially settled in an entity’s own stock.
Due to certain adjustments that could be made to the exercise price of the June 2012 Warrants if the Company issued or sold shares of its Class A common stock at a price that was less than the then-current warrant exercise price, the June 2012 Warrants have been classified as a liability, as opposed to equity, in accordance with ASC 815-10, as it was determined that the June 2012 Warrants were not indexed to the Company’s Class A common stock.
The fair value of the outstanding June 2012 Warrants was re-measured at the end of each reporting period to reflect the then-current fair market value. The fair value was also re-measured upon each warrant exercise, to determine the fair value adjustment to the warrant liability related to the warrant exercise. The June 2012 Warrants expired on December 11, 2017. All warrants that required fair value re-measurement were exercised prior to expiration, and, as such, the warrant liability was reduced to zero as of that date. The change in fair value of the June 2012 Warrants is recorded in the Consolidated Statements of Comprehensive Income (Loss), as estimated using the Lattice option-pricing model using the following range of assumptions for the year ended June 30, 2018:
Year Ended
June 30, 2018
Inputs into Lattice model for warrants:
Equivalent volatility21.06% - 162.92%
Equivalent interest rate0.95% - 1.14%
Floor$1.15
Stock price $2.56 - $2.60
Probability price < strike price0.00%
Fair value of call$1.13 - $2.79
Probability of fundamental transaction occurring0%
The warrant liabilities were considered recurring Level 3 financial instruments. The following table summarizes the activity of Level 3 financial instruments measured on a recurring basis for the year ended June 30, 2018:
Warrant Liability
Fair value, June 30, 2017
490,500
Reclassification of warrant liability upon exercise
(685,132)
Change in fair value of warrant liability
194,632
Fair value, June 30, 2018
$-
All warrants issued by the Company other than the above noted June 2012 Warrants were classified as equity. There were no outstanding warrants as of June 30, 2019 or 2018.
F-22
18.            
2022:

Fiscal year ending:

 

Finance

Leases

 

 

Operating

Leases

 

June 30, 2023

 

 

59,647

 

 

$721,901

 

June 30, 2024

 

 

11,811

 

 

 

1,204,323

 

June 30, 2025

 

 

 

 

 

1,225,047

 

June 30, 2026

 

 

 

 

 

1,193,987

 

June 30, 2027

 

 

 

 

 

1,163,610

 

Thereafter

 

 

 

 

 

6,928,833

 

Total future minimum payments

 

 

71,458

 

 

 

12,437,701

 

Less imputed interest

 

 

(4,656)

 

 

(1,994,002)

Present value of lease liabilities

 

$66,802

 

 

$10,443,699

 

13. Loans Payable

Avidbank Loan
Until February 26, 2019, the Company was party to the Second Amended and Restated Loan and Security Agreement (the “LSA”) entered into on December 21, 2016 with Avidbank Corporate Finance, a division of Avidbank (“Avidbank”), as amended by the First Amendment to the LSA dated December 20, 2017 (the “First Amendment”), the Second Amendment to the LSA dated January 16, 2018 (the “Second Amendment”), the Third Amendment to the LSA dated May 11, 2018 (the “Third Amendment”), the Fourth Amendment to the LSA dated September 7, 2018 (the “Fourth Amendment”), and the Fifth Amendment to the LSA dated October 30, 2018 (the “Fifth Amendment” and, together with the LSA, First Amendment, the Second Amendment, the Third Amendment, and the Fourth Amendment, the “Amended LSA”). The Amended LSA provided for an acquisition term loan in the original principal amount of $5,000,000 (the “Term I Loan”). Pursuant to the Second Amendment, Avidbank paid a single cash advance to the Company in an original principal amount of $7,294,000 (the “Term II Loan”), the proceeds of which were used to repay all amounts owing with respect to the Term Loan, which was approximately $4.4 million, with the remaining $2.9 million in proceeds used to repay the amounts owing under the note payable to the sellers (the “Sellers”) of ISP (the “Sellers Note”). The Term II Loan was for a five-year term, and bore interest at a per annum rate equal to two percent (2.0%) above the Prime Rate; provided, however, that at no time would the applicable rate be less than five-and-one-half percent (5.50%) per annum.
The Amended LSA also provided for a working capital revolving line of credit (the “Revolving Line”). Pursuant to the Amended LSA, Avidbank agreed to, in its discretion, make loan advances under the Revolving Line to the Company up to a maximum aggregate principal amount outstanding not to exceed the lesser of (i) One Million Dollars ($1,000,000), or (ii) eighty percent (80%) (the “Maximum Advance Rate”) of the aggregate balance of the Company’s eligible accounts receivable, as determined by Avidbank in accordance with the Amended LSA. Amounts borrowed under the Revolving Line could be repaid and re-borrowed at any time prior to the Revolving Maturity Date (as defined below), at which time all amounts would be immediately due and payable. There were no borrowings under the Revolving Line during the year ended June 30, 2019. As of February 26, 2019, the date on which the Company terminated the Amended LSA, there was no outstanding balance under the Revolving Line.
The Company’s obligations under the Amended LSA were collateralized by a first priority security interest (subject to permitted liens) in cash, U.S. inventory, accounts receivable and equipment. In addition, the Company’s wholly-owned subsidiary, Geltech, Inc., guaranteed the Company’s obligations under the Amended LSA.
The Amended LSA contained customary covenants, including, but not limited to: (i) limitations on the disposition of property; (ii) limitations on changing the Company’s business or permitting a change in control; (iii) limitations on additional indebtedness or encumbrances; (iv) restrictions on distributions; (v) limitations on certain investments; and (vi) limitations on the amount of cash held in financial institutions in Latvia. Additionally, the Amended LSA required the Company to maintain a fixed charge coverage ratio (as defined in the Amended LSA) of at least 1.15 to 1.00 and an asset coverage ratio (as defined in the Amended LSA) of at least 1.50 to 1.00.
The Third Amendment (i) amended the definition of “Permitted Indebtedness” and (ii) amended Section 6.8(a) of the Amended LSA to require that the Company, and each of its domestic subsidiaries, maintain all of its domestic depository and operating accounts with Avidbank beginning on June 1, 2018, and to prohibit the Company from maintaining a domestic account balance outside of Avidbank that exceeds Ten Thousand Dollars ($10,000) during the transition period. The Third Amendment also amended Section 6.9(a) of the Amended LSA to require that the Company maintain a fixed charge coverage ratio, as measured on June 30, 2018, of at least 1.10 to 1.00 and, thereafter, beginning with the quarter ended September 30, 2018, to maintain a fixed charge coverage ratio of at least 1.15 to 1.00. Additionally, pursuant to the Third Amendment, Avidbank granted the Company a waiver of default arising prior to the Third Amendment from its failure to comply with the fixed charge coverage ratio measured on March 31, 2018.
Pursuant to the Fourth Amendment, Avidbank granted the Company a waiver of default arising prior to the Fourth Amendment from its failure to comply with the fixed charge coverage ratio covenant measured on June 30, 2018. Based on the waiver, the Company was no longer in default on the Term II Loan or the Revolving Line. The Fourth Amendment also provided for the restriction of $1 million of the Company’s cash, which would be released upon two consecutive quarters of compliance with the fixed charge coverage ratio covenant, and so long as no event of default has occurred that is continuing on that date. The Fourth Amendment also provided that during the restrictive period, the calculation of the fixed charge coverage ratio would be determined as if the outstanding principal amount of the Term II Loan was $1 million less than the actual outstanding principal amount of the Term II Loan.
On October 30, 2018, the Company entered into the Fifth Amendment, which amended the definition of “Adjusted EBITDA” to allow for the addback of certain one-time expenses for purposes of determining the fixed charge coverage ratio and compliance with the related covenant. The Fifth Amendment also extended the maturity date of the Revolving Line from December 21, 2018 to March 21, 2019. As discussed in more detail below, on February 26, 2019, the Company entered into the Loan Agreement (as defined below) with

BankUnited N.A. (“BankUnited”), and used the proceeds from the BankUnited Term Loan (as defined below) to pay in full, all outstanding amounts owed pursuant to the Term II Loan. Accordingly, as of June 30, 2019, there was no outstanding balance under the Term II Loan.

F-23
BankUnited Loan
Loans

On February 26, 2019, the Company entered into a Loan Agreement (the “Loan Agreement”) with BankUnited for (i) a revolving line of credit up to maximum amount of $2,000,000 (the “BankUnited Revolving Line”), (ii) a term loan in the amount of up to $5,813,500 (“BankUnited Term Loan”), and (iii) a non-revolving guidance line of credit up to a maximum amount of $10,000,000 (the “Guidance Line” and, together with the BankUnited Revolving Line and BankUnited Term Loan, the “BankUnited Loans”).  Each of the BankUnited Loans is evidenced by a promissory note in favor of BankUnited (the “BankUnited Notes”).

On May 6, 2019, the Company entered into that certain First Amendment to Loan Agreement, effective February 26, 2019, with BankUnited (the “Amendment” and, together with the Loan Agreement, the “Amended Loan Agreement”).  The Amendment amended the definition of the fixed charge coverage ratio to more accurately reflect the parties’ understandings at the time the Loan Agreement was executed.

  On September 9, 2021, the Company entered into a letter agreement with BankUnited (the “Letter Agreement”).  The Letter Agreement:  (i) reduces the fixed charge coverage ratio to 1.0 for the quarter ending September 30, 2021 and to 1.1 for the quarter ended December 31, 2021; (ii) modifies the calculation for both the fixed charge coverage ratio and the total leverage ratio to provide for adjustments related to expenses incurred in connection with the events at LPOI and LPOIZ, which expenses must be approved by BankUnited; (iii) terminates the Guidance Line; and (iv) requires approval from BankUnited prior to our being able to draw upon the Revolving Line, subject to our compliance with the fixed charge coverage ratio for the quarters ending September 30, 2021 and December 31, 2021.  The Letter Agreement also granted the Company a waiver of default arising prior to the Letter Agreement for its failure to comply with the fixed charge coverage ratio measured on June 30, 2021.  Based on the waiver, the Company was no longer in default of the Amended Loan Agreement.  Finally, in connection with the Letter Agreement, the Company paid BankUnited a fee equal to $10,000.

On November 5, 2021, the Company entered into a letter agreement with BankUnited (the “Second Letter Agreement”). In accordance with the Second Letter Agreement, the parties agreed to initiate discussions regarding a possible modification, forbearance, or other resolution of the Amended Loan Agreement (as defined below), which resolution would occur on or before December 31, 2021. On December 20, 2021, the Company entered into the Second Amendment to the Loan Agreement dated February 26, 2019 (the “Second Amendment”), which further amended the Loan Agreement with BankUnited. In accordance with the Second Amendment, the parties agreed to the following terms, among others: (i) a maturity date of April 15, 2023 with respect to the Term Loan (as defined in the Amended Loan Agreement); (ii) an increased monthly payment amount of $100,000 commencing on November 1, 2022; (iii) beginning on December 20, 2021, each facility will bear interest at BankUnited’s then-prime rate of interest minus fifty (50) basis points (4.25% as of June 30, 2022), as adjusted from time to time, (iv) the Term Loan will bear a higher interest rate commencing on August 1, 2022; (v) an exit fee equal to 4% of the outstanding principal balance of the Term Loan on April 15, 2023 (to the extent the Term Loan is still outstanding on such date and has not been refinanced with another lender); and (vi) a fee of $50,000 payable upon execution of the Second Amendment. The Second Amendment also granted us a waiver of compliance for the Financial Covenants (as set forth in the Amended Loan Agreement) for the periods ended December 31, 2021, March 31, 2022 and June 30, 2022.

F-22

Table of Contents

On May 11, 2022, the Company entered into the Third Amendment to the Loan Agreement dated February 26, 2019 (the “Third Amendment”; and, together with the First Amendment, the Letter Agreement and the Second Letter Agreement, the “Amended Loan Agreement”), which further amended the Loan Agreement with BankUnited. In accordance with the Third Amendment, the parties agreed to the following terms, among others: (i) an amended maturity date of April 15, 2024 with respect to the Term Loan (as defined in the Amended Loan Agreement); and (ii) an amended exit fee equal to (a) 2% of the outstanding principal balance of the Term Loan on September 30, 2022, (b) 1% of the outstanding principal balance on December 31, 2022, (c) 1% of the outstanding principal balance on March 31, 2023, and (d) 4% of the outstanding principal balance on April 15, 2024 (to the extent the Term Loan is still outstanding on the respective dates and has not been refinanced with another lender).

BankUnited Revolving Line

Pursuant to the Amended Loan Agreement, BankUnited willagreed to make loan advances to the Company under the BankUnited Revolving Line to the Company up to a maximum aggregate principal amount outstanding not to exceed $2,000,000, which proceeds will becould have been used for working capital and general corporate purposes. Amounts borrowedThe BankUnited Revolving Line expired on February 26, 2022.  No amounts were outstanding under the BankUnited Revolving Line may be repaid and re-borrowed at any time prior toas of June 30, 2021 or February 26, 2022, at which time all amounts will be immediately due and payable.  The advances under the BankUnited Revolving Line bear interest, on the outstanding daily balance, at a per annum rate equal to 2.75% above the 30-day LIBOR.  Interest payments are due and payable, in arrears, on the first day of each month.  

2022.

BankUnited Term Loan

Pursuant to the Amended Loan Agreement, BankUnited advanced the Company $5,813,500 to satisfy in full the amounts owed to Avidbank including the Term II Loan, and to pay the fees and expenses incurred in connection with closing of the BankUnited Loans.  The BankUnited Term Loan is for a 5-year term, but co-terminus with the BankUnited Revolving Line. TheLine should the BankUnited Revolving Line not be renewed beyond February 26, 2022.  Management expects the BankUnited Revolving Line to be renewed.  Pursuant to the Second Amendment, the maturity date of the Term Loan bearswas April 15, 2023, and pursuant to the Third Amendment, the maturity date of the Term Loan is April 15, 2024. The Term Loan initially bore interest at a per annum rate equal to 2.75% above the 30-day LIBOR. However, pursuant to the Second Amendment, beginning on December 20, 2021, each facility bears interest at BankUnited’s then-prime rate of interest minus fifty (50) basis points (4.25% as of June 30, 2022), as adjusted from time to time.  Equal monthly principal payments of $48,445.83,approximately $48,446, plus accrued interest, are due and payable, in arrears, on the first day of each month during the term.  Pursuant to the Second Amendment, the monthly payment, including principal and interest, will increase to $100,000, commencing November 1, 2022. Upon maturity, all principal and interest shall be immediately due and payable.  As of June 30, 2019,2022, the applicable interest rate on the BankUnited Term Loan was 5.19%4.25%.

Guidance Line

Pursuant to the

The Amended Loan Agreement provided BankUnited, in its sole discretion, maycould make loan advances to the Company under the Guidance Line up to a maximum aggregate principal amount outstanding not to exceed $10,000,000, which proceeds will becould have been used for capital expenditures and approved business acquisitions.  Such advances must beThe Guidance Line terminated on September 9, 2022 in minimumaccordance with the Letter Agreement.  There were no amounts of $1,000,000 for acquisitions and $500,000 for capital expenditures, and will be limited to 80% of cost or as otherwise determined by BankUnited. Amounts borrowedoutstanding under the Guidance Line may not re-borrowed. The advances under the Guidance Line bear interest,at June 30, 2021 or on the outstanding daily balance, at a per annum rate equal to 2.75% above the 30-day LIBOR.  Interest payments are due and payable, in arrears, on the first day of each month. On each anniversary of the Amended Loan Agreement, monthly principal payments become payable, amortized based on a ten-year term.

September 9, 2022.

Security and Guarantees

The Company’s obligations under the Amended Loan Agreement are collateralized by a first priority security interest (subject to permitted liens) in all of its assets and the assets of the Company’s U.S. subsidiaries, GelTech, and ISP, pursuant to a Security Agreement granted by GelTech, ISP, and the Company in favor of BankUnited.  The Company’s equity interests in, and the assets of, its foreign subsidiaries are excluded from the security interest.  In addition, all of the Company’s subsidiaries have guaranteed the Company’s obligations under the Amended Loan Agreement and related documents, pursuant to Guaranty Agreements executed by the Company and its subsidiaries in favor of BankUnited.

F-23

Table of Contents

General Terms

The Amended Loan Agreement contains customary covenants, including, but not limited to: (i) limitations on the disposition of property; (ii) limitations on changing the Company’s business or permitting a change in control; (iii) limitations on additional indebtedness or encumbrances; (iv) restrictions on distributions; and (v) limitations on certain investments.  The Amended Loan Agreement also contains certain financial covenants, including obligations to maintain a fixed charge coverage ratio of 1.25 to 1.00 and a total leverage ratio of 4.00 to 1.00.  The Letter Agreement granted the Company a waiver of default arising prior to the Letter Agreement from its failure to comply with the fixed charge coverage ratio measured on June 30, 2021.  The Second Amendment to the Amended Loan Agreement granted us a waiver of compliance for the Financial Covenants (as set forth in the Amended Loan Agreement) through June 30, 2022.  Based on the waivers, the Company is no longer in default of the Amended Loan Agreement.  As of June 30, 2019,2022, the Company was in compliance with all requiredother covenants.

F-24

We may prepay any or all of the BankUnited Loans in whole or in part at any time, without penalty or premium.premium other than the exit fees, as discussed above. Late payments are subject to a late fee equal to five percent (5%) of the unpaid amount.  Amounts outstanding during an event of default accrue interest at a rate of five percent (5%) above the 30-day LIBOR applicable immediately prior to the occurrence of the event of default.  The Amended Loan Agreement contains other customary provisions with respect to events of default, expense reimbursement, and confidentiality.

Financing costs incurredrelated to the BankUnited Loans were recorded as a discount on debt and will beare being amortized over the term.  Amortization of approximately $117,000$52,000 and $13,700 is included in interest expense$19,000 for each the years ended June 30, 20192022 and 2018, respectively. For2021, respectively, is included in interest expense.

Equipment Loan

In December 2020, ISP Latvia entered into an equipment loan with a third party (the “Equipment Loan”), which party is also a significant customer, and which the year ended June 30, 2019, this includes approximately $94,000 of previously unamortized financing costs relatedEquipment Loan is subordinate to the Term IIBankUnited Loans, and collateralized by certain equipment. The initial advance under the Equipment Loan was 225,000 EUR (or USD $275,000), payable in equal installments over 60 months, the proceeds of which were expensed asused to make a prepayment to a vendor for equipment to be delivered at a future date.  The Equipment Loan bears interest at a fixed rate of February 26, 2019 when this note3.3%. An additional 225,000 EUR (or USD $267,000) was drawn in September 2021, which proceeds were paid to the vendor for the equipment, payable in full.

equal installments over 52 months.

Future maturities of loans payable are as follows:

 
 
BankUnited Term Loan
 
 
Unamortized Debt Costs
 
 
Total
 
Fiscal year ending:
 
 
 
 
 
 
 
 
 
June 30, 2020
 $581,350 
 $(17,334)
 $564,016 
June 30, 2021
  581,350 
  (17,334)
  564,016 
June 30, 2022
  581,350 
  (17,334)
  564,016 
June 30, 2023
  581,350 
  (17,334)
  564,016 
June 30, 2024
  3,342,763 
  (17,334)
  3,325,429 
Total payments
 $5,668,163 
 $(86,670)
 $5,581,493 
Less current portion
    
    
  (581,350)
Non-current portion
    
    
 $5,000,143 
19.            
Note Satisfaction

 

 

BankUnited

Term Loan

 

 

Equipment

Loan

 

 

Unamortized

Debt Costs

 

 

Total

 

Fiscal year ending:

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2023

 

$896,758

 

 

$103,005

 

 

 

(58,775)

 

$940,988

 

June 30, 2024

 

 

3,027,355

 

 

 

103,005

 

 

 

 

 

 

3,130,360

 

June 30, 2025

 

 

 

 

 

103,005

 

 

 

 

 

 

103,005

 

June 30, 2026

 

 

 

 

 

42,919

 

 

 

 

 

 

42,919

 

After June 30, 2026

 

 

 

 

 

 

 

 

 

 

 

 

Total payments

 

$3,924,113

 

 

$351,934

 

 

$(58,775)

 

 

4,217,272

 

Less current portion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(998,692)

Non-current portion

 

 

 

 

 

 

 

 

 

 

 

 

 

$3,218,580

 

Liquidity

The Company generally relies on cash from operations and Securities Purchase Agreement

Note Satisfactionequity offerings, and Securities Purchase Agreement
On January 16, 2018 (the “Satisfaction Date”),commercial debt, to the extent available, to satisfy its liquidity needs and to meet its payment obligations, including payments due under the BankUnited Term Loan.  The Company has commenced discussions with other lenders, and anticipates refinancing its debt obligations with a new lender prior to the maturity date of the Term Loan, of which there can be no assurances. If the Company entered into a Note Satisfactionis unable to refinance the credit facility with other commercial lenders prior to maturity, it may need to raise additional equity financing, source financing through non-commercial lenders or further reduce certain operating expenses and Securities Purchase Agreement (the “Note Satisfaction Agreement”) withcapital expenditures in order to repay the Sellers with respect to the Sellers Note. At the closing of the acquisition of ISP, as partial consideration for the shares of ISP,credit facility and all charges related thereto upon its maturity on April 14, 2024. In February 2022, the Company issuedfiled a shelf registration statement to facilitate the Sellers Note in the original principal amountissuance of $6,000,000, which principal payment amount was subsequently reduced to $5.7 million, after applying a working capital adjustment equal to approximately $293,000.
Pursuant to the Note Satisfaction Agreement, the Company and the Sellers agreed to satisfy the Sellers Note in full by (i) converting 39.5% of the outstanding principal amount of the Sellers Note into shares of the Company’sits Class A common stock, and (ii) paying the remaining 60.5%warrants exercisable for shares of the outstanding principal amount of the Sellers Note, plus all accrued but unpaid interest, in cash to the Sellers. As of the Satisfaction Date, the outstanding principal amount of the Sellers Note was $5,707,183, and there was $20,883 in accrued but unpaid interest thereon (collectively, the “Note Satisfaction Amount”). Accordingly, the Company paid approximately $3,453,582, plus all accrued but unpaid interest on the Sellers Note, in cash (the “Cash Payment”) and issued 967,208 shares ofits Class A common stock, (the “Shares”), which representsand/or units up to an aggregate offering price of $75.8 million from time to time. In connection with the balancefiling of the Note Satisfaction Amount divided byshelf registration statement, the Conversion Price. The “Conversion Price” equaled $2.33, representingCompany also included a prospectus supplement relating to an at-the-market equity program under which the average closing bid priceCompany may issue and sell shares of theits Class A common stock as reported by Bloomberg forup to an aggregate offering price of $25.2 million from time to time, decreasing the five (5) trading days preceding the Satisfaction Date. The Cash Payment was paid using approximately $600,000 of cash on hand and approximately $2.9 million in proceeds from the Term II Loan from Avidbank. As of the Satisfaction Date, the Sellers Note was deemed satisfied in full and terminated.
The Shares issued to the Sellers were exempt from the registration requirements of the Securities Act of 1933, as amended (the “Act”), pursuant to Section 4(a)(2) of the Act (in that the Shares were issued by us in a transaction not involving any public offering), and pursuant to Rule 506 of Regulation D as promulgated by the SECaggregate offering price available under the Act.
Registration Rights Agreement
In connection with the Note Satisfaction Agreement, the Company and the Sellers also entered into a Registration Rights Agreement dated January 16, 2018, pursuant to which the Company agreed to file with the Securities and Exchange Commission by February 15, 2018, and to cause to be declared effective, aits shelf registration statement to register the resale of the Shares issued to partially pay the Note Satisfaction Amount.$50.6 million. The Registration Statement on Form S-3 (File No. 333-223028)shelf registration statement was declared effective by the SEC on March 8, 2018.
F-25
20. Restructuring
1, 2022.  The Company has not issued any shares of its Class A common stock pursuant to the at-the-market equity program.

F-24

Table of Contents

There are a number of factors that could result in the need to raise additional funds, including a decline in revenue or a lack of anticipated sales growth, increased material costs, increased labor costs, planned production efficiency improvements not being realized, increases in property, casualty, benefit and liability insurance premiums, and increases in other costs. In July 2018,addition, greater than 50% of the Company’s cash and cash equivalents is held by its foreign subsidiaries and, although the Company regularly repatriates cash, it may not be readily available to repay its liabilities in the U.S.  The Company will also continue efforts to keep costs under control as it seeks renewed sales growth. The Company’s efforts are directed toward generating positive cash flow and profitability.  If these efforts are not successful, the Company may need to raise additional capital. Should capital not be available to the Company at reasonable terms, other actions may become necessary in addition to cost control measures and continued efforts to increase sales. These actions may include exploring strategic options for the sale of the Company, the sale of certain product lines, the creation of joint ventures or strategic alliances under which we announcedwill pursue business opportunities, the relocationcreation of licensing arrangements with respect to our technology, or other alternatives.

14. Contingencies

Legal

The Company from time to time is involved in various legal actions arising in the normal course of business.  Management, after reviewing with legal counsel all of these actions and consolidationproceedings, believes that the aggregate losses, if any, will not have a material adverse effect on the Company’s financial position or results of ISP’s New York facility (the “Irvington Facility”) intooperations.

In April 2021, the Company terminated several employees of its China subsidiaries, LPOIZ and LPOI, including the General Manager, the Sales Manager, and the Engineering Manager, after determining that they had engaged in malfeasance and conduct adverse to our existing facilities in Orlando, Florida and Riga, Latvia. We record charges for restructuringinterests, including efforts to misappropriate certain of our proprietary technology, diverting sales to entities owned or controlled by these former employees and other exit activities relatedsuspected acts of fraud, theft and embezzlement.  In connection with such terminations, the Company’s China subsidiaries have engaged in certain legal proceedings with the terminated employees.

The Company has incurred various expenses associated with its investigation into these matters prior and subsequent to the closure or relocationtermination of business activities at fair value, when incurred. Such charges include termination benefits, contract termination costs,the employees and costs to consolidate facilities or relocate employees. Forthe associated legal proceedings.  These expenses, which included legal, consulting and other transitional management fees, totaled $718,000 during the year ended June 30, 2019, we2021.  During the year ended June 30, 2022, approximately $400,000 of related expenses were incurred.  Such expenses were recorded approximately $1.2 million in expenses related to the relocation of the Irvington Facility. These charges are included as a component of the “Selling, general and administrative” expenses line item in ourthe accompanying Consolidated Statements of Comprehensive Income (Loss). 

The Company also identified a further liability in the amount of $210,000, which may be incurred in the future due to the actions of these employees.  This amount has been accrued as of June 30, 2021, pending further investigation, and included in “Other Expense, net” in the accompanying Consolidated Statement of Comprehensive Income (Loss).  These charges includeDuring fiscal 2022 it was determined that LPOIZ would not be responsible for this amount, and the accrual was reversed with the benefit included in “Other income (expense), net” in the accompanying Consolidated Statement of Comprehensive Income (Loss) for the year ended June 30, 2022.

Knowing that employee transitions in international subsidiaries can lead to lengthy legal proceedings that can interrupt the subsidiary’s ability to operate, compounded by the fact that our officers could not travel to China to oversee the transitions because of the travel restrictions imposed by COVID-19, the Company chose to enter into severance agreements with certain of the employees at the time of termination.  Pursuant to the severance agreements, LPOIZ and LPOI agreed to pay such employees severance of approximately $467,000 for our remaining obligation under$485,000 in the Irvington Lease until its expirationaggregate, to be paid over a six-month period.  After the execution of the severance agreements, we discovered additional wrongdoing by the terminated employees.  As a result, LPOIZ and LPOI have not yet paid the severance payments and have disputed the employees’ rights to such payments.  However, based on the likelihood that the courts in September 2020, asChina will determine that the Company’s subsidiaries will ultimately be obligated to pay these amounts, we have ceased use of this facility. Amounts accrued and included in our Consolidated Balance Sheetfor these payments as of June 30, 2019 related2021.  Such expenses were recorded as “Selling, general and administrative” expenses in the accompanying Consolidated Statement of Comprehensive Income (Loss) for the year ended June 30, 2021.  As of June 30, 2022, approximately $430,000 remains accrued; legal action is ongoing and our obligation to this activity are comprisedpay these amounts has been awarded to the former employees by the Chinese Labor Court.  We continue to seek legal options.

The Company has transitioned the management of LPOI and LPOIZ to a new management team without any significant detrimental effects on the ability of those subsidiaries to operate.  Management does not expect any material adverse impact to the business operations of LPOI or LPOIZ as a result of the remaining lease obligationtransition.

F-25

Table of Contents

The Company expects to incur additional legal fees and consulting expenses in future periods as all legal options and remedies are pursued; however, such future fees are expected to be at lower levels than have been incurred to date.

Although the Company has taken steps to minimize the business impacts from the termination of the management employees and transition to new management personnel, the Company experienced some short-term adverse impacts on LPOIZ’s and LPOI’s domestic sales in China and results of operations in the three-month period ended June 30, 2021, which continued throughout fiscal year 2022.  The Company has not experienced, nor does management anticipate, any material adverse impact on LPOIZ’s or LPOI’s production and supply of products to its other subsidiaries for their customers.

COVID-19

The Company’s business, results of operations financial condition, cash flows, and the stock price of its Class A common stock can be adversely affected by pandemics, epidemics, or other public health emergencies, such as the recent outbreak of the coronavirus (“COVID-19”), which has spread from China to many other countries across the world, including the United States.  In March 2020, the World Health Organization (the “WHO”) declared COVID-19 as a pandemic.  The COVID-19 pandemic has resulted in governments around the world implementing increasingly stringent measures to help control the spread of the virus, including “stay at home” orders, travel restrictions, business curtailments, school closures, and other measures.

To date, the Company has not experienced any significant direct financial impact of COVID-19 to its business.  However, the COVID-19 pandemic continues to impact economic conditions, which could impact the short-term and long-term demand from customers and, therefore, has the potential to negatively impact the Company’s results of operations, cash flows, and financial position in the future.  Management is actively monitoring this situation and any impact on our financial condition, liquidity, and results of operations.  However, given the daily evolution of the COVID-19 pandemic and the global responses to curb its spread, we are not presently able to estimate the effects of the COVID-19 pandemic on our future results of operations, financial, or liquidity in fiscal year 2023 or beyond.

Impact of Russian-Ukraine Conflict

In February 2022, Russian military forces invaded Ukraine.  This conflict has resulted in significant economic disruption and continues to adversely impact the broader global economy, including certain of our customers and suppliers.  Given the dynamic nature of this situation, the Company cannot reasonably estimate the impact of the Russian-Ukraine conflict on its financial condition, results of operations or cash flows into the foreseeable future. 

15. Foreign Operations

Assets and liabilities denominated in non-U.S. currencies are translated at rates of exchange prevailing on the balance sheet date, and revenues and expenses are translated at average rates of exchange for the period.  Gains or losses on the translation of the financial statements of a non-U.S. operation, where the functional currency is other than the U.S. dollar, are reflected as a separate component of equity, which was a cumulative gain of approximately $467,000,$935,000 and $2.1 million as of June 30, 2022 and 2021, respectively.  During the years ended June 30, 2022 and 2021, we also recognized net foreign currency transaction losses of approximately $3,000 and $1,000, respectively, included in “Deferred rent”the Consolidated Statements of Comprehensive Income (Loss) in the line item entitled “Other income (expense), net.” 

Assets and net assets in foreign countries are as follows:

China

Latvia

June 30,

2022

June 30,

2021

June 30,

2022

June 30,

2021

Assets

 $19.6 million

 $20.1 million

 $12.7 million

 $11.3 million

Net assets

 $15.7 million

 $16.6 million

 $10.0 million

 $9.0 million

16. Supplier and Customer Concentrations

The Company utilizes a number of glass compositions in manufacturing its molded glass aspheres and lens array products.  These glasses or equivalents are available from a large number of suppliers, including CDGM Glass Company Ltd., Ohara Corporation, and Sumita Optical Glass, Inc.  Base optical materials, used in certain of the Company’s specialty products, are manufactured and supplied by a number of optical and glass manufacturers. The Company also utilizes major infrared material suppliers located around the globe for a broad spectrum of infrared crystal and glass.  The Company believes that a satisfactory supply of such production materials will continue to be available, however, at higher, inflationary prices largely due to the war in the Ukraine, although there can be no assurance in this regard.

In fiscal year 2022, the Company had sales to three customers that comprised an aggregate of approximately 35% of its annual revenue, and 13% of its June 30, 2022 accounts receivable.  Sales to these customers as a percentage of our fiscal year 2022 revenue include one customer at 19%, another customer at 9%, and the third customer at 7%.  One of these customers comprised 7% of accounts receivable, a second customer comprised 6% of accounts receivable and the other customer had no accounts receivable balance as of June 30, 2022.  In fiscal year 2021, the Company had sales to three customers that comprised an aggregate of approximately $246,00038% of termination benefitsits annual revenue, and 31% of its June 30, 2021 accounts receivable.  Sales to these customers as a percentage of our fiscal year 2021 revenue include one customer at 18%, another customer at 10%, and the third customer at 10%.  One of these customers comprised 21% of accounts receivable, a second customer comprised 10% of accounts receivable and the other cost, includedcustomer had no accounts receivable balance as of June 30, 2021.  The loss of any of these customers, or a significant reduction in “Accrued payrollsales to any such customer, would adversely affect the Company’s revenues.

In fiscal year 2022, 61% of the Company’s net revenue was derived from sales outside of the U.S., with 95% of foreign sales derived from customers in Europe and benefits.”

Asia.  In fiscal year 2021, 68% of the Company’s net revenue was derived from sales outside of the U.S., with 95% of foreign sales derived from customers in Europe and Asia.

End of Consolidated Financial Statements

F-26
SIGNATURES

F-26

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

LIGHTPATH TECHNOLOGIES, INC.

Date:  September 14, 2019

15, 2022


By:

/s/ J. James GaynorShmuel Rubin

J. James Gaynor

Shmuel Rubin

President & Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

/s/ SHMUEL RUBIN

September 15, 2022

/s/ ALBERT MIRANDA

September 15, 2022

/s/   J.  JAMES GAYNOR
J. James Gaynor

Shmuel Rubin

President & Chief Executive Officer (Principal

(Principal Executive Officer)

September 11, 2019

/s/ DONALD O. RETREAGE, Jr.
Donald O. Retreage, Jr.

Albert Miranda

Chief Financial Officer

(Principal Financial Officer)

/s/ LOUIS LEEBURG

September 11, 20192022

/s/ SOHAIL KHAN

September 11, 2022

/s/  ROBERT RIPP
Robert Ripp

Louis Leeburg

Director (Chairman of the Board)

September 6, 2019

/s/    SOHAIL KHAN

Sohail Khan

Director

September 11, 2019

/s/  DR. STEVEN R. J. BRUECK
Dr. Steven R. J. Brueck
Director
September 4, 2019
/s/    LOUIS LEEBURG
Louis Leeburg
Director
September 3, 2019

/s/ M. SCOTT FARIS

M. Scott Faris
Director

September 3, 201914, 2022

/s/ JOSEPH MENAKER

Joseph Menaker
Director

September 4, 201912, 2022


M. Scott Faris

Director

Joseph Menaker

Director

/s/ CRAIG DUNHAM

September 11, 2022

/s/ DARCIE PECK

September 13, 2022

Craig Dunham

Director

Darcie Peck

Director

/s/ S. ERIC CREVISTON

September 12, 2022

S. Eric Creviston

Director

 

S-1

/s/ CRAIG DUNHAM
Craig Dunham
Director

September 10, 2019  

S-1